S. Agnihotri, K. E. Burrell, A. Wolf, S. Jalali, C. Hawkins et al., Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies, Arch Immunol Ther Exp (Warsz), vol.61, issue.1, pp.25-41, 2013.

T. T. Amatruda, D. A. Steele, V. Z. Slepak, and M. I. Simon, G alpha 16, a G protein alpha subunit specifically expressed in hematopoietic cells, Proc Natl Acad Sci, vol.88, issue.13, pp.5587-5591, 1991.

A. M. Aragay and M. W. Quick, Functional regulation of Galpha16 by protein kinase C, J Biol Chem, vol.274, issue.8, pp.4807-4815, 1999.

A. Armento, J. Ehlers, S. Schötterl, and U. Naumann, Molecular Mechanisms of Glioma Cell Motility, 2017.

T. Ashizawa, H. Miyata, A. Iizuka, M. Komiyama, C. Oshita et al., Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma, Int J Oncol, vol.43, issue.1, pp.219-227, 2013.

D. J. Askew and G. A. Silverman, Intracellular and extracellular serpins modulate lung disease, J Perinatol, vol.28, pp.127-135, 2008.

Y. Babaie, R. Herwig, B. Greber, T. C. Brink, W. Wruck et al., Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells, Stem Cells, vol.25, issue.2, pp.500-510, 2007.

A. Bajetto, F. Barbieri, A. Dorcaratto, S. Barbero, A. Daga et al., Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration, Neurochem Int, vol.49, issue.5, pp.423-432, 2006.

K. Baltensperger and H. Porzig, The P2U purinoceptor obligatorily engages the heterotrimeric G protein G16 to mobilize intracellular Ca2+ in human erythroleukemia cells, J Biol Chem, vol.272, issue.15, pp.10151-10159, 1997.

M. M. Belcheva and C. J. Coscia, Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase, Neurosignals, vol.11, issue.1, pp.34-44, 2002.

K. Bhat, V. Balasubramaniyan, B. Vaillant, R. Ezhilarasan, K. Hummelink et al., Mesenchymal differentiation mediated by NF-?B promotes radiation resistance in glioblastoma, Cancer Cell, vol.24, issue.3, pp.331-346, 2013.

M. A. Brockmann, A. Papadimitriou, M. Brandt, R. Fillbrandt, M. Westphal et al., Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4, Clin Cancer Res, vol.9, issue.12, pp.4578-4585, 2003.

L. Bryan, B. S. Paugh, D. Kapitonov, K. M. Wilczynska, S. M. Alvarez et al., Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness, Mol Cancer Res, vol.6, issue.9, pp.1469-1477, 2008.

L. Caja, C. Bellomo, and A. Moustakas, Transforming growth factor ? and bone morphogenetic protein actions in brain tumors, FEBS Lett, vol.589, issue.14, pp.1588-1597, 2015.

A. Carisey and C. Ballestrem, Vinculin, an adapter protein in control of cell adhesion signalling, Eur J Cell Biol, vol.90, issue.2-3, pp.157-163, 2011.

A. Carnero and M. Lleonart, The hypoxic microenvironment: A determinant of cancer stem cell evolution, Bioessays, vol.38, pp.65-74, 2016.

M. S. Carro, W. K. Lim, M. J. Alvarez, R. J. Bollo, X. Zhao et al., The transcriptional network for mesenchymal transformation of brain tumours, Nature, vol.463, issue.7279, pp.318-325, 2010.

H. Castel, L. Desrues, J. Joubert, M. Tonon, L. Prézeau et al., The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features, Front Endocrinol (Lausanne), vol.8, p.76, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02280590

M. D. Castellone, H. Teramoto, B. O. Williams, K. M. Druey, and J. S. Gutkind, Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis, Science, vol.310, issue.5753, pp.1504-1510, 2005.

M. Ceccarelli, F. P. Barthel, T. M. Malta, T. S. Sabedot, S. R. Salama et al., Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma, Cell, vol.164, issue.3, pp.550-563, 2016.

R. D. Cervantes-villagrana, S. R. Adame-garcía, I. García-jiménez, V. M. Color-aparicio, Y. M. Beltrán-navarro et al., G?? signaling to the chemotactic effector P-REX1 and mammalian cell migration is directly regulated by G?q and G?13 proteins, J Biol Chem, vol.294, issue.2, pp.531-546, 2019.

D. Chakravorty and S. M. Assmann, G protein subunit phosphorylation as a regulatory mechanism in heterotrimeric G protein signaling in mammals, yeast, and plants, Biochem J, vol.475, issue.21, pp.3331-3357, 2018.

G. Chandrika, K. Natesh, D. Ranade, A. Chugh, and P. Shastry, Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NF?B and PKC-? signaling, Sci Rep, vol.6, p.22455, 2016.

N. Chantaravisoot, P. Wongkongkathep, J. A. Loo, P. S. Mischel, and F. Tamanoi, Significance of filamin A in mTORC2 function in glioblastoma, Mol Cancer, vol.14, p.127, 2015.

M. Chen, Y. Zhang, and P. Zheng, Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis, PLoS ONE, vol.12, issue.5, p.177171, 2017.

W. Cheng, J. J. Kandel, D. J. Yamashiro, P. Canoll, and D. Anastassiou, A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma, PLoS ONE, vol.7, issue.4, p.34705, 2012.

A. E. Cherry and N. Stella, G protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenues, Neuroscience, vol.278, pp.222-236, 2014.

C. K. Choi, M. Vicente-manzanares, J. Zareno, L. A. Whitmore, A. Mogilner et al., Actin and alpha-actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motorindependent manner, Nat Cell Biol, vol.10, issue.9, pp.1039-1050, 2008.

C. R. Chow, K. Ebine, L. M. Knab, D. J. Bentrem, K. Kumar et al., Cancer Cell Invasion in Three-dimensional Collagen Is Regulated Differentially by G?13 Protein and Discoidin Domain Receptor 1-Par3 Protein Signaling, J Biol Chem, vol.291, issue.4, pp.1605-1618, 2016.

H. Clevers, K. M. Loh, and R. Nusse, Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control, Science, vol.346, issue.6205, p.1248012, 2014.

B. Colella, F. Faienza, D. Bartolomeo, and S. , EMT Regulation by Autophagy: A New Perspective in Glioblastoma Biology, Cancers (Basel), issue.3, p.11, 2019.

G. P. Coló, P. Hernández-varas, J. Lock, R. A. Bartolomé, N. Arellano-sánchez et al., Focal adhesion disassembly is regulated by a RIAM to MEK-1 pathway, J Cell Sci, vol.125, pp.5338-5352, 2012.

P. Coly, N. Perzo, L. Joncour, V. Lecointre, C. Schouft et al., Chemotactic G protein-coupled receptors control cell migration by repressing autophagosome biogenesis, Autophagy, vol.12, issue.12, pp.2344-2362, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02058096

M. Côté, M. D. Payet, M. N. Dufour, G. Guillon, and N. Gallo-payet, Association of the G protein alpha(q)/alpha11-subunit with cytoskeleton in adrenal glomerulosa cells: role in receptor-effector coupling, Endocrinology, vol.138, issue.8, pp.3299-3307, 1997.

D. R. Critchley, Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion, Biochem Soc Trans, vol.32, pp.831-836, 2004.

Y. Cui and S. Yamada, N-cadherin dependent collective cell invasion of prostate cancer cells is regulated by the N-terminus of ?-catenin, PLoS ONE, vol.8, issue.1, p.55069, 2013.

I. Davignon, M. D. Catalina, D. Smith, J. Montgomery, J. Swantek et al., Normal hematopoiesis and inflammatory responses despite discrete signaling defects in Galpha15 knockout mice, Mol Cell Biol, vol.20, issue.3, pp.797-804, 2000.

E. M. De-francesco, F. Sotgia, R. B. Clarke, M. P. Lisanti, and M. Maggiolini, G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts, Int J Mol Sci, vol.18, issue.12, 2017.

T. Demuth and M. E. Berens, Molecular mechanisms of glioma cell migration and invasion, J Neurooncol, vol.70, issue.2, pp.217-228, 2004.

I. Desbaillets, A. C. Diserens, N. Tribolet, M. F. Hamou, V. Meir et al., Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis, J Exp Med, vol.186, issue.8, pp.1201-1212, 1997.

P. Dillenburg-pilla, V. Patel, C. M. Mikelis, C. R. Zárate-bladés, C. L. Doçi et al., SDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/G?i/mTORC1 axis, FASEB J, vol.29, issue.3, pp.1056-1068, 2015.

D. Dong, H. Zhou, and G. Li, GPR78 promotes lung cancer cell migration and metastasis by activation of G?q-Rho GTPase pathway, BMB Rep, vol.49, issue.11, pp.623-628, 2016.

R. T. Dorsam and J. S. Gutkind, G-protein-coupled receptors and cancer, Nat Rev Cancer, vol.7, issue.2, pp.79-94, 2007.

G. B. Downes and N. Gautam, The G protein subunit gene families, Genomics, vol.62, issue.3, pp.544-552, 1999.

D. W. Dumbauld, T. T. Lee, A. Singh, J. Scrimgeour, C. A. Gersbach et al., How vinculin regulates force transmission, Proc Natl Acad Sci, vol.110, issue.24, pp.9788-9793, 2013.

C. Eckerich, S. Zapf, R. Fillbrandt, S. Loges, M. Westphal et al., Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration, Int J Cancer, vol.121, issue.2, pp.276-283, 2007.

L. A. Edwards, A. Li, D. Berel, M. Madany, N. Kim et al., ZEB1 regulates glioma stemness through LIF repression, Sci Rep, vol.7, issue.1, p.69, 2017.

M. Ehtesham, J. A. Winston, P. Kabos, and R. C. Thompson, CXCR4 expression mediates glioma cell invasiveness, Oncogene, vol.25, pp.2801-2806, 2006.

A. El-obeid, E. Bongcam-rudloff, M. Sörby, A. Ostman, M. Nistér et al., Cell scattering and migration induced by autocrine transforming growth factor alpha in human glioma cells in vitro, Cancer Res, vol.57, issue.24, pp.5598-5604, 1997.

F. Entschladen, K. S. Zänker, and D. G. Powe, Heterotrimeric G protein signaling in cancer cells with regard to metastasis formation, Cell Cycle, vol.10, issue.7, pp.1086-1091, 2011.

R. J. Epstein, The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies, Nat Rev Cancer, vol.4, issue.11, pp.901-909, 2004.

E. Ercetin, S. Richtmann, B. M. Delgado, G. Gomez-mariano, S. Wrenger et al., Clinical Significance of SERPINA1 Gene and Its Encoded Alpha1-antitrypsin Protein in NSCLC, Cancers (Basel), issue.9, p.11, 2019.

X. Fan, L. Khaki, T. S. Zhu, M. E. Soules, C. E. Talsma et al., NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts, Stem Cells, vol.28, issue.1, pp.5-16, 2010.

V. Fedele, F. Dai, A. P. Masilamani, D. H. Heiland, E. Kling et al., Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression, Mol Cancer Res, vol.15, issue.8, pp.998-1011, 2017.

A. Federico, S. Zappavigna, M. Romano, P. Grieco, A. Luce et al., Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans, Eur J Clin Invest, vol.44, issue.3, pp.285-294, 2014.

H. Feng, B. Hu, K. Liu, Y. Li, X. Lu et al., Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFR?-stimulated glioma tumorigenesis in mice and humans, J Clin Invest, vol.121, issue.12, pp.4670-4684, 2011.

H. Feng, K. W. Liu, P. Guo, P. Zhang, T. Cheng et al., Dynamin 2 mediates PDGFR?-SHP-2-promoted glioblastoma growth and invasion, Oncogene, vol.31, issue.21, pp.2691-2702, 2012.

X. Feng, M. S. Degese, R. Iglesias-bartolome, J. P. Vaque, A. A. Molinolo et al., Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry, Cancer Cell, vol.25, issue.6, pp.831-845, 2014.

G. Foltz, J. Yoon, H. Lee, L. Ma, Q. Tian et al., Epigenetic regulation of wnt pathway antagonists in human glioblastoma multiforme, Genes Cancer, vol.1, issue.1, pp.81-90, 2010.

R. Franco, S. Zappavigna, V. Gigantino, A. Luce, M. Cantile et al., Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion, J Exp Clin Cancer Res, vol.33, p.48, 2014.

D. Fuchs, M. Metzig, M. Bickeböller, C. Brandel, and W. Roth, The G?5 protein regulates sensitivity to TRAIL-induced cell death in colon carcinoma, Oncogene, vol.34, issue.21, pp.2753-2763, 2015.

C. Gao, G. Chen, S. Kuan, D. H. Zhang, D. D. Schlaepfer et al., FAK/PYK2 promotes the Wnt/?catenin pathway and intestinal tumorigenesis by phosphorylating GSK3?, 2015.

X. Gao and Z. Xu, Mechanisms of action of angiogenin, Acta Biochim Biophys Sin (Shanghai), vol.40, issue.7, pp.619-624, 2008.

A. Genna, S. Lapetina, N. Lukic, S. Twafra, T. Meirson et al., Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cells, J Cell Biol, vol.217, issue.1, pp.375-395, 2018.

F. Giannone, G. Malpeli, V. Lisi, S. Grasso, P. Shukla et al., The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis, Journal of Molecular Endocrinology, vol.44, issue.5, pp.259-269, 2010.

A. G. Gilman, G proteins: transducers of receptor-generated signals, Annu Rev Biochem, vol.56, pp.615-649, 1987.

F. Giovinazzo, G. Malpeli, S. Zanini, M. Parenti, L. Piemonti et al., Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction, Cellular Signalling, vol.25, issue.3, pp.651-659, 2013.

H. L. Goel and A. M. Mercurio, VEGF targets the tumour cell, Nat Rev Cancer, vol.13, issue.12, pp.871-882, 2013.

W. H. Goldmann, V. Auernheimer, I. Thievessen, and B. Fabry, Vinculin, cell mechanics and tumour cell invasion, Cell Biol Int, vol.37, issue.5, pp.397-405, 2013.

Z. G. Goldsmith and D. N. Dhanasekaran, G protein regulation of MAPK networks, Oncogene, vol.26, issue.22, pp.3122-3142, 2007.

Z. G. Goldsmith, J. H. Ha, M. Jayaraman, and D. N. Dhanasekaran, Lysophosphatidic Acid Stimulates the Proliferation of Ovarian Cancer Cells via the gep Proto-Oncogene G?(12), Genes Cancer, vol.2, issue.5, pp.563-575, 2011.

K. Gollapalli, S. Ghantasala, S. Kumar, R. Srivastava, S. Rapole et al., Subventricular zone involvement in Glioblastoma -A proteomic evaluation and clinicoradiological correlation, Sci Rep, vol.7, issue.1, p.1449, 2017.

R. Gorelik and A. Gautreau, Quantitative and unbiased analysis of directional persistence in cell migration, Nat Protoc, vol.9, issue.8, pp.1931-1943, 2014.

K. R. Grant, W. Harnett, G. Milligan, and M. M. Harnett, Differential G-protein expression during B-and T-cell development, Immunology, vol.90, issue.4, pp.564-571, 1997.

C. M. Greene, S. J. Marciniak, J. Teckman, I. Ferrarotti, M. L. Brantly et al., Nat Rev Dis Primers, vol.2, p.16051, 2016.

P. Grieco, R. Franco, G. Bozzuto, L. Toccacieli, A. Sgambato et al., Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells, J Cell Biochem, vol.112, issue.1, pp.341-353, 2011.

S. I. Grivennikov and K. M. , Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer, Cytokine Growth Factor Rev, vol.21, issue.1, pp.11-19, 2010.

J. L. Gu, W. Lu, C. Xia, X. Wu, and M. Liu, Regulation of hematopoietic-specific G-protein Galpha15 and Galpha16 by protein kinase C, J Cell Biochem, vol.88, issue.6, pp.1101-1111, 2003.

K. Guo, P. Fu, K. Juerchott, H. Motaln, J. Selbig et al., The expression of Wnt-inhibitor DKK1 (Dickkopf 1) is determined by intercellular crosstalk and hypoxia in human malignant gliomas, J Cancer Res Clin Oncol, vol.140, issue.8, pp.1261-1270, 2014.

J. H. Ha, J. D. Ward, L. Varadarajalu, S. G. Kim, and D. N. Dhanasekaran, The gep proto-oncogene G?12 mediates LPA-stimulated activation of CREB in ovarian cancer cells, Cell Signal, vol.26, issue.1, pp.122-132, 2014.

D. Hambardzumyan and G. Bergers, Glioblastoma: Defining Tumor Niches, Trends Cancer, vol.1, issue.4, pp.252-265, 2015.

M. E. Hardee and D. Zagzag, Mechanisms of glioma-associated neovascularization, Am J Pathol, vol.181, issue.4, pp.1126-1141, 2012.

L. E. Heasley, B. Storey, G. R. Fanger, L. Butterfield, J. Zamarripa et al., GTPasedeficient G alpha 16 and G alpha q induce PC12 cell differentiation and persistent activation of cJun NH2-terminal kinases, Mol Cell Biol, vol.16, issue.2, pp.648-656, 1996.

L. Hemmings, D. J. Rees, V. Ohanian, S. J. Bolton, A. P. Gilmore et al., Talin contains three actin-binding sites each of which is adjacent to a vinculin-binding site, J Cell Sci, vol.109, pp.2715-2726, 1996.

R. Higashita, L. Li, V. Van-putten, Y. Yamamura, F. Zarinetchi et al., Galpha16 mimics vasoconstrictor action to induce smooth muscle alpha-actin in vascular smooth muscle cells through a Jun-NH2-terminal kinase-dependent pathway, J Biol Chem, vol.272, issue.41, pp.25845-25850, 1997.

D. B. Hoelzinger, M. Nakada, T. Demuth, T. Rosensteel, L. B. Reavie et al., Autotaxin: a secreted autocrine/paracrine factor that promotes glioma invasion, J Neurooncol, vol.86, issue.3, pp.297-309, 2008.

E. C. Holland, J. Celestino, C. Dai, L. Schaefer, R. E. Sawaya et al., Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice, Nat Genet, vol.25, issue.1, pp.55-57, 2000.

J. Hu, W. Luo, and H. Wang, Angiogenin Upregulation Independently Predicts Unfavorable Overall Survival in Proneural Subtype of Glioblastoma, Technol Cancer Res Treat, vol.18, p.1533033819846636, 2019.

C. Huang, K. Jacobson, and M. D. Schaller, A role for JNK-paxillin signaling in cell migration, Cell Cycle, vol.3, issue.1, pp.4-6, 2004.

J. D. Humphries, P. Wang, C. Streuli, B. Geiger, M. J. Humphries et al., Vinculin controls focal adhesion formation by direct interactions with talin and actin, J Cell Biol, vol.179, issue.5, pp.1043-1057, 2007.

J. M. Hunt and R. Tuder, Alpha 1 anti-trypsin: one protein, many functions, Curr Mol Med, vol.12, issue.7, pp.827-835, 2012.

E. H. Hurowitz, J. M. Melnyk, Y. J. Chen, H. Kouros-mehr, M. I. Simon et al., Genomic characterization of the human heterotrimeric G protein alpha, beta, and gamma subunit genes, DNA Res, vol.7, issue.2, pp.111-120, 2000.

J. Ibarrondo, D. Joubert, M. N. Dufour, A. Cohen-solal, V. Homburger et al., Close association of the alpha subunits of Gq and G11 G proteins with actin filaments in WRK1 cells: relation to G protein-mediated phospholipase C activation, Proc Natl Acad Sci, vol.92, issue.18, pp.8413-8417, 1995.

R. Iglesias-bartolome, D. Torres, R. Marone, X. Feng, D. Martin et al., Inactivation of a G?(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis, Nat Cell Biol, vol.17, issue.6, pp.793-803, 2015.

G. Innamorati, F. Giannone, F. Guzzi, G. E. Rovati, M. R. Accomazzo et al., Heterotrimeric G proteins demonstrate differential sensitivity to ?arrestin dependent desensitization, Cellular Signalling, vol.21, issue.7, pp.1135-1142, 2009.

Y. Iwadate, Epithelial-mesenchymal transition in glioblastoma progression, Oncol Lett, vol.11, issue.3, pp.1615-1620, 2016.

A. A. Jarjour, M. Durko, T. L. Luk, N. Marçal, M. Shekarabi et al., Autocrine netrin function inhibits glioma cell motility and promotes focal adhesion formation, PLoS ONE, vol.6, issue.9, p.25408, 2011.

B. B. Johansson, L. Minsaas, A. Aragay, J. V. Joseph, S. Conroy et al., Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1?-ZEB1 axis, Cancer Lett, vol.272, issue.1, pp.107-116, 2005.

M. Karsy, J. Guan, R. Jensen, L. E. Huang, and H. Colman, The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells Regulation, World Neurosurg, vol.88, pp.222-236, 2016.

H. Kim, S. Zheng, S. S. Amini, S. M. Virk, T. Mikkelsen et al., Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution, Genome Res, vol.25, issue.3, pp.316-327, 2015.

Y. Kishi, S. Okudaira, M. Tanaka, K. Hama, D. Shida et al., Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid, J Biol Chem, vol.281, issue.25, pp.17492-17500, 2006.

J. Kloepper, L. Riedemann, Z. Amoozgar, G. Seano, K. Susek et al., Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival, Proc Natl Acad Sci, vol.113, issue.16, pp.4476-4481, 2016.

S. Koochekpour, M. Jeffers, S. Rulong, G. Taylor, E. Klineberg et al., Met and hepatocyte growth factor/scatter factor expression in human gliomas, Cancer Res, vol.57, issue.23, pp.5391-5398, 1997.

J. Kouno, H. Nagai, T. Nagahata, M. Onda, H. Yamaguchi et al., Up-regulation of CC chemokine, CCL3L1, and receptors, CCR3, CCR5 in human glioblastoma that promotes cell growth, J Neurooncol, vol.70, issue.3, pp.301-307, 2004.

T. Kozasa, J. R. Hepler, A. V. Smrcka, M. I. Simon, S. G. Rhee et al., Purification and characterization of recombinant G16 alpha from Sf9 cells: activation of purified phospholipase C isozymes by G-protein alpha subunits, Proc Natl Acad Sci, vol.90, pp.9176-9180, 1993.

A. Krishnan, A. Mustafa, M. S. Almén, R. Fredriksson, M. J. Williams et al., Evolutionary hierarchy of vertebrate-like heterotrimeric G protein families, Mol Phylogenet Evol, vol.91, pp.27-40, 2015.

G. Kunarso, N. Chia, J. Jeyakani, C. Hwang, X. Lu et al., Transposable elements have rewired the core regulatory network of human embryonic stem cells, Nat Genet, vol.42, issue.7, pp.631-634, 2010.

J. Kuo, X. Han, C. Hsiao, J. R. Yates, and C. M. Waterman, Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for ?-Pix in negative regulation of focal adhesion maturation, Nat Cell Biol, vol.13, issue.4, pp.383-393, 2011.

A. Lal, C. A. Glazer, H. M. Martinson, H. S. Friedman, G. E. Archer et al., Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion, Cancer Res, vol.62, issue.12, pp.3335-3339, 2002.

J. Langhans, L. Schneele, N. Trenkler, V. Bandemer, H. Nonnenmacher et al., The effects of PI3K-mediated signalling on glioblastoma cell behaviour, Oncogenesis, vol.6, issue.11, p.398, 2017.

W. W. Lau, A. S. Chan, L. S. Poon, J. Zhu, and Y. H. Wong, G??-mediated activation of protein kinase D exhibits subunit specificity and requires G??-responsive phospholipase C? isoforms, Cell Commun Signal, vol.11, issue.1, p.22, 2013.

F. Lausecker, X. Tian, K. Inoue, Z. Wang, C. E. Pedigo et al., Vinculin is required to maintain glomerular barrier integrity, Kidney Int, vol.93, issue.3, pp.643-655, 2018.

C. R. Lavalle, K. M. George, E. R. Sharlow, J. S. Lazo, P. Wipf et al., Protein kinase D as a potential new target for cancer therapy, Biochim Biophys Acta, vol.1806, issue.2, pp.183-192, 2010.

C. D. Lawson and A. J. Ridley, Rho GTPase signaling complexes in cell migration and invasion, J Cell Biol, vol.217, issue.2, pp.447-457, 2018.

C. Lecointre, L. Desrues, J. E. Joubert, N. Perzo, P. Guichet et al., Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma, Oncogene, vol.34, issue.39, pp.5080-5094, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02067683

C. H. Lee, A. Katz, and M. I. Simon, Multiple regions of G alpha 16 contribute to the specificity of activation by the C5a receptor, Mol Pharmacol, vol.47, issue.2, pp.218-223, 1995.

C. H. Lee, D. Park, D. Wu, S. G. Rhee, and M. I. Simon, Members of the Gq alpha subunit gene family activate phospholipase C beta isozymes, J Biol Chem, vol.267, issue.23, pp.16044-16047, 1992.

H. Lee, A. Herrmann, J. Deng, M. Kujawski, G. Niu et al., Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors, Cancer Cell, vol.15, issue.4, pp.283-293, 2009.

M. Lee and Y. H. Wong, CCR1-mediated activation of Nuclear Factor-kappaB in THP-1 monocytic cells involves Pertussis Toxin-insensitive Galpha(14) and Galpha(16) signaling cascades, J Leukoc Biol, vol.86, issue.6, pp.1319-1329, 2009.

A. Leyme, A. Marivin, L. Perez-gutierrez, L. T. Nguyen, and M. Garcia-marcos, Integrins activate trimeric G proteins via the nonreceptor protein GIV/Girdin, J Cell Biol, vol.210, issue.7, pp.1165-1184, 2015.

H. Li, L. Yang, H. Fu, J. Yan, Y. Wang et al., Association between G?i2 and ELMO1/Dock180 connects chemokine signalling with Rac activation and metastasis, Nat Commun, vol.4, p.1706, 2013.

X. Li, C. Wu, N. Chen, H. Gu, Y. A. Cao et al., PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma, Oncotarget, vol.7, issue.22, pp.33440-33450, 2016.

Z. Li, S. Cai, Y. Liu, C. Yang, Y. Tian et al., Over-expression of G?i3 in human glioma is required for Akt-mTOR activation and cell growth, Oncotarget, vol.5, issue.0, 2016.

Z. Li, S. Cai, Y. Liu, C. Yang, Y. Tian et al., Over-expression of G?i3 in human glioma is required for Akt-mTOR activation and cell growth, Oncotarget, vol.5, issue.0, 2016.

Z. Li, Y. Chen, T. An, P. Liu, J. Zhu et al., Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway, J Exp Clin Cancer Res, vol.38, issue.1, p.139, 2019.

A. Liu and Y. H. Wong, G16-mediated activation of nuclear factor kappaB by the adenosine A1 receptor involves c-Src, protein kinase C, and ERK signaling, J Biol Chem, vol.279, issue.51, pp.53196-53204, 2004.

C. Liu, K. Pham, D. Luo, B. A. Reynolds, P. Hothi et al., Expression and functional heterogeneity of chemokine receptors CXCR4 and CXCR7 in primary patient-derived glioblastoma cells, PLoS ONE, vol.8, issue.3, p.59750, 2013.

C. Liu, Y. Tu, X. Sun, J. Jiang, J. X. Bo et al., Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations, Clin Exp Med, vol.11, issue.2, pp.105-112, 2011.

C. Liu, C. Chang, K. Hsueh, H. Su, T. Chiou et al., Migration/Invasion of Malignant Gliomas and Implications for Therapeutic Treatment, Int J Mol Sci, vol.19, issue.4, 2018.

W. Liu, F. Yue, M. Zheng, A. Merlot, D. Bae et al., The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1. Oncotarget, vol.6, issue.11, pp.8851-8874, 2015.

X. Liu, K. Liu, J. Qin, L. Hao, X. Li et al., C/EBP? promotes angiogenesis through secretion of IL-6, which is inhibited by genistein, in EGFRvIIIpositive glioblastoma, Int J Cancer, vol.136, issue.11, pp.2524-2534, 2015.

R. Lo, H. Cheung, and Y. H. Wong, Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK-and ERK-dependent mechanism, J Biol Chem, vol.278, issue.52, pp.52154-52165, 2003.

R. Lo and Y. H. Wong, Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway, Cell Signal, vol.18, issue.12, pp.2143-2153, 2006.

A. D. Lokits, H. Indrischek, J. Meiler, H. E. Hamm, and P. F. Stadler, Tracing the evolution of the heterotrimeric G protein ? subunit in Metazoa, BMC Evol Biol, vol.18, issue.1, p.51, 2018.

M. Y. Lombardi and M. Assem, Glioblastoma Genomics: A Very Complicated Story, 2017.

A. M. López-colomé, I. Lee-rivera, R. Benavides-hidalgo, and E. López, Paxillin: a crossroad in pathological cell migration, J Hematol Oncol, vol.10, issue.1, p.50, 2017.

D. N. Louis, H. Ohgaki, O. D. Wiestler, W. K. Cavenee, P. C. Burger et al., The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol, vol.114, issue.2, pp.97-109, 2007.

D. N. Louis, A. Perry, G. Reifenberger, A. Von-deimling, D. Figarella-branger et al., The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary, Acta Neuropathol, vol.131, issue.6, pp.803-820, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01479018

G. Lu, J. T. Chang, Z. Liu, Y. Chen, M. Li et al., Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma, Mol Neurobiol, vol.53, issue.9, pp.6511-6525, 2016.

A. M. Magro, A. D. Magro, C. Cunningham, and M. R. Miller, Down-regulation of vinculin upon MK886-induced apoptosis in LN18 glioblastoma cells, Neoplasma, vol.54, issue.6, pp.517-526, 2007.

S. Mahavadi, A. D. Nalli, H. Wang, D. M. Kendig, M. S. Crowe et al., Regulation of gastric smooth muscle contraction via Ca2+-dependent and Ca2+-independent actin polymerization, PLoS ONE, vol.13, issue.12, p.209359, 2018.

E. Majewska and M. Szeliga, AKT/GSK3? Signaling in Glioblastoma, Neurochem Res, vol.42, issue.3, pp.918-924, 2017.

E. Malchinkhuu, K. Sato, Y. Horiuchi, C. Mogi, S. Ohwada et al., Role of p38 mitogen-activated kinase and c-Jun terminal kinase in migration response to lysophosphatidic acid and sphingosine-1-phosphate in glioma cells, Oncogene, vol.24, issue.44, pp.6676-6688, 2005.

A. Mansouri, J. Karamchandani, and S. Das, Molecular Genetics of Secondary Glioblastoma, 2017.

M. Y. Mapara, K. Bommert, R. C. Bargou, C. Leng, C. Beck et al., G protein subunit G alpha 16 expression is restricted to progenitor B cells during human B-cell differentiation, Blood, vol.85, issue.7, pp.1836-1842, 1995.

J. Mathieu, Z. Zhang, W. Zhou, A. J. Wang, J. M. Heddleston et al., HIF induces human embryonic stem cell markers in cancer cells, Cancer Res, vol.71, issue.13, pp.4640-4652, 2011.

D. Matias, J. Balça-silva, G. C. Da-graça, C. M. Wanjiru, L. W. Macharia et al., Microglia/Astrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors, Front Cell Neurosci, vol.12, p.235, 2018.

M. Mccord, Y. Mukouyama, M. R. Gilbert, and S. Jackson, Targeting WNT Signaling for Multifaceted Glioblastoma Therapy. Front Cell Neurosci, vol.11, p.318, 2017.

T. Mcgranahan, G. Li, and S. Nagpal, History and current state of immunotherapy in glioma and brain metastasis, Ther Adv Med Oncol, vol.9, issue.5, pp.347-368, 2017.

S. A. Mikheeva, A. M. Mikheev, A. Petit, R. Beyer, R. G. Oxford et al., TWIST1 promotes invasion through mesenchymal change in human glioblastoma, Mol Cancer, vol.9, p.194, 2010.

A. Mondal, K. Singh, D. Panda, S. Shiras, and A. , Extracellular Vesicles As Modulators of Tumor Microenvironment and Disease Progression in Glioma, Front Oncol, vol.7, p.144, 2017.

K. M. Mrozik, O. W. Blaschuk, C. M. Cheong, A. Zannettino, and K. Vandyke, N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer, BMC Cancer, vol.18, issue.1, p.939, 2018.

J. R. Muppidi, R. Schmitz, J. A. Green, W. Xiao, A. B. Larsen et al., Loss of signalling via G?13 in germinal centre B-cell-derived lymphoma, Nature, vol.516, issue.7530, pp.254-258, 2014.

J. K. Myung, S. A. Choi, S. Kim, K. Wang, and S. Park, Snail plays an oncogenic role in glioblastoma by promoting epithelial mesenchymal transition, Int J Clin Exp Pathol, vol.7, issue.5, pp.1977-1987, 2014.

M. Nishikawa, A. Inoue, T. Ohnishi, S. Kohno, S. Ohue et al., Significance of Glioma Stem-Like Cells in the Tumor Periphery That Express High Levels of CD44 in Tumor Invasion, Early Progression, and Poor Prognosis in Glioblastoma, Stem Cells Int, p.5387041, 2018.

N. Nomura, M. Nomura, N. Mizuki, and J. Hamada, Rac1 mediates phorbol 12-myristate 13-acetateinduced migration of glioblastoma cells via paxillin, Oncol Rep, vol.20, issue.4, pp.705-711, 2008.

J. Norgauer, B. Metzner, W. Czech, and I. Schraufstatter, Reconstitution of chemokine-induced actin polymerization in undifferentiated human leukemia cells (HL-60) by heterologous expression of interleukin-8 receptors, Inflamm Res, vol.45, issue.3, pp.127-131, 1996.

A. Nürnberg, T. Kitzing, and R. Grosse, Nucleating actin for invasion, Nat Rev Cancer, vol.11, issue.3, pp.177-187, 2011.

S. Offermanns and M. I. Simon, G? 15 and G? 16 Couple a Wide Variety of Receptors to Phospholipase C, Journal of Biological Chemistry, vol.270, issue.25, pp.15175-15180, 1995.

M. O'hayre, M. S. Degese, and J. S. Gutkind, Novel insights into G protein and G protein-coupled receptor signaling in cancer, Curr Opin Cell Biol, vol.27, pp.126-135, 2014.

M. O'hayre, J. Vázquez-prado, I. Kufareva, E. W. Stawiski, T. M. Handel et al., The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer, Nat Rev Cancer, vol.13, issue.6, pp.412-424, 2013.

Y. Oka, L. R. Saraiva, Y. Y. Kwan, and S. I. Korsching, The fifth class of Galpha proteins, Proc Natl Acad Sci, vol.106, issue.5, pp.1484-1489, 2009.

T. Okuda, T. Tasaki, S. Nakata, K. Yamashita, H. Yoshioka et al., Efficacy of Combination Therapy with MET and VEGF Inhibitors for MET-overexpressing Glioblastoma, Anticancer Res, vol.37, issue.7, pp.3871-3876, 2017.

J. J. Olsen, S. Pohl, A. Deshmukh, M. Visweswaran, N. C. Ward et al., The Role of Wnt Signalling in Angiogenesis, Clin Biochem Rev, vol.38, issue.3, pp.131-142, 2017.

S. Ookawa, M. Wanibuchi, Y. Kataoka-sasaki, M. Sasaki, S. Oka et al., Digital Polymerase Chain Reaction Quantification of SERPINA1 Predicts Prognosis in High-Grade Glioma, World Neurosurg, vol.111, pp.783-789, 2018.

Q. T. Ostrom, H. Gittleman, P. Liao, C. Rouse, Y. Chen et al., CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in, Neuro-oncology, vol.16, pp.1-63, 2007.

S. Otsuka and G. Bebb, The CXCR4/SDF-1 chemokine receptor axis: a new target therapeutic for nonsmall cell lung cancer, J Thorac Oncol, vol.3, issue.12, pp.1379-1383, 2008.

D. Park, D. Y. Jhon, R. Kriz, J. Knopf, and S. G. Rhee, Cloning, sequencing, expression, and Gqindependent activation of phospholipase C-beta 2, J Biol Chem, vol.267, issue.23, pp.16048-16055, 1992.

S. B. Park, K. W. Seo, A. Y. So, M. S. Seo, K. R. Yu et al., SOX2 has a crucial role in the lineage determination and proliferation of mesenchymal stem cells through Dickkopf-1 and c-MYC, Cell Death Differ, vol.19, issue.3, pp.534-545, 2012.

S. Park, J. Won, S. Kim, Y. Lee, C. Park et al., Molecular Testing of Brain Tumor, J Pathol Transl Med, vol.51, issue.3, pp.205-223, 2017.

D. W. Parsons, S. Jones, X. Zhang, J. Lin, R. J. Leary et al., An integrated genomic analysis of human glioblastoma multiforme, Science, vol.321, issue.5897, pp.1807-1812, 2008.

B. S. Paugh, S. W. Paugh, L. Bryan, D. Kapitonov, K. M. Wilczynska et al., EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells, FASEB J, vol.22, issue.2, pp.455-465, 2008.

R. D. Peavy, K. B. Hubbard, A. Lau, R. B. Fields, K. Xu et al., Differential effects of Gq alpha, G14 alpha, and G15 alpha on vascular smooth muscle cell survival and gene expression profiles, Mol Pharmacol, vol.67, issue.6, pp.2102-2114, 2005.

K. H. Pedone and J. R. Hepler, The importance of N-terminal polycysteine and polybasic sequences for G14alpha and G16alpha palmitoylation, plasma membrane localization, and signaling function, J Biol Chem, vol.282, issue.35, pp.25199-25212, 2007.

X. Peng, J. L. Maiers, D. Choudhury, S. W. Craig, and K. A. Demali, 2012. ?-Catenin uses a novel mechanism to activate vinculin, J Biol Chem, vol.287, issue.10, pp.7728-7737
URL : https://hal.archives-ouvertes.fr/hal-02317451

X. Peng, E. S. Nelson, J. L. Maiers, and K. A. Demali, New insights into vinculin function and regulation, Int Rev Cell Mol Biol, vol.287, pp.191-231, 2011.

S. L. Perrin, M. S. Samuel, B. Koszyca, M. P. Brown, L. M. Ebert et al., Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments, Biochem Soc Trans, vol.47, issue.2, pp.625-638, 2019.

M. Pfeilstöcker, H. Karlic, J. Salamon, E. Krömer, H. Mühlberger et al., Expression of G alpha 16, a G-protein alpha subunit specific for hematopoiesis in acute leukemia, Leukemia, vol.10, issue.7, pp.1117-1121, 1996.

H. S. Phillips, S. Kharbanda, R. Chen, W. F. Forrest, R. H. Soriano et al., Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis, Cancer Cell, vol.9, issue.3, pp.157-173, 2006.

T. D. Pollard and G. G. Borisy, Cellular motility driven by assembly and disassembly of actin filaments, Cell, vol.112, issue.4, pp.453-465, 2003.

D. F. Quail and J. A. Joyce, The Microenvironmental Landscape of Brain Tumors, Cancer Cell, vol.31, issue.3, pp.326-341, 2017.

A. J. Radenbaugh, S. Ma, A. Ewing, J. M. Stuart, E. A. Collisson et al., RADIA: RNA and DNA integrated analysis for somatic mutation detection, PLoS ONE, vol.9, issue.11, p.111516, 2014.

S. K. Ray, The Transcription Regulator Krüppel-Like Factor 4 and Its Dual Roles of Oncogene in Glioblastoma and Tumor Suppressor in Neuroblastoma, For Immunopathol Dis Therap, vol.7, issue.1-2, pp.127-139, 2016.

G. Riddick, S. Kotliarova, V. Rodriguez, H. S. Kim, A. Linkous et al., A Core Regulatory Circuit in Glioblastoma Stem Cells Links MAPK Activation to a, Transcriptional Program of Neural Stem Cell Identity. Sci Rep, vol.7, p.43605, 2017.

A. J. Ridley, Rho GTPase signalling in cell migration, Curr Opin Cell Biol, vol.36, pp.103-112, 2015.

P. J. Roberts and C. J. Der, Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer, Oncogene, vol.26, issue.22, pp.3291-3310, 2007.

B. M. Rock, L. Xin, and J. N. Wilcox, Two Gq class G proteins are expressed in human keratinocytes, J Invest Dermatol, vol.109, issue.5, pp.645-649, 1997.

S. Roesch, C. Rapp, S. Dettling, and C. Herold-mende, When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma, Int J Mol Sci, vol.19, issue.2, 2018.

A. Roos, Z. Ding, J. C. Loftus, and N. L. Tran, Molecular and Microenvironmental Determinants of Glioma Stem-Like Cell Survival and Invasion, Front Oncol, vol.7, p.120, 2017.

B. D. Rowland, R. Bernards, and D. S. Peeper, The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene, Nat Cell Biol, vol.7, issue.11, pp.1074-1082, 2005.

A. Roy, A. Coum, V. D. Marinescu, J. Põlajeva, A. Smits et al., Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells, Oncotarget, vol.6, issue.27, pp.23647-23661, 2015.

J. B. Rubin, A. L. Kung, R. S. Klein, J. A. Chan, Y. Sun et al., A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors, Proc Natl Acad Sci, vol.100, issue.23, pp.13513-13518, 2003.

E. Sahai and C. J. Marshall, Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis, Nat Cell Biol, vol.5, issue.8, pp.711-719, 2003.

M. Sanson, Y. Marie, S. Paris, A. Idbaih, J. Laffaire et al., Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas, J Clin Oncol, vol.27, issue.25, pp.4150-4154, 2009.

M. Sato, M. Hiraoka, H. Suzuki, Y. Bai, R. Kurotani et al., Identification of transcription factor E3 (TFE3) as a receptor-independent activator of G?16: gene regulation by nuclear G? subunit and its activator, J Biol Chem, vol.286, issue.20, pp.17766-17776, 2011.

W. F. Schwindinger and J. D. Robishaw, Heterotrimeric G-protein betagamma-dimers in growth and differentiation, Oncogene, vol.20, issue.13, pp.1653-1660, 2001.

G. Sciumè, A. Soriani, M. Piccoli, L. Frati, A. Santoni et al., CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-?1, Neuro-oncology, vol.12, issue.7, pp.701-710, 2010.

W. L. See and J. Mukherjee, Chapter 22 -Targeting the RAS-RAF-MEK-ERK Signaling Pathway in Gliomas, Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy, pp.323-332, 2018.

A. Sehgal, C. Keener, A. L. Boynton, J. Warrick, and G. P. Murphy, CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells, J Surg Oncol, vol.69, issue.2, pp.99-104, 1998.

S. Seidel, B. K. Garvalov, V. Wirta, V. Stechow, L. Schänzer et al., A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha, Brain, vol.133, pp.983-995, 2010.

J. Servitja, M. J. Marinissen, A. Sodhi, X. R. Bustelo, and J. S. Gutkind, Rac1 function is required for Src-induced transformation. Evidence of a role for Tiam1 and Vav2 in Rac activation by Src, J Biol Chem, vol.278, issue.36, pp.34339-34346, 2003.

K. Seystahl, A. Papachristodoulou, I. Burghardt, H. Schneider, K. Hasenbach et al., Biological Role and Therapeutic Targeting of TGF-?3 in Glioblastoma, Mol Cancer Ther, vol.16, issue.6, pp.1177-1186, 2017.

J. Sheng and Z. Xu, Three decades of research on angiogenin: a review and perspective, Acta Biochim Biophys Sin (Shanghai), vol.48, issue.5, pp.399-410, 2016.

D. L. Silbergeld and M. R. Chicoine, Isolation and characterization of human malignant glioma cells from histologically normal brain, J Neurosurg, vol.86, issue.3, pp.525-531, 1997.

M. I. Simon, M. P. Strathmann, and N. Gautam, Diversity of G proteins in signal transduction, Science, vol.252, issue.5007, pp.802-808, 1991.

S. Sit and E. Manser, Rho GTPases and their role in organizing the actin cytoskeleton, J Cell Sci, vol.124, pp.679-683, 2011.

Y. Sonoda, T. Ozawa, K. D. Aldape, D. F. Deen, M. S. Berger et al., Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma, Cancer Res, vol.61, issue.18, pp.6674-6678, 2001.

D. Spiering and L. Hodgson, Dynamics of the Rho-family small GTPases in actin regulation and motility, Cell Adh Migr, vol.5, issue.2, pp.170-180, 2011.

G. Stancheva, T. Goranova, M. Laleva, M. Kamenova, A. Mitkova et al., IDH1/IDH2 but not TP53 mutations predict prognosis in Bulgarian glioblastoma patients, Biomed Res Int, p.654727, 2014.

A. A. Stepanenko and V. P. Chekhonin, Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy? Cancers (Basel), p.10, 2018.

M. Strathmann and M. I. Simon, G protein diversity: a distinct class of alpha subunits is present in vertebrates and invertebrates, Proc Natl Acad Sci, vol.87, issue.23, pp.9113-9117, 1990.

R. Stupp, W. P. Mason, M. J. Van-den-bent, M. Weller, B. Fisher et al., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, vol.352, issue.10, pp.987-996, 2005.

R. Stupp, S. Taillibert, A. Kanner, W. Read, D. Steinberg et al., Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial, JAMA, vol.318, issue.23, pp.2306-2316, 2017.

R. Stupp, S. Taillibert, A. A. Kanner, S. Kesari, D. M. Steinberg et al., Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial, JAMA, vol.314, issue.23, pp.2535-2543, 2015.

Y. Su, M. Ho, and Y. H. Wong, A hematopoietic perspective on the promiscuity and specificity of Galpha16 signaling, Neurosignals, vol.17, issue.1, pp.71-81, 2009.

L. Sun, Y. Zhang, C. Wu, Y. Liang, J. et al., Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma, CNS Neurosci Ther, vol.23, issue.1, pp.69-75, 2017.

L. Svensson, P. Stanley, F. Willenbrock, and N. Hogg, The G?q/11 proteins contribute to T lymphocyte migration by promoting turnover of integrin LFA-1 through recycling, PLoS ONE, vol.7, issue.6, p.38517, 2012.

K. F. Swaney and R. Li, Function and regulation of the Arp2/3 complex during cell migration in diverse environments, Curr Opin Cell Biol, vol.42, pp.63-72, 2016.

V. Syrovatkina, K. O. Alegre, R. Dey, and X. Huang, Regulation, Signaling, and Physiological Functions of G-Proteins, J Mol Biol, vol.428, issue.19, pp.3850-3868, 2016.

Z. Tan, K. Chen, W. Wu, Y. Zhou, J. Zhu et al., Overexpression of HOXC10 promotes angiogenesis in human glioma via interaction with PRMT5 and upregulation of VEGFA expression, Theranostics, vol.8, issue.18, pp.5143-5158, 2018.

D. D. Tang and B. D. Gerlach, The roles and regulation of the actin cytoskeleton, intermediate filaments and microtubules in smooth muscle cell migration, Respir Res, vol.18, issue.1, p.54, 2017.

X. Tang, J. R. Qu, G. Wang, X. Li, Z. Yuan et al., GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the G?q-p63RhoGEF-Rho GTPase pathway, Cancer Res, vol.73, pp.6206-6218, 1920.

S. Tenailleau, I. Corre, and S. Hermouet, Specific expression of heterotrimeric G proteins G12 and G16 during human myeloid differentiation, Exp Hematol, vol.25, issue.9, pp.927-934, 1997.

M. Teo, S. Martin, K. Owusu-agyemang, S. Nowicki, B. Clark et al., A survival analysis of GBM patients in the West of Scotland pre-and postintroduction of the Stupp regime, Br J Neurosurg, vol.28, issue.3, pp.351-355, 2014.

M. Touat, A. Idbaih, M. Sanson, and K. L. Ligon, Glioblastoma targeted therapy: updated approaches from recent biological insights, Ann Oncol, vol.28, issue.7, pp.1457-1472, 2017.

L. Treps, R. Perret, S. Edmond, R. D. Gavard, and J. , Glioblastoma stem-like cells secrete the proangiogenic VEGF-A factor in extracellular vesicles, J Extracell Vesicles, vol.6, issue.1, p.1359479, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01573268

D. Triner and Y. M. Shah, Hypoxia-inducible factors: a central link between inflammation and cancer, J Clin Invest, vol.126, issue.10, pp.3689-3698, 2016.

C. Tso, P. Shintaku, J. Chen, Q. Liu, J. Liu et al., Primary glioblastomas express mesenchymal stem-like properties, Mol Cancer Res, vol.4, issue.9, pp.607-619, 2006.

C. E. Turner, J. R. Glenney, and K. Burridge, Paxillin: a new vinculin-binding protein present in focal adhesions, J Cell Biol, vol.111, issue.3, pp.1059-1068, 1990.

J. Twizere, J. Springael, M. Boxus, A. Burny, F. Dequiedt et al., Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling, Blood, vol.109, issue.3, pp.1051-1060, 2007.

H. Ueda, S. Saga, H. Shinohara, R. Morishita, K. Kato et al., Association of the gamma12 subunit of G proteins with actin filaments, J Cell Sci, vol.110, pp.1503-1511, 1997.

A. Vakilian, H. Khorramdelazad, P. Heidari, Z. Sheikh-rezaei, and G. Hassanshahi, CCL2/CCR2 signaling pathway in glioblastoma multiforme, Neurochem Int, vol.103, pp.1-7, 2017.

C. D. Van-raamsdonk, V. Bezrookove, G. Green, J. Bauer, L. Gaugler et al., Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi, Nature, vol.457, issue.7229, pp.599-602, 2009.

J. Vázquez-prado, I. Bracho-valdés, R. D. Cervantes-villagrana, and G. Reyes-cruz, G?? Pathways in Cell Polarity and Migration Linked to Oncogenic GPCR Signaling: Potential Relevance in Tumor Microenvironment, Mol Pharmacol, vol.90, issue.5, pp.573-586, 2016.

K. K. Velpula, A. A. Rehman, B. Chelluboina, V. R. Dasari, C. S. Gondi et al., Glioma stem cell invasion through regulation of the interconnected ERK, integrin ?6 and N-cadherin signaling pathway, Cell Signal, vol.24, issue.11, pp.2076-2084, 2012.

R. Verhaak, K. A. Hoadley, E. Purdom, V. Wang, Y. Qi et al., Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1, Cancer Cell, vol.17, issue.1, pp.98-110, 2010.

S. D. Vleeschouwer, , 2017.

H. Wang, C. Liao, N. Chow, L. Huang, J. Chuang et al., Whether CD44 is an applicable marker for glioma stem cells, Am J Transl Res, vol.9, issue.11, pp.4785-4806, 2017.

L. Wang, T. Huang, W. Chen, X. Gao, T. Zhou et al., Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells, Oncol Rep, vol.28, issue.6, pp.2043-2048, 2012.

Y. Wang, X. Xu, M. Pan, and J. T. , ELMO1 Directly Interacts with G?? Subunit to Transduce GPCR Signaling to Rac1 Activation in Chemotaxis, J Cancer, vol.7, issue.8, pp.973-983, 2016.

Z. Wang, J. Yang, G. Xu, W. Wang, C. Liu et al., Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors, Oncotarget, vol.6, issue.5, pp.3147-3164, 2015.

H. Welch, W. J. Coadwell, C. D. Ellson, G. J. Ferguson, S. R. Andrews et al., P-Rex1, a PtdIns(3,4,5)P3-and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac, Cell, vol.108, issue.6, pp.809-821, 2002.

M. K. Wendt, N. Balanis, C. R. Carlin, and W. P. Schiemann, STAT3 and epithelial-mesenchymal transitions in carcinomas, JAKSTAT, vol.3, issue.1, p.28975, 2014.

N. Wettschureck and S. Offermanns, Mammalian G proteins and their cell type specific functions, Physiol Rev, vol.85, issue.4, pp.1159-1204, 2005.

T. M. Wilkie, D. J. Gilbert, A. S. Olsen, X. N. Chen, T. T. Amatruda et al., Evolution of the mammalian G protein alpha subunit multigene family, Nat Genet, vol.1, issue.2, pp.85-91, 1992.

T. M. Wilkie, P. A. Scherle, M. P. Strathmann, V. Z. Slepak, and M. I. Simon, Characterization of G-protein alpha subunits in the Gq class: expression in murine tissues and in stromal and hematopoietic cell lines, Proc Natl Acad Sci, vol.88, issue.22, pp.10049-10053, 1991.

D. Wu, Y. Kuang, Y. Wu, and H. Jiang, Selective coupling of beta 2-adrenergic receptor to hematopoietic-specific G proteins, J Biol Chem, vol.270, issue.27, pp.16008-16010, 1995.

J. Wu, N. Xie, X. Zhao, E. C. Nice, and C. Huang, Dissection of aberrant GPCR signaling in tumorigenesis--a systems biology approach, Cancer Genomics Proteomics, vol.9, issue.1, pp.37-50, 2012.

V. Wu, H. Yeerna, N. Nohata, J. Chiou, O. Harismendy et al., Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy, J Biol Chem, vol.294, issue.29, pp.11062-11086, 2019.

W. Xia, W. Fu, X. Cai, M. Wang, H. Chen et al., Angiogenin promotes U87MG cell proliferation by activating NF-?B signaling pathway and downregulating its binding partner FHL3, PLoS ONE, vol.10, issue.2, p.116983, 2015.

L. Yadav, N. Puri, V. Rastogi, P. Satpute, and V. Sharma, Tumour Angiogenesis and Angiogenic Inhibitors: A Review, J Clin Diagn Res, vol.9, issue.6, pp.1-05, 2015.

V. N. Yadav, D. Zamler, G. J. Baker, P. Kadiyala, A. Erdreich-epstein et al., CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study, Oncotarget, vol.7, issue.50, pp.83701-83719, 2016.

H. Yagi, W. Tan, P. Dillenburg-pilla, A. S. Amornphimoltham, P. Simaan et al., A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells, Sci Signal, vol.4, issue.91, p.60, 2011.

B. Yamini, NF-?B, Mesenchymal Differentiation and Glioblastoma. Cells, vol.7, issue.9, 2018.

H. Yan, D. W. Parsons, J. G. Mclendon, R. Rasheed, B. A. Yuan et al., IDH1 and IDH2 mutations in gliomas, N Engl J Med, vol.360, issue.8, pp.765-773, 2009.

H. W. Yang, L. G. Menon, P. M. Black, R. S. Carroll, and M. D. Johnson, SNAI2/Slug promotes growth and invasion in human gliomas, BMC Cancer, vol.10, p.301, 2010.

M. Yang, H. Sang, A. Rahman, D. Wu, A. B. Malik et al., G alpha 16 couples chemoattractant receptors to NF-kappa B activation, J Immunol, vol.166, issue.11, pp.6885-6892, 2001.

X. Ye, S. Xu, Y. Xin, S. Yu, Y. Ping et al., Tumorassociated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-?1 signaling pathway, J Immunol, vol.189, issue.1, pp.444-453, 2012.

W. Yeung and Y. H. Wong, The RhoA-specific guanine nucleotide exchange factor p63RhoGEF binds to activated Galpha(16) and inhibits the canonical phospholipase Cbeta pathway, Cell Signal, vol.21, issue.8, pp.1317-1325, 2009.

A. Yoda, G. Adelmant, J. Tamburini, B. Chapuy, N. Shindoh et al., Mutations in G protein ? subunits promote transformation and kinase inhibitor resistance, Nat Med, vol.21, issue.1, pp.71-75, 2015.

M. Y. Yu, M. K. Ho, A. M. Liu, and Y. H. Wong, Mutations on the Switch III region and the alpha3 helix of Galpha16 differentially affect receptor coupling and regulation of downstream effectors, J Mol Signal, vol.3, p.17, 2008.

Q. Yu, L. Xu, L. Chen, B. Sun, Y. Zhiyun et al., Vinculin expression in non-small cell lung cancer, J Int Med Res, p.300060519839523, 2019.

J. Yuan, G. Xiao, G. Peng, D. Liu, Z. Wang et al., MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ, Biochem Biophys Res Commun, vol.457, issue.2, pp.171-176, 2015.

D. I. Yule, C. W. Baker, and J. A. Williams, Calcium signaling in rat pancreatic acinar cells: a role for Galphaq, Galpha11, and Galpha14, vol.276, pp.271-279, 1999.

D. Zagzag, M. Esencay, O. Mendez, H. Yee, I. Smirnova et al., Hypoxia-and vascular endothelial growth factor-induced stromal cellderived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures, Am J Pathol, vol.173, issue.2, pp.545-560, 2008.

S. Zanini, F. Giovinazzo, D. Alaimo, B. Lawrence, R. Pfragner et al., GNA15 expression in small intestinal neuroendocrine neoplasia: Functional and signalling pathway analyses, Cellular Signalling, vol.27, issue.5, pp.899-907, 2015.

J. Zhang, H. Cai, L. Sun, P. Zhan, M. Chen et al., LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/?-catenin pathway and predicts poor survival of glioma patients, J Exp Clin Cancer Res, vol.37, issue.1, p.225, 2018.

L. Zhang, G. Mu, Q. Ding, Y. Li, Y. Shi et al., Phosphatase and Tensin Homolog (PTEN) Represses Colon Cancer Progression through Inhibiting Paxillin Transcription via PI3K/AKT/NF-?B Pathway, J Biol Chem, vol.290, issue.24, pp.15018-15029, 2015.

S. Zhang, X. Yang, L. Wang, and C. Zhang, Interplay between inflammatory tumor microenvironment and cancer stem cells, Oncol Lett, vol.16, issue.1, pp.679-686, 2018.

Z. Yu, M. Moschetta, D. Huynh, Y. Tai, Z. Yong et al., Pyk2 promotes tumor progression in multiple myeloma, Blood, vol.124, issue.17, pp.2675-2686, 2014.

Z. Zhang, X. Tan, J. Luo, B. Cui, S. Lei et al., GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF-?B signaling pathway in colorectal cancer cells, Cancer Med, vol.7, issue.11, pp.5611-5620, 2018.

L. Zhao, Y. Wang, Y. Xue, W. Lv, Y. Zhang et al., Critical roles of chemokine receptor CCR5 in regulating glioblastoma proliferation and invasion, Acta Biochim Biophys Sin (Shanghai), vol.47, issue.11, pp.890-898, 2015.

Y. Zhao and A. A. Adjei, Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor, Oncologist, vol.20, issue.6, pp.660-673, 2015.

G. Zhou, Y. J. Song, and P. , Correlation of ERK/MAPK signaling pathway with proliferation and apoptosis of colon cancer cells, Oncol Lett, vol.17, issue.2, pp.2266-2270, 2019.

I. H. Abu-taha, J. Heijman, Y. Feng, C. Vettel, D. Dobrev et al., Regulation of heterotrimeric G-protein signaling by NDPK/NME proteins and caveolins: an update, Lab Invest, vol.98, issue.2, pp.190-197, 2018.

N. Afifiyan, B. Tillman, B. A. French, O. Sweeny, M. Masouminia et al., The role of Tec kinase signaling pathways in the development of Mallory Denk Bodies in balloon cells in alcoholic hepatitis, Exp Mol Pathol, vol.103, issue.2, pp.191-199, 2017.

S. Agnihotri, K. E. Burrell, A. Wolf, S. Jalali, C. Hawkins et al., Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies, Arch Immunol Ther Exp (Warsz), vol.61, issue.1, pp.25-41, 2013.

M. Aittaleb, C. A. Boguth, and J. Tesmer, Structure and function of heterotrimeric G protein-regulated Rho guanine nucleotide exchange factors, Mol Pharmacol, vol.77, issue.2, pp.111-125, 2010.

J. Albarrán-juárez, R. Gilsbach, R. P. Piekorz, K. Pexa, N. Beetz et al., Modulation of ?2-Adrenoceptor Functions by Heterotrimeric G?i Protein Isoforms, J Pharmacol Exp Ther, vol.331, issue.1, pp.35-44, 2009.

A. Albini, A. Bruno, D. M. Noonan, and L. Mortara, Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy, Front Immunol, vol.9, p.527, 2018.

K. Aldape, K. M. Brindle, L. Chesler, R. Chopra, A. Gajjar et al., Challenges to curing primary brain tumours, Nat Rev Clin Oncol, vol.16, issue.8, pp.509-520, 2019.

S. I. Al-juboori, J. Vadakekolathu, S. Idri, S. Wagner, D. Zafeiris et al., PYK2 promotes HER2-positive breast cancer invasion, J Exp Clin Cancer Res, vol.38, issue.1, p.210, 2019.

T. T. Amatruda, D. A. Steele, V. Z. Slepak, and M. I. Simon, G alpha 16, a G protein alpha subunit specifically expressed in hematopoietic cells, Proc Natl Acad Sci, vol.88, issue.13, pp.5587-5591, 1991.

E. S. Amirian, G. N. Armstrong, R. Zhou, C. C. Lau, E. B. Claus et al., The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium, Am J Epidemiol, vol.183, issue.2, pp.85-91, 2016.

T. Aoki and S. Narumiya, Prostaglandin E2-EP2 signaling as a node of chronic inflammation in the colon tumor microenvironment, Inflamm Regen, vol.37, p.4, 2017.

C. L. Appin and D. J. Brat, Molecular pathways in gliomagenesis and their relevance to neuropathologic diagnosis, Adv Anat Pathol, vol.22, issue.1, pp.50-58, 2015.

A. M. Aragay and M. W. Quick, Functional regulation of Galpha16 by protein kinase C, J Biol Chem, vol.274, issue.8, pp.4807-4815, 1999.

F. Ardito, M. Giuliani, D. Perrone, G. Troiano, L. Muzio et al., The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review), Int J Mol Med, vol.40, issue.2, pp.271-280, 2017.

A. Armento, J. Ehlers, S. Schötterl, and U. Naumann, Molecular Mechanisms of Glioma Cell Motility, 2017.

T. Ashizawa, H. Miyata, A. Iizuka, M. Komiyama, C. Oshita et al., Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stemlike cells derived from recurrent glioblastoma, Int J Oncol, vol.43, issue.1, pp.219-227, 2013.

D. J. Askew and G. A. Silverman, Intracellular and extracellular serpins modulate lung disease, J Perinatol, vol.28, pp.127-135, 2008.

P. Atherton, B. Stutchbury, D. Wang, D. Jethwa, R. Tsang et al., Vinculin controls talin engagement with the actomyosin machinery, Nat Commun, vol.6, p.10038, 2015.

T. K. Attwood and J. B. Findlay, Fingerprinting G-protein-coupled receptors, Protein Eng, vol.7, issue.2, pp.195-203, 1994.

M. Aubry, M. De-tayrac, A. Etcheverry, A. Clavreul, S. Saikali et al., From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity, Oncotarget, vol.6, issue.14, pp.12094-12109, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01117090

M. Audet and M. Bouvier, Restructuring G-protein-coupled receptor activation, Cell, vol.151, issue.1, pp.14-23, 2012.

S. Avasarala, R. K. Bikkavilli, M. Van-scoyk, W. Zhang, A. Lapite et al., Heterotrimeric G-Protein, G?16, Is a Critical Downstream Effector of Non-Canonical Wnt Signaling and a Potent Inhibitor of Transformed Cell Growth in Non Small Cell Lung Cancer, PLoS ONE, vol.8, issue.10, p.76895, 2013.

M. A. Ayoub, M. Damian, C. Gespach, E. Ferrandis, O. Lavergne et al., Inhibition of heterotrimeric G protein signaling by a small molecule acting on Galpha subunit, J Biol Chem, vol.284, issue.42, pp.29136-29145, 2009.

M. A. Ayoub, E. Trinquet, K. Pfleger, and J. Pin, Differential association modes of the thrombin receptor PAR1 with Galphai1, Galpha12, and beta-arrestin 1, vol.24, pp.3522-3535, 2010.

I. Azpiazu, H. Cruzblanca, P. Li, M. Linder, M. Zhuo et al., A G protein gamma subunitspecific peptide inhibits muscarinic receptor signaling, J Biol Chem, vol.274, issue.50, pp.35305-35308, 1999.

R. Baan, Y. Grosse, B. Lauby-secretan, E. Ghissassi, F. Bouvard et al., Carcinogenicity of radiofrequency electromagnetic fields, vol.12, pp.624-626, 2011.
URL : https://hal.archives-ouvertes.fr/ineris-00969545

Y. Babaie, R. Herwig, B. Greber, T. C. Brink, W. Wruck et al., Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells, Stem Cells, vol.25, issue.2, pp.500-510, 2007.

T. L. Bach, Q. Chen, W. T. Kerr, Y. Wang, L. Lian et al., Phospholipase cbeta is critical for T cell chemotaxis, J Immunol, vol.179, issue.4, pp.2223-2227, 2007.

A. Bajetto, F. Barbieri, A. Dorcaratto, S. Barbero, A. Daga et al., Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration, Neurochem Int, vol.49, issue.5, pp.423-432, 2006.

K. Baltensperger and H. Porzig, The P2U purinoceptor obligatorily engages the heterotrimeric G protein G16 to mobilize intracellular Ca2+ in human erythroleukemia cells, J Biol Chem, vol.272, issue.15, pp.10151-10159, 1997.

F. A. Baltoumas, M. C. Theodoropoulou, and S. J. Hamodrakas, Interactions of the ?-subunits of heterotrimeric G-proteins with GPCRs, effectors and RGS proteins: a critical review and analysis of interacting surfaces, conformational shifts, structural diversity and electrostatic potentials, J Struct Biol, vol.182, issue.3, pp.209-218, 2013.

J. M. Barnes, L. Przybyla, and V. M. Weaver, Tissue mechanics regulate brain development, homeostasis and disease, J Cell Sci, vol.130, issue.1, pp.71-82, 2017.

H. A. Basheer, E. Pakanavicius, P. A. Cooper, S. D. Shnyder, L. Martin et al., Hypoxia modulates CCR7 expression in head and neck cancers, Oral Oncol, vol.80, pp.64-73, 2018.

A. Basu and D. Pal, Two faces of protein kinase C?: the contrasting roles of PKC? in cell survival and cell death, ScientificWorldJournal, vol.10, pp.2272-2284, 2010.

A. Basu and U. Sivaprasad, Protein kinase Cepsilon makes the life and death decision, Cell Signal, vol.19, issue.8, pp.1633-1642, 2007.

T. T. Batchelor, P. Mulholland, B. Neyns, L. B. Nabors, M. Campone et al., Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma, J Clin Oncol, vol.31, issue.26, pp.3212-3218, 2013.

N. S. Bayin, J. D. Frenster, J. R. Kane, J. Rubenstein, A. S. Modrek et al., GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growth, Oncogenesis, vol.5, issue.10, p.263, 2016.

D. Beier, J. B. Schulz, and C. P. Beier, Chemoresistance of glioblastoma cancer stem cells--much more complex than expected, Mol Cancer, vol.10, p.128, 2011.

M. M. Belcheva and C. J. Coscia, Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase, Neurosignals, vol.11, issue.1, pp.34-44, 2002.

V. S. Benson, K. Pirie, J. Schüz, G. K. Reeves, V. Beral et al., Mobile phone use and risk of brain neoplasms and other cancers: prospective study, Int J Epidemiol, vol.42, issue.3, pp.792-802, 2013.

M. J. Berridge, Module 2: Cell Signalling Pathways, Cell Signalling Biology, vol.6, p.1002, 2014.

V. Bertagnolo, M. Benedusi, F. Brugnoli, P. Lanuti, M. Marchisio et al., Phospholipase C-beta 2 promotes mitosis and migration of human breast cancer-derived cells, Carcinogenesis, vol.28, issue.8, pp.1638-1645, 2007.

V. Bertagnolo, M. Benedusi, P. Querzoli, M. Pedriali, E. Magri et al., PLC-beta2 is highly expressed in breast cancer and is associated with a poor outcome: a study on tissue microarrays, Int J Oncol, vol.28, issue.4, pp.863-872, 2006.

A. Bertaut, C. Truntzer, R. Madkouri, C. G. Kaderbhai, V. Derangère et al., Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma, Oncotarget, vol.7, issue.43, pp.70948-70958, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01410048

C. Bessa, J. Soares, L. Raimundo, J. B. Loureiro, C. Gomes et al., Discovery of a small-molecule protein kinase C?-selective activator with promising application in colon cancer therapy, Cell Death Dis, vol.9, issue.2, p.23, 2018.

K. Bhat, V. Balasubramaniyan, B. Vaillant, R. Ezhilarasan, K. Hummelink et al., Mesenchymal differentiation mediated by NF-?B promotes radiation resistance in glioblastoma, Cancer Cell, vol.24, issue.3, pp.331-346, 2013.

D. Bian, C. Mahanivong, J. Yu, S. M. Frisch, Z. K. Pan et al., The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration, Oncogene, vol.25, issue.15, pp.2234-2244, 2006.

S. W. Bickler, E. Lizardo, D. M. Cauvi, D. Maio, and A. , The transition from a rural to an urban environment in Africa alters G protein-coupled receptor signaling, Med Hypotheses, vol.95, pp.49-53, 2016.

T. Van-biesen, L. M. Luttrell, B. E. Hawes, and R. J. Lefkowitz, Mitogenic signaling via G protein-coupled receptors, Endocr Rev, vol.17, issue.6, pp.698-714, 1996.

L. Birnbaumer, Expansion of signal transduction by G proteins. The second 15 years or so: from 3 to 16 alpha subunits plus betagamma dimers, Biochim Biophys Acta, vol.1768, issue.4, pp.772-793, 2007.

J. Blahos, T. Fischer, I. Brabet, D. Stauffer, G. Rovelli et al., A novel site on the Galpha -protein that recognizes heptahelical receptors, J Biol Chem, vol.276, issue.5, pp.3262-3269, 2001.

H. Block, A. Stadtmann, D. Riad, J. Rossaint, C. Sohlbach et al., Gnb isoforms control a signaling pathway comprising Rac1, Plc?2, and Plc?3 leading to LFA-1 activation and neutrophil arrest in vivo, Blood, vol.127, issue.3, pp.314-324, 2016.

J. B. Blumer and S. M. Lanier, Activators of G protein signaling exhibit broad functionality and define a distinct core signaling triad, Mol Pharmacol, vol.85, issue.3, pp.388-396, 2014.

J. B. Blumer, A. V. Smrcka, and S. M. Lanier, Mechanistic pathways and biological roles for receptorindependent activators of G-protein signaling, Pharmacol Ther, vol.113, issue.3, pp.488-506, 2007.

M. Boissan, S. Dabernat, E. Peuchant, U. Schlattner, I. Lascu et al., The mammalian Nm23/NDPK family: from metastasis control to cilia movement, Mol Cell Biochem, vol.329, issue.1-2, pp.51-62, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00403256

A. Bondar and J. Lazar, Dissociated G?GTP and G?? protein subunits are the major activated form of heterotrimeric Gi/o proteins, J Biol Chem, vol.289, issue.3, pp.1271-1281, 2014.

V. A. Boussiotis and A. Charest, Immunotherapies for malignant glioma, Oncogene, vol.37, issue.9, pp.1121-1141, 2018.

J. L. Boyer, G. L. Waldo, and T. K. Harden, Beta gamma-subunit activation of G-protein-regulated phospholipase C, J Biol Chem, vol.267, issue.35, pp.25451-25456, 1992.

A. A. Brandes, A. F. Carpentier, S. Kesari, J. M. Sepulveda-sanchez, H. R. Wheeler et al., A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma, Neuro-oncology, vol.18, issue.8, pp.1146-1156, 2016.

A. A. Brandes, A. Tosoni, U. Basso, M. Reni, F. Valduga et al., Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO), J Clin Oncol, vol.22, issue.23, pp.4779-4786, 2004.

J. J. Bravo-cordero, M. Magalhaes, R. J. Eddy, L. Hodgson, and J. Condeelis, Functions of cofilin in cell locomotion and invasion, Nat Rev Mol Cell Biol, vol.14, issue.7, pp.405-415, 2013.

E. Brugnera, L. Haney, C. Grimsley, M. Lu, S. F. Walk et al., Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex, Nat Cell Biol, vol.4, issue.8, pp.574-582, 2002.

F. Brugnoli, S. Grassilli, Y. Al-qassab, S. Capitani, and V. Bertagnolo, PLC-?2 is modulated by low oxygen availability in breast tumor cells and plays a phenotype dependent role in their hypoxia-related malignant potential, Mol Carcinog, vol.55, issue.12, pp.2210-2221, 2016.

L. Bryan, B. S. Paugh, D. Kapitonov, K. M. Wilczynska, S. M. Alvarez et al., Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness, Mol Cancer Res, vol.6, issue.9, pp.1469-1477, 2008.

X. Bu, C. Zhao, and X. Dai, Involvement of COX-2/PGE(2) Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer, Gastroenterol Res Pract, p.214269, 2011.

E. Buck and R. Iyengar, Modular design of Gbeta as the basis for reversible specificity in effector stimulation, J Biol Chem, vol.276, issue.38, pp.36014-36019, 2001.

E. Buck, J. Li, Y. Chen, G. Weng, S. Scarlata et al., Resolution of a signal transfer region from a general binding domain in gbeta for stimulation of phospholipase C-beta2, Science, vol.283, issue.5406, pp.1332-1335, 1999.

E. Buck, P. Schatz, S. Scarlata, and R. Iyengar, Role of dynamic interactions in effective signal transfer for Gbeta stimulation of phospholipase C-beta 2, J Biol Chem, vol.277, issue.51, pp.49707-49715, 2002.

J. Buckner, C. Giannini, J. Eckel-passow, D. Lachance, I. Parney et al., Management of diffuse low-grade gliomas in adults -use of molecular diagnostics, Nat Rev Neurol, vol.13, issue.6, pp.340-351, 2017.

A. M. Buhl, N. L. Johnson, N. Dhanasekaran, and G. L. Johnson, G alpha 12 and G alpha 13 stimulate Rhodependent stress fiber formation and focal adhesion assembly, J Biol Chem, vol.270, issue.42, pp.24631-24634, 1995.

C. M. Bunce and F. L. Khanim, The "known-knowns", and "known-unknowns" of extracellular Nm23-H1/NDPK proteins, Lab Invest, vol.98, issue.5, pp.602-608, 2018.

M. Bünemann, M. Frank, and M. J. Lohse, Gi protein activation in intact cells involves subunit rearrangement rather than dissociation, Proc Natl Acad Sci, vol.100, issue.26, pp.16077-16082, 2003.

A. M. Cacace, M. Ueffing, A. Philipp, E. K. Han, W. Kolch et al., PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase, Oncogene, vol.13, issue.12, pp.2517-2526, 1996.

L. Caja, C. Bellomo, and A. Moustakas, Transforming growth factor ? and bone morphogenetic protein actions in brain tumors, FEBS Lett, vol.589, issue.14, pp.1588-1597, 2015.

A. J. Cameron, K. J. Procyk, M. Leitges, and P. J. Parker, PKC alpha protein but not kinase activity is critical for glioma cell proliferation and survival, Int J Cancer, vol.123, issue.4, pp.769-779, 2008.

C. Network, D. J. Brat, R. Verhaak, K. D. Aldape, W. Yung et al., Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas, N Engl J Med, vol.372, issue.26, pp.2481-2498, 2015.

J. Cao, J. Liu, J. Long, J. Fu, L. Huang et al., microRNA-23b suppresses epithelial-mesenchymal transition (EMT) and metastasis in hepatocellular carcinoma via targeting Pyk2, Biomed Pharmacother, vol.89, pp.642-650, 2017.

A. Carisey and C. Ballestrem, Vinculin, an adapter protein in control of cell adhesion signalling, Eur J Cell Biol, vol.90, issue.2-3, pp.157-163, 2011.

A. Do-carmo, J. Balça-silva, D. Matias, and M. C. Lopes, PKC signaling in glioblastoma, Cancer Biol Ther, vol.14, issue.4, pp.287-294, 2013.

A. Carnero and M. Lleonart, The hypoxic microenvironment: A determinant of cancer stem cell evolution, Bioessays, vol.38, pp.65-74, 2016.

M. S. Carro, W. K. Lim, M. J. Alvarez, R. J. Bollo, X. Zhao et al., The transcriptional network for mesenchymal transformation of brain tumours, Nature, vol.463, issue.7279, pp.318-325, 2010.

H. Castel, L. Desrues, J. Joubert, M. Tonon, L. Prézeau et al., The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features, Front Endocrinol (Lausanne), vol.8, p.76, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02280590

M. D. Castellone, H. Teramoto, B. O. Williams, K. M. Druey, and J. S. Gutkind, Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis, Science, vol.310, issue.5753, pp.1504-1510, 2005.

M. Ceccarelli, F. P. Barthel, T. M. Malta, T. S. Sabedot, S. R. Salama et al., Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma, Cell, vol.164, issue.3, pp.550-563, 2016.

R. D. Cervantes-villagrana, S. R. Adame-garcía, I. García-jiménez, V. M. Color-aparicio, Y. M. Beltrán-navarro et al., G?? signaling to the chemotactic effector P-REX1 and mammalian cell migration is directly regulated by G?q and G?13 proteins, J Biol Chem, vol.294, issue.2, pp.531-546, 2019.

S. Chakrabarti and A. R. Gintzler, Phosphorylation of Gbeta is augmented by chronic morphine and enhances Gbetagamma stimulation of adenylyl cyclase activity, Brain Res Mol Brain Res, vol.119, issue.2, pp.144-151, 2003.

D. Chakravorty and S. M. Assmann, G protein subunit phosphorylation as a regulatory mechanism in heterotrimeric G protein signaling in mammals, yeast, and plants, Biochem J, vol.475, issue.21, pp.3331-3357, 2018.

G. Chandrika, K. Natesh, D. Ranade, A. Chugh, and P. Shastry, Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NF?B and PKC-? signaling, Sci Rep, vol.6, p.22455, 2016.

A. L. Chang, J. Miska, D. A. Wainwright, M. Dey, C. V. Rivetta et al., CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells, Cancer Res, vol.76, pp.5671-5682, 2016.

L. Chang, J. Su, X. Jia, and H. Ren, Treating malignant glioma in Chinese patients: update on temozolomide, Onco Targets Ther, vol.7, pp.235-244, 2014.

N. Chang, S. H. Ahn, D. Kong, H. W. Lee, and D. Nam, The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment, Mol Cell Endocrinol, vol.451, pp.53-65, 2017.

N. Chantaravisoot, P. Wongkongkathep, J. A. Loo, P. S. Mischel, and F. Tamanoi, Significance of filamin A in mTORC2 function in glioblastoma, Mol Cancer, vol.14, p.127, 2015.

C. A. Chen and D. R. Manning, Regulation of G proteins by covalent modification, Oncogene, vol.20, issue.13, pp.1643-1652, 2001.

Z. Chen and D. Hambardzumyan, Immune Microenvironment in Glioblastoma Subtypes, Front Immunol, vol.9, p.1004, 2018.

J. Cherfils and M. Chabre, Activation of G-protein Galpha subunits by receptors through Galpha-Gbeta and Galpha-Ggamma interactions, Trends Biochem Sci, vol.28, issue.1, pp.13-17, 2003.

A. E. Cherry and N. Stella, G protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenues, Neuroscience, vol.278, pp.222-236, 2014.

O. L. Chinot, W. Wick, W. Mason, R. Henriksson, F. Saran et al., Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma, N Engl J Med, vol.370, issue.8, pp.709-722, 2014.

S. Chittaranjan, S. Chan, C. Yang, K. C. Yang, V. Chen et al., Mutations in CIC and IDH1 cooperatively regulate 2-hydroxyglutarate levels and cell clonogenicity, Oncotarget, vol.5, issue.17, pp.7960-7979, 2014.

H. Choe, Y. J. Kim, J. H. Park, T. Morizumi, E. F. Pai et al., Crystal structure of metarhodopsin II, Nature, vol.471, issue.7340, pp.651-655, 2011.

C. K. Choi, M. Vicente-manzanares, J. Zareno, L. A. Whitmore, A. Mogilner et al., Actin and alpha-actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motor-independent manner, Nat Cell Biol, vol.10, issue.9, pp.1039-1050, 2008.

C. R. Chow, K. Ebine, L. M. Knab, D. J. Bentrem, K. Kumar et al., Cancer Cell Invasion in Three-dimensional Collagen Is Regulated Differentially by G?13 Protein and Discoidin Domain Receptor 1-Par3 Protein Signaling, J Biol Chem, vol.291, issue.4, pp.1605-1618, 2016.

K. Chow, H. J. Park, J. George, K. Yamamoto, A. D. Gallup et al., S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma, Cancer Res, vol.77, pp.5360-5373, 2017.

Y. Chuang, N. L. Tran, N. Rusk, M. Nakada, M. E. Berens et al., Role of synaptojanin 2 in glioma cell migration and invasion, Cancer Res, vol.64, issue.22, pp.8271-8275, 2004.

J. Ciarkowski, M. Witt, and R. Slusarz, A hypothesis for GPCR activation, J Mol Model, vol.11, issue.4-5, pp.407-415, 2005.

M. J. Cismowski and S. M. Lanier, Activation of heterotrimeric G-proteins independent of a G-protein coupled receptor and the implications for signal processing, Rev Physiol Biochem Pharmacol, vol.155, pp.57-80, 2005.

S. Civciristov, A. M. Ellisdon, R. Suderman, C. K. Pon, B. A. Evans et al., Preassembled GPCR signaling complexes mediate distinct cellular responses to ultralow ligand concentrations, Sci Signal, vol.11, issue.551, 2018.

D. E. Clapham and E. J. Neer, New roles for G-protein beta gamma-dimers in transmembrane signalling, Nature, vol.365, issue.6445, pp.403-406, 1993.

D. E. Clapham and E. J. Neer, G protein beta gamma subunits, Annu Rev Pharmacol Toxicol, vol.37, pp.167-203, 1997.

M. J. Clark, C. Harrison, H. Zhong, R. R. Neubig, and J. R. Traynor, Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways, J Biol Chem, vol.278, issue.11, pp.9418-9425, 2003.

D. Clynes, D. R. Higgs, and R. J. Gibbons, The chromatin remodeller ATRX: a repeat offender in human disease, Trends Biochem Sci, vol.38, issue.9, pp.461-466, 2013.

L. Cocco, M. Y. Follo, L. Manzoli, and P. Suh, Phosphoinositide-specific phospholipase C in health and disease, J Lipid Res, vol.56, issue.10, pp.1853-1860, 2015.

L. Cocco, S. Rubbini, L. Manzoli, A. M. Billi, I. Faenza et al., Inositides in the nucleus: presence and characterisation of the isozymes of phospholipase beta family in NIH 3T3 cells, Biochim Biophys Acta, vol.1438, issue.2, pp.295-299, 1999.

P. Coffino, H. R. Bourne, and G. M. Tomkins, Somatic genetic analysis of cyclic AMP action: selection of unresponsive mutants, J Cell Physiol, vol.85, issue.3, pp.603-610, 1975.

E. Cohen, H. Zhu, M. W. Lingen, L. E. Martin, W. Kuo et al., A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle, Cancer Res, vol.69, issue.1, pp.65-74, 2009.

B. Colella, F. Faienza, D. Bartolomeo, and S. , EMT Regulation by Autophagy: A New Perspective in Glioblastoma Biology, Cancers (Basel), issue.3, p.11, 2019.

B. D. Coleman, A. Marivin, K. Parag-sharma, V. Digiacomo, S. Kim et al., Evolutionary Conservation of a GPCR-Independent Mechanism of Trimeric G Protein Activation, Mol Biol Evol, vol.33, issue.3, pp.820-837, 2016.

J. L. Coll, A. Ben-ze'ev, R. M. Ezzell, R. Fernández, J. L. Baribault et al., Targeted disruption of vinculin genes in F9 and embryonic stem cells changes cell morphology, adhesion, and locomotion, Proc Natl Acad Sci, vol.92, pp.9161-9165, 1920.

G. P. Coló, P. Hernández-varas, J. Lock, R. A. Bartolomé, N. Arellano-sánchez et al., Focal adhesion disassembly is regulated by a RIAM to MEK-1 pathway, J Cell Sci, vol.125, pp.5338-5352, 2012.

P. Coly, N. Perzo, L. Joncour, V. Lecointre, C. Schouft et al., Chemotactic G protein-coupled receptors control cell migration by repressing autophagosome biogenesis, Autophagy, vol.12, issue.12, pp.2344-2362, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02058096

B. R. Conklin, Z. Farfel, K. D. Lustig, J. D. Bourne, and H. R. , Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha, Nature, vol.363, issue.6426, pp.274-276, 1993.

M. Cooke, A. Magimaidas, V. Casado-medrano, and M. G. Kazanietz, Protein kinase C in cancer: The top five unanswered questions, Mol Carcinog, vol.56, issue.6, pp.1531-1542, 2017.

M. Côté, M. D. Payet, M. N. Dufour, G. Guillon, and N. Gallo-payet, Association of the G protein alpha(q)/alpha11-subunit with cytoskeleton in adrenal glomerulosa cells: role in receptoreffector coupling, Endocrinology, vol.138, issue.8, pp.3299-3307, 1997.

J. Côté and K. Vuori, GEF what? Dock180 and related proteins help Rac to polarize cells in new ways, Trends Cell Biol, vol.17, issue.8, pp.383-393, 2007.

I. Crespo, A. L. Vital, M. Gonzalez-tablas, C. Patino-m-del, A. Otero et al., Molecular and Genomic Alterations in Glioblastoma Multiforme, Am J Pathol, vol.185, issue.7, pp.1820-1833, 2015.

D. R. Critchley, Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion, Biochem Soc Trans, vol.32, pp.831-836, 2004.

V. A. Cuddapah, K. L. Turner, S. Seifert, and H. Sontheimer, Bradykinin-induced chemotaxis of human gliomas requires the activation of KCa3.1 and ClC-3, J Neurosci, vol.33, issue.4, pp.1427-1440, 2013.

Y. Cui and S. Yamada, N-cadherin dependent collective cell invasion of prostate cancer cells is regulated by the N-terminus of ?-catenin, PLoS ONE, vol.8, issue.1, p.55069, 2013.

Y. Daaka, L. M. Luttrell, and R. J. Lefkowitz, Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A, Nature, vol.390, issue.6655, pp.88-91, 1997.

L. Dang, D. W. White, S. Gross, B. D. Bennett, M. A. Bittinger et al., Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, Nature, vol.465, issue.7300, p.966, 2010.

I. Davignon, M. D. Catalina, D. Smith, J. Montgomery, J. Swantek et al., Normal hematopoiesis and inflammatory responses despite discrete signaling defects in Galpha15 knockout mice, Mol Cell Biol, vol.20, issue.3, pp.797-804, 2000.

M. E. Davis, Glioblastoma: Overview of Disease and Treatment, Clin J Oncol Nurs, vol.20, issue.5, 2016.

E. M. De-francesco, F. Sotgia, R. B. Clarke, M. P. Lisanti, and M. Maggiolini, G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts, Int J Mol Sci, vol.18, issue.12, 2017.

D. Vleeschouwer, S. Bergers, and G. , Glioblastoma: To Target the Tumor Cell or the Microenvironment?, 2017.

C. Debray, P. Vereecken, N. Belot, P. Teillard, J. Brion et al., Multifaceted role of galectin-3 on human glioblastoma cell motility, Biochem Biophys Res Commun, vol.325, issue.4, pp.1393-1398, 2004.

P. Dehal and J. L. Boore, Two rounds of whole genome duplication in the ancestral vertebrate, PLoS Biol, vol.3, issue.10, p.314, 2005.

A. Von-deimling, A. Korshunov, and C. Hartmann, The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations, Brain Pathol, vol.21, issue.1, pp.74-87, 2011.

T. Demuth, J. L. Rennert, D. B. Hoelzinger, L. B. Reavie, M. Nakada et al., Glioma cells on the run -the migratory transcriptome of 10 human glioma cell lines, BMC Genomics, vol.9, p.54, 2008.

C. Denis, A. Saulière, S. Galandrin, J. Sénard, and C. Galés, Probing heterotrimeric G protein activation: applications to biased ligands, Curr Pharm Des, vol.18, issue.2, pp.128-144, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00662107

I. Desbaillets, A. C. Diserens, N. Tribolet, M. F. Hamou, V. Meir et al., Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis, J Exp Med, vol.186, issue.8, pp.1201-1212, 1997.

A. Desjardins, M. Gromeier, J. E. Herndon, N. Beaubier, D. P. Bolognesi et al., Recurrent Glioblastoma Treated with Recombinant Poliovirus, N Engl J Med, vol.379, issue.2, pp.150-161, 2018.

K. M. Detjen, F. H. Brembeck, M. Welzel, A. Kaiser, H. Haller et al., Activation of protein kinase Calpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest, J Cell Sci, vol.113, pp.3025-3035, 2000.

N. Dieudonné, D. Micheli, R. Hottinger, and A. , , 2016.

, Rev Med Suisse, vol.12, issue.516, pp.853-856

G. J. Digby, R. M. Lober, P. R. Sethi, and N. A. Lambert, Some G protein heterotrimers physically dissociate in living cells, Proc Natl Acad Sci, vol.103, issue.47, pp.17789-17794, 2006.

V. Digiacomo, A. Marivin, and M. Garcia-marcos, When Heterotrimeric G Proteins Are Not Activated by G Protein-Coupled Receptors: Structural Insights and Evolutionary Conservation, Biochemistry, vol.57, issue.3, pp.255-257, 2018.

L. Dimitrov, C. S. Hong, C. Yang, Z. Zhuang, and J. D. Heiss, New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in glioma, Int J Med Sci, vol.12, issue.3, pp.201-213, 2015.

J. Dingus and J. D. Hildebrandt, Synthesis and assembly of G protein ?? dimers: comparison of in vitro and in vivo studies, Subcell Biochem, vol.63, pp.155-180, 2012.

S. K. Dissanayake, M. Wade, C. E. Johnson, M. P. O'connell, P. D. Leotlela et al., The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition, J Biol Chem, vol.282, issue.23, pp.17259-17271, 2007.

N. Divecha and R. F. Irvine, Phospholipid signaling, Cell, vol.80, issue.2, pp.90409-90412, 1995.

T. P. Diwanji, A. Engelman, J. W. Snider, and P. Mohindra, Epidemiology, diagnosis, and optimal management of glioma in adolescents and young adults, Adolesc Health Med Ther, vol.8, pp.99-113, 2017.

D. Dong, H. Zhou, and G. Li, GPR78 promotes lung cancer cell migration and metastasis by activation of G?q-Rho GTPase pathway, BMB Rep, vol.49, issue.11, pp.623-628, 2016.

A. Dongre and R. A. Weinberg, New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer, Nat Rev Mol Cell Biol, vol.20, issue.2, pp.69-84, 2019.

R. T. Dorsam and J. S. Gutkind, G-protein-coupled receptors and cancer, Nat Rev Cancer, vol.7, issue.2, pp.79-94, 2007.

G. B. Downes and N. Gautam, The G protein subunit gene families, Genomics, vol.62, issue.3, pp.544-552, 1999.

R. Du, K. V. Lu, C. Petritsch, P. Liu, R. Ganss et al., HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion, Cancer Cell, vol.13, issue.3, pp.206-220, 2008.

N. M. Duc, H. R. Kim, and K. Y. Chung, Structural mechanism of G protein activation by G proteincoupled receptor, Eur J Pharmacol, vol.763, pp.214-222, 2015.

D. W. Dumbauld, T. T. Lee, A. Singh, J. Scrimgeour, C. A. Gersbach et al., How vinculin regulates force transmission, Proc Natl Acad Sci, vol.110, issue.24, pp.9788-9793, 2013.

D. J. Dupré, M. Robitaille, M. Richer, N. Ethier, A. M. Mamarbachi et al., Dopamine receptorinteracting protein 78 acts as a molecular chaperone for Ggamma subunits before assembly with Gbeta, J Biol Chem, vol.282, issue.18, pp.13703-13715, 2007.

L. A. Edwards, A. Li, D. Berel, M. Madany, N. Kim et al., ZEB1 regulates glioma stemness through LIF repression, Sci Rep, vol.7, issue.1, p.69, 2017.

M. Ehtesham, M. E. Issar, N. M. Kasl, R. A. Khan, I. S. Thompson et al., The role of the CXCR4 cell surface chemokine receptor in glioma biology, J Neurooncol, vol.113, issue.2, pp.153-162, 2013.

H. H. Engelhard, The role of interstitial BCNU chemotherapy in the treatment of malignant glioma, Surg Neurol, vol.53, issue.5, pp.458-464, 2000.

F. Entschladen, K. S. Zänker, and D. G. Powe, Heterotrimeric G protein signaling in cancer cells with regard to metastasis formation, Cell Cycle, vol.10, issue.7, pp.1086-1091, 2011.

R. J. Epstein, The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies, Nat Rev Cancer, vol.4, issue.11, pp.901-909, 2004.

E. Ercetin, S. Richtmann, B. M. Delgado, G. Gomez-mariano, S. Wrenger et al., Clinical Significance of SERPINA1 Gene and Its Encoded Alpha1-antitrypsin Protein in NSCLC, Cancers (Basel), issue.9, p.11, 2019.

P. Euskirchen, J. Radke, M. S. Schmidt, S. Heuling, E. Kadikowski et al., Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma, PLoS ONE, vol.12, issue.9, p.185376, 2017.

I. Faenza, A. Matteucci, L. Manzoli, A. M. Billi, M. Aluigi et al., A role for nuclear phospholipase Cbeta 1 in cell cycle control, J Biol Chem, vol.275, issue.39, pp.30520-30524, 2000.

Q. Fan, C. Cheng, Z. A. Knight, D. Haas-kogan, D. Stokoe et al., EGFR signals to mTOR through PKC and independently of Akt in glioma, Sci Signal, vol.2, issue.55, p.4, 2009.

M. Fedele, L. Cerchia, S. Pegoraro, R. Sgarra, and G. Manfioletti, Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma, Int J Mol Sci, vol.20, issue.11, 2019.

V. Fedele, F. Dai, A. P. Masilamani, D. H. Heiland, E. Kling et al., Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression, Mol Cancer Res, vol.15, issue.8, pp.998-1011, 2017.

A. Federico, S. Zappavigna, M. Dallio, G. Misso, F. Merlino et al., Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors, Curr Cancer Drug Targets, vol.17, issue.2, pp.109-121, 2017.

A. Federico, S. Zappavigna, M. Romano, P. Grieco, A. Luce et al., Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans, Eur J Clin Invest, vol.44, issue.3, pp.285-294, 2014.

A. D. Federman, B. R. Conklin, K. A. Schrader, R. R. Reed, and H. R. Bourne, Hormonal stimulation of adenylyl cyclase through Gi-protein beta gamma subunits, Nature, vol.356, issue.6365, pp.159-161, 1992.

E. Feng, C. Sui, T. Wang, and G. Sun, Temozolomide with or without Radiotherapy in Patients with Newly Diagnosed Glioblastoma Multiforme: A Meta-Analysis, Eur Neurol, vol.77, issue.3-4, pp.201-210, 2017.

H. Feng, B. Hu, M. J. Jarzynka, Y. Li, S. Keezer et al., Phosphorylation of dedicator of cytokinesis 1 (Dock180) at tyrosine residue Y722 by Src family kinases mediates EGFRvIII-driven glioblastoma tumorigenesis, Proc Natl Acad Sci, vol.109, issue.8, pp.3018-3023, 2012.

H. Feng, B. Hu, K. Liu, Y. Li, X. Lu et al., Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFR?stimulated glioma tumorigenesis in mice and humans, J Clin Invest, vol.121, issue.12, pp.4670-4684, 2011.

X. Feng, N. Arang, D. C. Rigiracciolo, J. S. Lee, H. Yeerna et al., A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK, Cancer Cell, 2019.

X. Feng, M. S. Degese, R. Iglesias-bartolome, J. P. Vaque, A. A. Molinolo et al., Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry, Cancer Cell, vol.25, issue.6, pp.831-845, 2014.

J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, vol.136, issue.5, pp.359-386, 2015.

C. Fernandes, A. Costa, L. Osório, R. C. Lago, P. Linhares et al., Current Standards of Care in Glioblastoma Therapy, 2017.

M. Fève, J. Saliou, M. Zeniou, S. Lennon, C. Carapito et al., Comparative expression study of the endo-G protein coupled receptor (GPCR) repertoire in human glioblastoma cancer stem-like cells, U87-MG cells and non malignant cells of neural origin unveils new potential therapeutic targets, PLoS ONE, vol.9, issue.3, p.91519, 2014.

T. A. Fields and P. J. Casey, Phosphorylation of Gz alpha by protein kinase C blocks interaction with the beta gamma complex, J Biol Chem, vol.270, issue.39, pp.23119-23125, 1995.

A. C. Filley, M. Henriquez, and M. Dey, Recurrent glioma clinical trial, CheckMate-143: the game is not over yet, Oncotarget, vol.8, issue.53, pp.91779-91794, 2017.

R. Fiume, G. Ramazzotti, G. Teti, F. Chiarini, I. Faenza et al., Involvement of nuclear PLCbeta1 in lamin B1 phosphorylation and G2/M cell cycle progression, FASEB J, vol.23, issue.3, pp.957-966, 2009.

T. Flock, A. S. Hauser, N. Lund, D. E. Gloriam, S. Balaji et al., Selectivity determinants of GPCR-G-protein binding, Nature, vol.545, issue.7654, pp.317-322, 2017.

M. Y. Follo, I. Faenza, M. Piazzi, W. L. Blalock, L. Manzoli et al., Nuclear PI-PLC?1: an appraisal on targets and pathology, Adv Biol Regul, vol.54, pp.2-11, 2014.

S. P. Fortin-ensign, I. T. Mathews, M. H. Symons, M. E. Berens, and N. L. Tran, Implications of Rho GTPase Signaling in Glioma Cell Invasion and Tumor Progression, Front Oncol, vol.3, p.241, 2013.

S. P. Fortin, M. J. Ennis, C. A. Schumacher, C. R. Zylstra-diegel, B. O. Williams et al., Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells, Mol Cancer Res, vol.10, issue.7, pp.958-968, 2012.

G. Foltz, J. Yoon, H. Lee, L. Ma, Q. Tian et al., Epigenetic regulation of wnt pathway antagonists in human glioblastoma multiforme, Genes Cancer, vol.1, issue.1, pp.81-90, 2010.

R. Franco, E. Martínez-pinilla, G. Navarro, and M. Zamarbide, Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer's disease, Prog Neurobiol, 2017.

M. Frank, L. Thümer, M. J. Lohse, and M. Bünemann, G Protein activation without subunit dissociation depends on a G{alpha}(i)-specific region, J Biol Chem, vol.280, issue.26, pp.24584-24590, 2005.

R. Fredriksson, M. C. Lagerström, L. Lundin, and H. B. Schiöth, The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints, Mol Pharmacol, vol.63, issue.6, pp.1256-1272, 2003.

D. Friedmann-morvinski, Glioblastoma Heterogeneity and Cancer Cell Plasticity. CRO, vol.19, issue.5, 2014.

T. Frielle, S. Collins, K. W. Daniel, M. G. Caron, R. J. Lefkowitz et al., Cloning of the cDNA for the human beta 1-adrenergic receptor, Proc Natl Acad Sci, vol.84, issue.22, pp.7920-7924, 1987.

D. Fuchs, M. Metzig, M. Bickeböller, C. Brandel, and W. Roth, The G?5 protein regulates sensitivity to TRAIL-induced cell death in colon carcinoma, Oncogene, vol.34, issue.21, pp.2753-2763, 2015.

M. Fukaya, M. Uchigashima, S. Nomura, Y. Hasegawa, H. Kikuchi et al., Predominant expression of phospholipase Cbeta1 in telencephalic principal neurons and cerebellar interneurons, and its close association with related signaling molecules in somatodendritic neuronal elements, Eur J Neurosci, vol.28, issue.9, pp.1744-1759, 2008.

F. B. Furnari, T. Fenton, R. M. Bachoo, A. Mukasa, J. M. Stommel et al., Malignant astrocytic glioma: genetics, biology, and paths to treatment, Genes Dev, vol.21, issue.21, pp.2683-2710, 2007.

M. Gabay, M. E. Pinter, F. A. Wright, P. Chan, A. J. Murphy et al., Ric-8 proteins are molecular chaperones that direct nascent G protein ? subunit membrane association, Sci Signal, vol.4, p.79, 0200.

K. Gabrusiewicz, B. Rodriguez, J. Wei, Y. Hashimoto, L. M. Healy et al., Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype, JCI Insight, vol.1, issue.2, 2016.

C. Galés and M. Bouvier, New talk between receptor and trimeric G proteins: "an intertwined body dance, 2007.

, Med Sci (Paris), vol.23, issue.11, pp.1031-1034

C. Galés, R. V. Rebois, M. Hogue, P. Trieu, A. Breit et al., Real-time monitoring of receptor and G-protein interactions in living cells, Nat Methods, vol.2, issue.3, pp.177-184, 2005.

S. Gallo, A. Vitacolonna, A. Bonzano, P. Comoglio, and T. Crepaldi, ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy, Int J Mol Sci, vol.20, issue.9, 2019.

C. Gao, G. Chen, S. Kuan, D. H. Zhang, D. D. Schlaepfer et al., FAK/PYK2 promotes the Wnt/?catenin pathway and intestinal tumorigenesis by phosphorylating GSK3?, 2015.

X. Gao and Z. Xu, Mechanisms of action of angiogenin, Acta Biochim Biophys Sin (Shanghai), vol.40, issue.7, pp.619-624, 2008.

X. Gao, S. Sinha, M. Belcastro, C. Woodard, V. Ramamurthy et al., Splice isoforms of phosducin-like protein control the expression of heterotrimeric G proteins, J Biol Chem, vol.288, issue.36, pp.25760-25768, 2013.

J. García-nafría and C. G. Tate, Cryo-EM structures of GPCRs coupled to Gs, Gi and Go, Mol Cell Endocrinol, 2019.

J. A. Gardner, J. H. Ha, M. Jayaraman, and D. N. Dhanasekaran, The gep proto-oncogene G?13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells, Pancreas, vol.42, issue.5, pp.819-828, 2013.

A. D. Garg, L. Vandenberk, C. Koks, T. Verschuere, L. Boon et al., Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma, Sci Transl Med, vol.8, issue.328, pp.328-355, 2016.

T. Garzon-muvdi, P. Schiapparelli, C. Ap-rhys, H. Guerrero-cazares, C. Smith et al., Regulation of brain tumor dispersal by NKCC1 through a novel role in focal adhesion regulation, PLoS Biol, vol.10, issue.5, p.1001320, 2012.

A. Genna, S. Lapetina, N. Lukic, S. Twafra, T. Meirson et al., Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cells, J Cell Biol, vol.217, issue.1, pp.375-395, 2018.

M. Gerlinger, A. J. Rowan, S. Horswell, M. Math, J. Larkin et al., Intratumor heterogeneity and branched evolution revealed by multiregion sequencing, N Engl J Med, vol.366, issue.10, pp.883-892, 2012.

S. Ghil, K. L. Mccoy, and J. R. Hepler, Regulator of G protein signaling 2 (RGS2) and RGS4 form distinct G protein-dependent complexes with protease activated-receptor 1 (PAR1) in live cells, PLoS ONE, vol.9, issue.4, p.95355, 2014.

D. Ghosh, S. Nandi, and S. Bhattacharjee, Combination therapy to checkmate Glioblastoma: clinical challenges and advances, Clin Transl Med, vol.7, issue.1, p.33, 2018.

F. Giannone, G. Malpeli, V. Lisi, S. Grasso, P. Shukla et al., The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis, Journal of Molecular Endocrinology, vol.44, issue.5, pp.259-269, 2010.

M. R. Gilbert, J. J. Dignam, T. S. Armstrong, J. S. Wefel, D. T. Blumenthal et al., A randomized trial of bevacizumab for newly diagnosed glioblastoma, N Engl J Med, vol.370, issue.8, pp.699-708, 2014.

M. R. Gilbert, M. Wang, K. D. Aldape, R. Stupp, M. E. Hegi et al., Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial, J Clin Oncol, vol.31, issue.32, pp.4085-4091, 2013.

S. Gillespie, X. D. Zhang, and P. Hersey, Variable expression of protein kinase C epsilon in human melanoma cells regulates sensitivity to TRAIL-induced apoptosis, Mol Cancer Ther, vol.4, issue.4, pp.668-676, 2005.

A. G. Gilman, G proteins: transducers of receptor-generated signals, Annu Rev Biochem, vol.56, pp.615-649, 1987.

F. Giovinazzo, G. Malpeli, S. Zanini, M. Parenti, L. Piemonti et al., Ectopic expression of the heterotrimeric G15 protein in pancreatic carcinoma and its potential in cancer signal transduction, Cellular Signalling, vol.25, issue.3, pp.651-659, 2013.

R. Glass and M. Synowitz, CNS macrophages and peripheral myeloid cells in brain tumours, Acta Neuropathol, vol.128, issue.3, pp.347-362, 2014.

H. L. Goel and A. M. Mercurio, VEGF targets the tumour cell, Nat Rev Cancer, vol.13, issue.12, pp.871-882, 2013.

A. Gohla, R. Harhammer, and G. Schultz, The G-protein G13 but not G12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to Rho, J Biol Chem, vol.273, issue.8, pp.4653-4659, 1998.

W. H. Goldmann, V. Auernheimer, I. Thievessen, and B. Fabry, Vinculin, cell mechanics and tumour cell invasion, Cell Biol Int, vol.37, issue.5, pp.397-405, 2013.

Z. G. Goldsmith and D. N. Dhanasekaran, G protein regulation of MAPK networks, Oncogene, vol.26, issue.22, pp.3122-3142, 2007.

Z. G. Goldsmith, J. H. Ha, M. Jayaraman, and D. N. Dhanasekaran, Lysophosphatidic Acid Stimulates the Proliferation of Ovarian Cancer Cells via the gep Proto-Oncogene G?(12), Genes Cancer, vol.2, issue.5, pp.563-575, 2011.

K. Gollapalli, S. Ghantasala, S. Kumar, R. Srivastava, S. Rapole et al., Subventricular zone involvement in Glioblastoma -A proteomic evaluation and clinicoradiological correlation, Sci Rep, vol.7, issue.1, p.1449, 2017.

R. Gomel, C. Xiang, S. Finniss, H. K. Lee, W. Lu et al., The localization of protein kinase Cdelta in different subcellular sites affects its proapoptotic and antiapoptotic functions and the activation of distinct downstream signaling pathways, Mol Cancer Res, vol.5, issue.6, pp.627-639, 2007.

H. Gong, X. Gao, S. Feng, M. R. Siddiqui, A. Garcia et al., Evidence of a common mechanism of disassembly of adherens junctions through G?13 targeting of VE-cadherin, J Exp Med, vol.211, issue.3, pp.579-591, 2014.

A. M. Gonzalez-guerrico and M. G. Kazanietz, Phorbol ester-induced apoptosis in prostate cancer cells via autocrine activation of the extrinsic apoptotic cascade: a key role for protein kinase C delta, J Biol Chem, vol.280, issue.47, pp.38982-38991, 2005.

M. C. De-gooijer, G. Navarro, M. Bernards, R. Wurdinger, T. Van-tellingen et al., An Experimenter's Guide to Glioblastoma Invasion Pathways, Trends Mol Med, vol.24, issue.9, pp.763-780, 2018.

J. R. Graff, A. M. Mcnulty, K. R. Hanna, B. W. Konicek, R. L. Lynch et al., The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts, Cancer Res, vol.65, issue.16, pp.7462-7469, 2005.

K. R. Grant, W. Harnett, G. Milligan, and M. M. Harnett, Differential G-protein expression during B-and T-cell development, Immunology, vol.90, issue.4, pp.564-571, 1997.

C. M. Greene, S. J. Marciniak, J. Teckman, I. Ferrarotti, M. L. Brantly et al., Nat Rev Dis Primers, vol.2, p.16051, 2016.

A. Gresset, J. Sondek, and T. K. Harden, The phospholipase C isozymes and their regulation, Subcell Biochem, vol.58, pp.61-94, 2012.

S. Grinberg, G. Hasko, D. Wu, and S. J. Leibovich, Suppression of PLCbeta2 by endotoxin plays a role in the adenosine A(2A) receptor-mediated switch of macrophages from an inflammatory to an angiogenic phenotype, Am J Pathol, vol.175, issue.6, pp.2439-2453, 2009.

E. M. Griner and M. G. Kazanietz, Protein kinase C and other diacylglycerol effectors in cancer, Nat Rev Cancer, vol.7, issue.4, pp.281-294, 2007.

G. Grishina and C. H. Berlot, A surface-exposed region of G(salpha) in which substitutions decrease receptor-mediated activation and increase receptor affinity, Mol Pharmacol, vol.57, issue.6, pp.1081-1092, 2000.

S. I. Grivennikov and K. M. , Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer, Cytokine Growth Factor Rev, vol.21, issue.1, pp.11-19, 2010.

E. Gronseth, L. Wang, D. R. Harder, and R. Ramchandran, The Role of Astrocytes in Tumor Growth and Progression, Astrocyte -Physiology and Pathology, 2018.

J. L. Gu, W. Lu, C. Xia, X. Wu, and M. Liu, Regulation of hematopoietic-specific G-protein Galpha15 and Galpha16 by protein kinase C, J Cell Biochem, vol.88, issue.6, pp.1101-1111, 2003.

Y. Gu, Q. Feng, H. Liu, Q. Zhou, A. Hu et al., Bioinformatic evidences and analysis of putative biomarkers in pancreatic ductal adenocarcinoma, Heliyon, vol.5, issue.8, p.2378, 2019.

K. Guo, P. Fu, K. Juerchott, H. Motaln, J. Selbig et al., The expression of Wnt-inhibitor DKK1 (Dickkopf 1) is determined by intercellular crosstalk and hypoxia in human malignant gliomas, J Cancer Res Clin Oncol, vol.140, issue.8, pp.1261-1270, 2014.

J. H. Ha, R. Radhakrishnan, M. Jayaraman, M. Yan, J. D. Ward et al., LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response, Cancer Res, vol.78, issue.8, pp.1923-1934, 2018.

J. H. Ha, J. D. Ward, L. Varadarajalu, S. G. Kim, and D. N. Dhanasekaran, The gep proto-oncogene G?12 mediates LPA-stimulated activation of CREB in ovarian cancer cells, Cell Signal, vol.26, issue.1, pp.122-132, 2014.

C. W. Habela, N. J. Ernest, A. F. Swindall, and H. Sontheimer, Chloride accumulation drives volume dynamics underlying cell proliferation and migration, J Neurophysiol, vol.101, issue.2, pp.750-757, 2009.

D. Hambardzumyan and G. Bergers, Glioblastoma: Defining Tumor Niches, Trends Cancer, vol.1, issue.4, pp.252-265, 2015.

D. Hambardzumyan, D. H. Gutmann, and H. Kettenmann, The role of microglia and macrophages in glioma maintenance and progression, Nat Neurosci, vol.19, issue.1, pp.20-27, 2016.

S. Han, J. Kim, M. Han, H. Sim, K. Kim et al., SNAI1 is involved in the proliferation and migration of glioblastoma cells, Cell Mol Neurobiol, vol.31, issue.3, pp.489-496, 2011.

J. Hanoune and N. Defer, Regulation and role of adenylyl cyclase isoforms, Annu Rev Pharmacol Toxicol, vol.41, pp.145-174, 2001.

C. Hansen, J. Howlin, A. Tengholm, O. Dyachok, W. F. Vogel et al., Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner, J Biol Chem, vol.284, issue.40, pp.27533-27543, 2009.

C. A. Hansen, A. G. Schroering, D. J. Carey, and J. D. Robishaw, Localization of a heterotrimeric G protein gamma subunit to focal adhesions and associated stress fibers, J Cell Biol, vol.126, issue.3, pp.811-819, 1994.

L. Hardell, M. Carlberg, F. Söderqvist, and K. H. Mild, Case-control study of the association between malignant brain tumours diagnosed between 2007 and 2009 and mobile and cordless phone use, Int J Oncol, vol.43, issue.6, pp.1833-1845, 2013.

T. K. Harden, G. L. Waldo, S. N. Hicks, and J. Sondek, Mechanism of activation and inactivation of Gq/phospholipase C-? signaling nodes, Chem Rev, vol.111, issue.10, pp.6120-6129, 2011.

A. W. Harris, Differentiated functions expressed by cultured mouse lymphoma cells. I. Specificity and kinetics of cell responses to corticosteroids, Exp Cell Res, vol.60, issue.3, pp.90527-90533, 1970.

M. G. Hart, R. Garside, G. Rogers, K. Stein, and R. Grant, Temozolomide for high grade glioma, Cochrane Database Syst Rev, issue.4, p.7415, 2013.

M. J. Hart, X. Jiang, T. Kozasa, W. Roscoe, W. D. Singer et al., Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13, Science, vol.280, issue.5372, pp.2112-2114, 1998.

W. P. Hausdorff, J. A. Pitcher, D. K. Luttrell, M. E. Linder, H. Kurose et al., Tyrosine phosphorylation of G protein alpha subunits by pp60c-src, Proc Natl Acad Sci, vol.89, issue.13, pp.5720-5724, 1992.

B. E. Hayward, V. Moran, L. Strain, and D. T. Bonthron, Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins, Proc Natl Acad Sci, vol.95, issue.26, pp.15475-15480, 1998.

X. He, L. Zhang, Y. Chen, M. Remke, D. Shih et al., The G protein ? subunit G?s is a tumor suppressor in Sonic hedgehog-driven medulloblastoma, Nat Med, vol.20, issue.9, pp.1035-1042, 2014.

L. E. Heasley, B. Storey, G. R. Fanger, L. Butterfield, J. Zamarripa et al., GTPasedeficient G alpha 16 and G alpha q induce PC12 cell differentiation and persistent activation of cJun NH2-terminal kinases, Mol Cell Biol, vol.16, issue.2, pp.648-656, 1996.

M. E. Hegi, A. Diserens, T. Gorlia, M. Hamou, N. De-tribolet et al., MGMT gene silencing and benefit from temozolomide in glioblastoma, N Engl J Med, vol.352, issue.10, pp.997-1003, 2005.

D. H. Heiland, G. Haaker, D. Delev, B. Mercas, W. Masalha et al., Comprehensive analysis of PD-L1 expression in glioblastoma multiforme, Oncotarget, vol.8, issue.26, pp.42214-42225, 2017.

L. Hemmings, D. J. Rees, V. Ohanian, S. J. Bolton, A. P. Gilmore et al., Talin contains three actin-binding sites each of which is adjacent to a vinculin-binding site, J Cell Sci, vol.109, pp.2715-2726, 1996.

H. Heiland, D. Ravi, V. M. Behringer, S. P. Frenking, J. H. Wurm et al., Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma, Nat Commun, vol.10, issue.1, p.2541, 2019.

J. R. Hepler, G protein coupled receptor signaling complexes in live cells, Cell Logist, vol.4, p.29392, 2014.

S. Herlitze, D. E. Garcia, K. Mackie, B. Hille, T. Scheuer et al., Modulation of Ca2+ channels by G-protein beta gamma subunits, Nature, vol.380, issue.6571, pp.258-262, 1996.

R. Higashita, L. Li, V. Van-putten, Y. Yamamura, F. Zarinetchi et al., Galpha16 mimics vasoconstrictor action to induce smooth muscle alpha-actin in vascular smooth muscle cells through a Jun-NH2-terminal kinase-dependent pathway, J Biol Chem, vol.272, issue.41, pp.25845-25850, 1997.

D. Hilger, M. Masureel, and B. K. Kobilka, Structure and dynamics of GPCR signaling complexes, Nat Struct Mol Biol, vol.25, issue.1, pp.4-12, 2018.

S. J. Hill and J. G. Baker, The ups and downs of Gs-to Gi-protein switching, Br J Pharmacol, vol.138, issue.7, pp.1188-1189, 2003.

B. Hille, G protein-coupled mechanisms and nervous signaling, Neuron, vol.9, issue.2, pp.187-195, 1992.

S. Hino, C. Tanji, K. I. Nakayama, and A. Kikuchi, Phosphorylation of beta-catenin by cyclic AMPdependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination, Mol Cell Biol, vol.25, issue.20, pp.9063-9072, 2005.

H. Hippe, M. Luedde, S. Lutz, H. Koehler, T. Eschenhagen et al., Regulation of cardiac cAMP synthesis and contractility by nucleoside diphosphate kinase B/G protein beta gamma dimer complexes, Circ Res, vol.100, issue.8, pp.1191-1199, 2007.

M. K. Ho and Y. H. Wong, Structure and function of the pertussis-toxin-insensitive Gz protein, Biol Signals Recept, vol.7, issue.2, pp.80-89, 1998.

M. Ho, J. Chan, C. Wong, and Y. H. Wong, Identification of a stretch of six divergent amino acids on the alpha5 helix of Galpha16 as a major determinant of the promiscuity and efficiency of receptor coupling, Biochem J, vol.380, issue.2, pp.361-369, 2004.

S. R. Holbrook and S. H. Kim, Molecular model of the G protein alpha subunit based on the crystal structure of the HRAS protein, Proc Natl Acad Sci, vol.86, issue.6, pp.1751-1755, 1989.

E. C. Holland, J. Celestino, C. Dai, L. Schaefer, R. E. Sawaya et al., Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice, Nat Genet, vol.25, issue.1, pp.55-57, 2000.

S. Hollinger and J. R. Hepler, Cellular regulation of RGS proteins: modulators and integrators of G protein signaling, Pharmacol Rev, vol.54, issue.3, pp.527-559, 2002.

K. Horibata and A. W. Harris, Mouse myelomas and lymphomas in culture, Exp Cell Res, vol.60, issue.1, pp.61-77, 1970.

A. Hornia, Z. Lu, T. Sukezane, M. Zhong, T. Joseph et al., Antagonistic effects of protein kinase C alpha and delta on both transformation and phospholipase D activity mediated by the epidermal growth factor receptor, Mol Cell Biol, vol.19, issue.11, pp.7672-7680, 1999.

Y. Hou, I. Azpiazu, A. Smrcka, and N. Gautam, Selective role of G protein gamma subunits in receptor interaction, J Biol Chem, vol.275, issue.50, pp.38961-38964, 2000.

J. A. Hsia, J. Moss, E. L. Hewlett, and M. Vaughan, ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding, J Biol Chem, vol.259, issue.2, pp.1086-1090, 1984.

J. Hu, Y. Wang, X. Zhang, J. R. Lloyd, J. H. Li et al., Structural basis of G protein-coupled receptor-G protein interactions, Nat Chem Biol, vol.6, issue.7, pp.541-548, 2010.

J. Hu, X. Wang, J. Zhou, F. Wang, X. Li et al., Activation of PKC-alpha is required for migration of C6 glioma cells, Acta Neurobiol Exp (Wars), vol.70, issue.3, pp.239-245, 2010.

J. Hu, W. Luo, and H. Wang, Angiogenin Upregulation Independently Predicts Unfavorable Overall Survival in Proneural Subtype of Glioblastoma, Technol Cancer Res Treat, vol.18, p.1533033819846636, 2019.

C. Huang, K. Jacobson, and M. D. Schaller, A role for JNK-paxillin signaling in cell migration, Cell Cycle, vol.3, issue.1, pp.4-6, 2004.

Y. Huang, X. J. Shen, Q. Zou, S. P. Wang, S. M. Tang et al., Biological functions of microRNAs: a review, J Physiol Biochem, vol.67, issue.1, pp.129-139, 2011.

. Kléouforo-paul, DEMBELE Activation of Adhesion GPCR EMR2/ADGRE2 Induces Macrophage Differentiation and Inflammatory Responses via G?16/Akt/MAPK/NF-?B Signaling Pathways, Front Immunol, vol.8, p.373

M. A. Hull, S. Ko, and G. Hawcroft, Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer?, Mol Cancer Ther, vol.3, issue.8, pp.1031-1039, 2004.

J. D. Humphries, P. Wang, C. Streuli, B. Geiger, M. J. Humphries et al., Vinculin controls focal adhesion formation by direct interactions with talin and actin, J Cell Biol, vol.179, issue.5, pp.1043-1057, 2007.

J. M. Hunt, R. ;. Tuder, . Jb, H. K. Fong, D. B. Teplow et al., Isolation and characterization of a cDNA clone for the gamma subunit of bovine retinal transducin, Proc Natl Acad Sci, vol.12, issue.7, pp.6948-6952, 1984.

E. H. Hurowitz, J. M. Melnyk, Y. J. Chen, H. Kouros-mehr, M. I. Simon et al., Genomic characterization of the human heterotrimeric G protein alpha, beta, and gamma subunit genes, DNA Res, vol.7, issue.2, pp.111-120, 2000.

J. H. Hurst and S. B. Hooks, Regulator of G-protein signaling (RGS) proteins in cancer biology, Biochem Pharmacol, vol.78, issue.10, pp.1289-1297, 2009.

S. F. Hussain, D. Yang, D. Suki, K. Aldape, E. Grimm et al., The role of human gliomainfiltrating microglia/macrophages in mediating antitumor immune responses, Neurooncology, vol.8, issue.3, pp.261-279, 2006.

S. Huveneers and E. Danen, Adhesion signaling -crosstalk between integrins, Src and Rho, J Cell Sci, vol.122, pp.1059-1069, 2009.

J. Ibarrondo, D. Joubert, M. N. Dufour, A. Cohen-solal, V. Homburger et al., Close association of the alpha subunits of Gq and G11 G proteins with actin filaments in WRK1 cells: relation to G protein-mediated phospholipase C activation, Proc Natl Acad Sci, vol.92, issue.18, pp.8413-8417, 1995.

R. Iglesias-bartolome, D. Torres, R. Marone, X. Feng, D. Martin et al., Inactivation of a G?(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis, Nat Cell Biol, vol.17, issue.6, pp.793-803, 2015.

T. Iguchi, K. Sakata, K. Yoshizaki, K. Tago, N. Mizuno et al., Orphan G protein-coupled receptor GPR56 regulates neural progenitor cell migration via a G alpha 12/13 and Rho pathway, J Biol Chem, vol.283, issue.21, pp.14469-14478, 2008.

T. Iiri, Z. Farfel, and H. R. Bourne, G-protein diseases furnish a model for the turn-on switch, Nature, vol.394, issue.6688, pp.35-38, 1998.

D. Illenberger, F. Schwald, D. Pimmer, W. Binder, G. Maier et al., Stimulation of phospholipase C-beta2 by the Rho GTPases Cdc42Hs and Rac1, EMBO J, vol.17, issue.21, pp.6241-6249, 1998.

D. Illenberger, C. Walliser, B. Nurnberg, M. Diaz-lorente, and P. Gierschik, Specificity and structural requirements of phospholipase C-beta stimulation by Rho GTPases versus G protein beta gamma dimers, J Biol Chem, vol.278, issue.5, pp.3006-3014, 2003.

D. Illenberger, C. Walliser, B. Nurnberg, M. Diaz-lorente, and P. Gierschik, Specificity and structural requirements of phospholipase C-beta stimulation by Rho GTPases versus G protein beta gamma dimers, J Biol Chem, vol.278, issue.5, pp.3006-3014, 2003.

D. Im, Intercellular Lipid Mediators and GPCR Drug Discovery, Biomol Ther (Seoul), vol.21, issue.6, pp.411-422, 2013.

G. Innamorati, F. Giannone, F. Guzzi, G. E. Rovati, M. R. Accomazzo et al., Heterotrimeric G proteins demonstrate differential sensitivity to ?-arrestin dependent desensitization, Cellular Signalling, vol.21, issue.7, pp.1135-1142, 2009.

A. Inoue, F. Raimondi, F. Kadji, G. Singh, T. Kishi et al., Illuminating G-Protein-Coupling Selectivity of GPCRs, Cell, 2019.

Y. Iwadate, Epithelial-mesenchymal transition in glioblastoma progression, Oncol Lett, vol.11, issue.3, pp.1615-1620, 2016.

K. K. Jain, A Critical Overview of Targeted Therapies for Glioblastoma, Front Oncol, vol.8, p.419, 2018.

C. Janetopoulos, T. Jin, and P. Devreotes, Receptor-mediated activation of heterotrimeric G-proteins in living cells, Science, vol.291, issue.5512, pp.2408-2411, 2001.

J. M. Janz and D. L. Farrens, Rhodopsin activation exposes a key hydrophobic binding site for the transducin alpha-subunit C terminus, J Biol Chem, vol.279, issue.28, pp.29767-29773, 2004.

A. A. Jarjour, M. Durko, T. L. Luk, N. Marçal, M. Shekarabi et al., Autocrine netrin function inhibits glioma cell motility and promotes focal adhesion formation, PLoS ONE, vol.6, issue.9, p.25408, 2011.

M. Jarry, M. Diallo, C. Lecointre, L. Desrues, T. Tokay et al., The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation, Biochem J, vol.428, issue.1, pp.113-124, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00479207

B. Jastrzebska, Y. Tsybovsky, and K. Palczewski, Complexes between photoactivated rhodopsin and transducin: progress and questions, Biochem J, vol.428, issue.1, pp.1-10, 2010.

C. L. Jelsema and J. Axelrod, Stimulation of phospholipase A2 activity in bovine rod outer segments by the beta gamma subunits of transducin and its inhibition by the alpha subunit, Proc Natl Acad Sci, vol.84, issue.11, pp.3623-3627, 1987.

X. Jian, W. A. Clark, J. Kowalak, S. P. Markey, W. F. Simonds et al., Gbetagamma affinity for bovine rhodopsin is determined by the carboxyl-terminal sequences of the gamma subunit, J Biol Chem, vol.276, issue.51, pp.48518-48525, 2001.

H. Jiang, Y. Kuang, Y. Wu, W. Xie, M. I. Simon et al., Roles of phospholipase C beta2 in chemoattractant-elicited responses, Proc Natl Acad Sci, vol.94, issue.15, pp.7971-7975, 1997.

X. Jiang, S. Tu, J. Cui, M. Lin, H. Xia et al., Antisense targeting protein kinase C alpha and beta1 inhibits gastric carcinogenesis, Cancer Res, vol.64, issue.16, pp.5787-5794, 2004.

Y. Jiao, P. J. Killela, Z. J. Reitman, A. B. Rasheed, C. M. Heaphy et al., Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas, Oncotarget, vol.3, issue.7, pp.709-722, 2012.

B. B. Johansson, L. Minsaas, and A. M. Aragay, Proteasome involvement in the degradation of the G(q) family of Galpha subunits, FEBS J, vol.272, issue.20, pp.5365-5377, 2005.

J. V. Joseph, S. Conroy, K. Pavlov, P. Sontakke, T. Tomar et al., Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1?-ZEB1 axis, Cancer Lett, vol.359, issue.1, pp.107-116, 2015.

I. Kaafarani, S. Fernandez-sauze, C. Berenguer, O. Chinot, C. Delfino et al., Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice, FASEB J, vol.23, issue.10, pp.3424-3435, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01848088

S. Kahana, S. Finniss, S. Cazacu, C. Xiang, H. Lee et al., Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKC?-dependent downregulation of AKT and XIAP expressions, Cell Signal, vol.23, issue.8, pp.1348-1357, 2011.

U. D. Kahlert, D. Maciaczyk, S. Doostkam, B. A. Orr, B. Simons et al., Activation of canonical WNT/?-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition, Cancer Lett, vol.325, issue.1, pp.42-53, 2012.

U. D. Kahlert, G. Nikkhah, and J. Maciaczyk, Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas, Cancer Lett, vol.331, issue.2, pp.131-138, 2013.

R. Kalluri and R. A. Weinberg, The basics of epithelial-mesenchymal transition, J Clin Invest, vol.119, issue.6, pp.1420-1428, 2009.

N. A. Kalogriopoulos, S. D. Rees, T. Ngo, N. J. Kopcho, A. V. Ilatovskiy et al., Structural basis for GPCR-independent activation of heterotrimeric Gi proteins, Proc Natl Acad Sci, 2019.

P. Kanchanawong, G. Shtengel, A. M. Pasapera, E. B. Ramko, M. W. Davidson et al., Nanoscale architecture of integrin-based cell adhesions, Nature, vol.468, issue.7323, pp.580-584, 2010.

M. Karsy, J. Guan, R. Jensen, L. E. Huang, and H. Colman, The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells Regulation, World Neurosurg, vol.88, pp.222-236, 2016.

H. R. Kaslow and D. L. Burns, Pertussis toxin and target eukaryotic cells: binding, entry, and activation, FASEB J, vol.6, issue.9, pp.2684-2690, 1992.

K. Kato, D. Yamanouchi, K. Esbona, K. Kamiya, F. Zhang et al., Caspase-mediated protein kinase C-delta cleavage is necessary for apoptosis of vascular smooth muscle cells, Am J Physiol Heart Circ Physiol, vol.297, issue.6, pp.2253-2261, 2009.

H. Katoh, J. Aoki, Y. Yamaguchi, Y. Kitano, A. Ichikawa et al., induce Rho-dependent neurite retraction through different signaling pathways, Constitutively active Galpha12, Galpha13, and Galphaq, vol.273, pp.28700-28707, 1998.

H. Katoh, K. Hiramoto, and M. Negishi, Activation of Rac1 by RhoG regulates cell migration, J Cell Sci, vol.119, pp.56-65, 2006.

S. Kaul, V. Anantharam, Y. Yang, C. J. Choi, A. Kanthasamy et al., Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells, J Biol Chem, vol.280, issue.31, pp.28721-28730, 2005.

T. Kawakami and X. W. , Phospholipase C-? in immune cells, Adv Biol Regul, vol.53, issue.3, pp.249-257, 2013.

R. H. Kehlenbach, J. Matthey, and W. B. Huttner, XL alpha s is a new type of G protein, Nature, vol.372, issue.6508, pp.804-809, 1994.

J. H. Kehrl, The impact of RGS and other G-protein regulatory proteins on G?i-mediated signaling in immunity, Biochem Pharmacol, vol.114, pp.40-52, 2016.

P. Kelly, B. J. Moeller, J. Juneja, M. A. Booden, C. J. Der et al., The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis, Proc Natl Acad Sci, vol.103, issue.21, pp.8173-8178, 2006.

P. Kelly, L. N. Stemmle, J. F. Madden, T. A. Fields, Y. Daaka et al., A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion, J Biol Chem, vol.281, issue.36, pp.26483-26490, 2006.

S. M. Khan, R. Sleno, S. Gora, P. Zylbergold, J. Laverdure et al., The expanding roles of G?? subunits in G protein-coupled receptor signaling and drug action, Pharmacol Rev, vol.65, issue.2, pp.545-577, 2013.

C. G. Kim, D. Park, and S. G. Rhee, The role of carboxyl-terminal basic amino acids in Gqalpha-dependent activation, particulate association, and nuclear localization of phospholipase C-beta1, J Biol Chem, vol.271, issue.35, pp.21187-21192, 1996.

H. Kim, S. Zheng, S. S. Amini, S. M. Virk, T. Mikkelsen et al., Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution, Genome Res, vol.25, issue.3, pp.316-327, 2015.

D. M. Kim, S. Choi, Y. I. Yeom, S. Min, and I. Kim, Genome-scale functional analysis of the human genes modulating p53 activity by regulating MDM2 expression in a p53-independent manner, Biochem Biophys Res Commun, vol.478, issue.2, pp.976-981, 2016.

J. Kim, I. Lee, H. J. Cho, C. Park, Y. Jung et al., Spatiotemporal Evolution of the Primary Glioblastoma Genome, Cancer Cell, vol.28, issue.3, pp.318-328, 2015.

A. J. Kimple, M. Soundararajan, S. Q. Hutsell, A. K. Roos, D. J. Urban et al., Structural determinants of G-protein alpha subunit selectivity by regulator of G-protein signaling 2 (RGS2), J Biol Chem, vol.284, issue.29, pp.19402-19411, 2009.

S. Klein, H. Reuveni, and A. Levitzki, Signal transduction by a nondissociable heterotrimeric yeast G protein, Proc Natl Acad Sci, vol.97, issue.7, pp.3219-3223, 2000.

H. Koh, Phospholipase C-?1 and schizophrenia-related behaviors, Adv Biol Regul, vol.53, issue.3, pp.242-248, 2013.

I. Koh, J. Cha, J. Park, J. Choi, S. Kang et al., The mode and dynamics of glioblastoma cell invasion into a decellularized tissue-derived extracellular matrix-based three-dimensional tumor model, Sci Rep, vol.8, issue.1, p.4608, 2018.

Z. A. Kohutek, C. G. Dipierro, G. T. Redpath, and I. M. Hussaini, ADAM-10-mediated N-cadherin cleavage is protein kinase C-alpha dependent and promotes glioblastoma cell migration, J Neurosci, vol.29, issue.14, pp.4605-4615, 2009.

M. Konishi, Y. Hayakawa, and K. Koike, Role of Muscarinic Acetylcholine Signaling in Gastrointestinal Cancers, Biomedicines, vol.7, issue.3, 2019.

M. Konishi, Y. Hayakawa, and K. Koike, Role of Muscarinic Acetylcholine Signaling in Gastrointestinal Cancers, Biomedicines, vol.7, issue.3, 2019.

J. Kouno, H. Nagai, T. Nagahata, M. Onda, H. Yamaguchi et al., Up-regulation of CC chemokine, CCL3L1, and receptors, CCR3, CCR5 in human glioblastoma that promotes cell growth, J Neurooncol, vol.70, issue.3, pp.301-307, 2004.

G. V. Koukourakis, V. Kouloulias, G. Zacharias, C. Papadimitriou, P. Pantelakos et al., Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article, Molecules, vol.14, issue.4, pp.1561-1577, 2009.

T. Kozasa, J. R. Hepler, A. V. Smrcka, M. I. Simon, S. G. Rhee et al., Purification and characterization of recombinant G16 alpha from Sf9 cells: activation of purified phospholipase C isozymes by G-protein alpha subunits, Proc Natl Acad Sci, vol.90, pp.9176-9180, 1993.

A. Krishnan, A. Mustafa, M. S. Almén, R. Fredriksson, M. J. Williams et al., Evolutionary hierarchy of vertebrate-like heterotrimeric G protein families, Mol Phylogenet Evol, vol.91, pp.27-40, 2015.

J. Krupinski, F. Coussen, H. A. Bakalyar, W. J. Tang, P. G. Feinstein et al., Adenylyl cyclase amino acid sequence: possible channel-or transporter-like structure, Science, vol.244, issue.4912, pp.1558-1564, 1989.

M. Kühl, L. C. Sheldahl, M. Park, J. R. Miller, and R. T. Moon, The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape, Trends Genet, vol.16, issue.7, pp.279-283, 2000.

V. Kumar, Y. Jong, and K. L. O'malley, Activated nuclear metabotropic glutamate receptor mGlu5 couples to nuclear Gq/11 proteins to generate inositol 1,4,5-trisphosphate-mediated nuclear Ca2+ release, J Biol Chem, vol.283, pp.14072-14083, 1920.

G. Kunarso, N. Chia, J. Jeyakani, C. Hwang, X. Lu et al., Transposable elements have rewired the core regulatory network of human embryonic stem cells, Nat Genet, vol.42, issue.7, pp.631-634, 2010.

J. Kuo, X. Han, C. Hsiao, J. R. Yates, and C. M. Waterman, Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for ?-Pix in negative regulation of focal adhesion maturation, Nat Cell Biol, vol.13, issue.4, pp.383-393, 2011.

M. Kurayoshi, N. Oue, H. Yamamoto, M. Kishida, A. Inoue et al., Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion, Cancer Res, vol.66, issue.21, pp.10439-10448, 2006.

A. Kwiatkowska, S. Didier, S. Fortin, Y. Chuang, T. White et al., The small GTPase RhoG mediates glioblastoma cell invasion, Mol Cancer, vol.11, p.65, 2012.

M. Lachance, N. Ethier, G. Wolbring, P. P. Schnetkamp, and T. E. Hébert, Stable association of G proteins with beta 2AR is independent of the state of receptor activation, Cell Signal, vol.11, issue.7, pp.523-533, 1999.

M. Lacroix, D. Abi-said, D. R. Fourney, Z. L. Gokaslan, W. Shi et al., A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival, J Neurosurg, vol.95, issue.2, pp.190-198, 2001.

F. Lai, M. Szczodrak, J. M. Oelkers, M. Ladwein, F. Acconcia et al., Cortactin promotes migration and platelet-derived growth factorinduced actin reorganization by signaling to Rho-GTPases, Mol Biol Cell, vol.20, issue.14, pp.3209-3223, 2009.

N. A. Lambert, Dissociation of heterotrimeric g proteins in cells, Sci Signal, vol.1, issue.25, p.5, 2008.

D. G. Lambright, J. P. Noel, H. E. Hamm, and P. B. Sigler, Structural determinants for activation of the alphasubunit of a heterotrimeric G protein, Nature, vol.369, issue.6482, pp.621-628, 1994.

D. G. Lambright, J. Sondek, A. Bohm, N. P. Skiba, H. E. Hamm et al., The 2.0 A crystal structure of a heterotrimeric G protein, Nature, vol.379, issue.6563, pp.311-319, 1996.

V. J. Lamorte, A. T. Harootunian, A. M. Spiegel, R. Y. Tsien, and J. R. Feramisco, Mediation of growth factor induced DNA synthesis and calcium mobilization by Gq and Gi2, J Cell Biol, vol.121, issue.1, pp.91-99, 1993.

F. Lan, Y. Yang, J. Han, Q. Wu, H. Yu et al., Sulforaphane reverses chemo-resistance to temozolomide in glioblastoma cells by NF-?B-dependent pathway downregulating MGMT expression, Int J Oncol, vol.48, issue.2, pp.559-568, 2016.

J. Langhans, L. Schneele, N. Trenkler, V. Bandemer, H. Nonnenmacher et al., The effects of PI3K-mediated signalling on glioblastoma cell behaviour, Oncogenesis, vol.6, issue.11, p.398, 2017.

R. Lappano and M. Maggiolini, G protein-coupled receptors: novel targets for drug discovery in cancer, Nat Rev Drug Discov, vol.10, issue.1, pp.47-60, 2011.

R. Lappano, D. Rigiracciolo, D. Marco, P. Avino, S. Cappello et al., Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling, AAPS J, vol.18, issue.2, pp.305-310, 2016.

N. R. Latorraca, A. J. Venkatakrishnan, and R. O. Dror, GPCR Dynamics: Structures in Motion, Chem Rev, vol.117, issue.1, pp.139-155, 2017.

J. Lau, S. Ilkhanizadeh, S. Wang, Y. A. Miroshnikova, N. A. Salvatierra et al., STAT3 Blockade Inhibits Radiation-Induced Malignant Progression in Glioma, Cancer Res, vol.75, issue.20, pp.4302-4311, 2015.

W. W. Lau, A. S. Chan, L. S. Poon, J. Zhu, and Y. H. Wong, G??-mediated activation of protein kinase D exhibits subunit specificity and requires G??-responsive phospholipase C? isoforms, Cell Commun Signal, vol.11, issue.1, p.22, 2013.

W. W. Lau, A. S. Chan, L. S. Poon, J. Zhu, and Y. H. Wong, G??-mediated activation of protein kinase D exhibits subunit specificity and requires G??-responsive phospholipase C? isoforms, Cell Commun Signal, vol.11, issue.1, p.22, 2013.

F. Lausecker, X. Tian, K. Inoue, Z. Wang, C. E. Pedigo et al., Vinculin is required to maintain glomerular barrier integrity, Kidney Int, vol.93, issue.3, pp.643-655, 2018.

C. R. Lavalle, K. M. George, E. R. Sharlow, J. S. Lazo, P. Wipf et al., Protein kinase D as a potential new target for cancer therapy, Biochim Biophys Acta, vol.1806, issue.2, pp.183-192, 2010.

I. Lavon, D. Zrihan, B. Zelikovitch, Y. Fellig, D. Fuchs et al., Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas, Clin Cancer Res, vol.13, issue.5, pp.1429-1437, 2007.

C. D. Lawson and A. J. Ridley, Rho GTPase signaling complexes in cell migration and invasion, J Cell Biol, vol.217, issue.2, pp.447-457, 2018.

L. Mercier, M. Mathieu, V. Haibe-kains, B. Bontempi, G. Mijatovic et al., Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses, J Neuropathol Exp Neurol, vol.67, issue.5, pp.456-469, 2008.

E. Le-rhun, E. L. Rhun, S. Taillibert, and M. C. Chamberlain, The future of high-grade glioma: Where we are and where are we going, Surg Neurol Int, vol.6, issue.1, pp.9-44, 2015.

C. Lecointre, L. Desrues, J. E. Joubert, N. Perzo, P. Guichet et al., Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma, Oncogene, vol.34, issue.39, pp.5080-5094, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02067683

C. H. Lee, A. Katz, and M. I. Simon, Multiple regions of G alpha 16 contribute to the specificity of activation by the C5a receptor, Mol Pharmacol, vol.47, issue.2, pp.218-223, 1995.

C. H. Lee, D. Park, D. Wu, S. G. Rhee, and M. I. Simon, Members of the Gq alpha subunit gene family activate phospholipase C beta isozymes, J Biol Chem, vol.267, issue.23, pp.16044-16047, 1992.

H. Lee, A. Herrmann, J. Deng, M. Kujawski, G. Niu et al., Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors, Cancer Cell, vol.15, issue.4, pp.283-293, 2009.

J. Lee, H. S. Kim, J. Lee, J. Park, S. C. Shin et al., Small molecule activator of Nm23/NDPK as an inhibitor of metastasis, Sci Rep, vol.8, issue.1, p.10909, 2018.

M. Lee and Y. H. Wong, CCR1-mediated activation of Nuclear Factor-kappaB in THP-1 monocytic cells involves Pertussis Toxin-insensitive Galpha(14) and Galpha(16) signaling cascades, J Leukoc Biol, vol.86, issue.6, pp.1319-1329, 2009.

M. Leirdal and M. Sioud, Protein kinase Calpha isoform regulates the activation of the MAP kinase ERK1/2 in human glioma cells: involvement in cell survival and gene expression, Mol Cell Biol Res Commun, vol.4, issue.2, pp.106-110, 2000.

J. Lemée, A. Clavreul, and P. Menei, Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone, Neuro-oncology, vol.17, issue.10, pp.1322-1332, 2015.

F. Li, D. Godoy, M. Rattan, and S. , Role of adenylate and guanylate cyclases in beta1-, beta2-, and beta3-adrenoceptor-mediated relaxation of internal anal sphincter smooth muscle, J Pharmacol Exp Ther, vol.308, issue.3, pp.1111-1120, 2004.

G. Li, H. Wei, Z. Chen, S. Lv, C. Yin et al., STAT3 silencing with lentivirus inhibits growth and induces apoptosis and differentiation of U251 cells, J Neurooncol, vol.91, issue.2, pp.165-174, 2009.

H. Li, L. Yang, H. Fu, J. Yan, Y. Wang et al., Association between G?i2 and ELMO1/Dock180 connects chemokine signalling with Rac activation and metastasis, Nat Commun, vol.4, p.1706, 2013.

Z. Li, S. Cai, Y. Liu, C. Yang, Y. Tian et al., Over-expression of G?i3 in human glioma is required for Akt-mTOR activation and cell growth, Oncotarget, vol.5, issue.0, 2016.

X. Li, C. Wu, N. Chen, H. Gu, Y. A. Cao et al., PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma, Oncotarget, vol.7, issue.22, pp.33440-33450, 2016.

Z. Li, H. Jiang, W. Xie, Z. Zhang, A. V. Smrcka et al., Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction, Science, vol.287, issue.5455, pp.1046-1049, 2000.

Z. Li, Y. Chen, T. An, P. Liu, J. Zhu et al., Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway, J Exp Clin Cancer Res, vol.38, issue.1, p.139, 2019.

H. Liang, G. Chen, J. Li, and F. Yang, Snail expression contributes to temozolomide resistance in glioblastoma, Am J Transl Res, vol.11, issue.7, pp.4277-4289, 2019.

J. Liang, Y. Piao, L. Holmes, G. N. Fuller, V. Henry et al., Neutrophils promote the malignant glioma phenotype through S100A4, Clin Cancer Res, vol.20, issue.1, pp.187-198, 2014.

L. M. Liau, K. Ashkan, D. D. Tran, J. L. Campian, J. E. Trusheim et al., First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma, J Transl Med, vol.16, issue.1, p.142, 2018.

M. V. Liberti and J. W. Locasale, The Warburg Effect: How Does it Benefit Cancer Cells?, Trends Biochem Sci, vol.41, issue.3, pp.211-218, 2016.

S. Lim, N. Miller, J. Nam, X. L. Chen, Y. Lim et al., Pyk2 inhibition of p53 as an adaptive and intrinsic mechanism facilitating cell proliferation and survival, J Biol Chem, vol.285, issue.3, pp.1743-1753, 2010.

C. A. Lipinski, N. L. Tran, E. Menashi, C. Rohl, J. Kloss et al., The tyrosine kinase pyk2 promotes migration and invasion of glioma cells, Neoplasia, vol.7, issue.5, pp.435-445, 2005.

L. Lisi, G. Ciotti, D. Braun, S. Kalinin, D. Currò et al., Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma, Neurosci Lett, vol.645, pp.106-112, 2017.

J. Liu, Y. Wang, W. I. Goh, H. Goh, M. A. Baird et al., Talin determines the nanoscale architecture of focal adhesions, Proc Natl Acad Sci, vol.112, issue.35, pp.4864-4873, 2015.

W. Liu, F. Yue, M. Zheng, A. Merlot, D. Bae et al., The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1. Oncotarget, vol.6, issue.11, pp.8851-8874, 2015.

A. Liu and Y. H. Wong, G16-mediated activation of nuclear factor kappaB by the adenosine A1 receptor involves c-Src, protein kinase C, and ERK signaling, J Biol Chem, vol.279, issue.51, pp.53196-53204, 2004.

C. Liu, C. Chang, K. Hsueh, H. Su, T. Chiou et al., Migration/Invasion of Malignant Gliomas and Implications for Therapeutic Treatment, Int J Mol Sci, vol.19, issue.4, 2018.

L. Che, K. Pham, D. Luo, B. A. Reynolds, P. Hothi et al., Expression and functional heterogeneity of chemokine receptors CXCR4 and CXCR7 in primary patient-derived glioblastoma cells, PLoS ONE, vol.8, issue.3, p.59750, 2013.

W. W. Liu, R. R. Mattingly, and J. C. Garrison, Transformation of Rat-1 fibroblasts with the v-src oncogene increases the tyrosine phosphorylation state and activity of the alpha subunit of Gq/G11, Proc Natl Acad Sci, vol.93, issue.16, pp.8258-8263, 1996.

X. Liu, J. Yu, S. Song, X. Yue, and Q. Li, Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer, Oncotarget, vol.8, issue.63, pp.107334-107345, 2017.

. Liu-xujie, K. Liu, J. Qin, L. Hao, X. Li et al., C/EBP? promotes angiogenesis through secretion of IL-6, which is inhibited by genistein, in EGFRvIII-positive glioblastoma, Int J Cancer, vol.136, issue.11, pp.2524-2534, 2015.

. Liu-yawei, R. Carlsson, M. Ambjørn, M. Hasan, W. Badn et al., PD-L1 expression by neurons nearby tumors indicates better prognosis in glioblastoma patients, J Neurosci, vol.33, issue.35, pp.14231-14245, 2013.

L. Yan, A. Kosaka, M. Ikeura, G. Kohanbash, W. Fellows-mayle et al., Premetastatic soil and prevention of breast cancer brain metastasis, Neuro-oncology, vol.15, issue.7, pp.891-903, 2013.

Y. Liu, M. Chen, L. Cheng, Z. Zhang, Y. Jiang et al., microRNA-200a downregulation in human glioma leads to G?i1 over-expression, Akt activation, and cell proliferation, Oncogene, vol.37, issue.21, pp.2890-2902, 2018.

L. Zhifeng, X. Yang, C. Chen, B. Liu, B. Ren et al., Expression of the Arp2/3 complex in human gliomas and its role in the migration and invasion of glioma cells, Oncol Rep, vol.30, issue.5, pp.2127-2136, 2013.

R. Lo, H. Cheung, and Y. H. Wong, Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK-and ERK-dependent mechanism, J Biol Chem, vol.278, issue.52, pp.52154-52165, 2003.

R. Lo, A. Liu, H. Wise, and Y. H. Wong, Prostacyclin receptor-induced STAT3 phosphorylation in human erythroleukemia cells is mediated via Galpha(s) and Galpha(16) hybrid signaling, Cell Signal, vol.20, issue.11, pp.2095-2106, 2008.

R. Lo and Y. H. Wong, Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway, Cell Signal, vol.18, issue.12, pp.2143-2153, 2006.

M. A. Lochrie, J. B. Hurley, and M. I. Simon, Sequence of the alpha subunit of photoreceptor G protein: homologies between transducin, ras, and elongation factors, Science, vol.228, issue.4695, pp.96-99, 1985.

M. A. Lochrie and M. I. Simon, G protein multiplicity in eukaryotic signal transduction systems, Biochemistry, vol.27, issue.14, pp.4957-4965, 1988.

D. E. Logothetis, Y. Kurachi, J. Galper, E. J. Neer, and D. E. Clapham, The beta gamma subunits of GTPbinding proteins activate the muscarinic K+ channel in heart, Nature, vol.325, issue.6102, pp.321-326, 1987.

A. D. Lokits, H. Indrischek, J. Meiler, H. E. Hamm, and P. F. Stadler, Tracing the evolution of the heterotrimeric G protein ? subunit in Metazoa, BMC Evol Biol, vol.18, issue.1, p.51, 2018.

A. Lombard, N. Goffart, and B. Rogister, Glioblastoma Circulating Cells: Reality, Trap or Illusion? Stem Cells Int, p.182985, 2015.

M. Y. Lombardi and M. Assem, Glioblastoma Genomics: A Very Complicated Story, 2017.

D. L. Longo and L. R. Baden, Exploiting Viruses to Treat Diseases, N Engl J Med, vol.379, issue.2, pp.194-196, 2018.

G. K. Lønne, L. Cornmark, I. O. Zahirovic, G. Landberg, K. Jirström et al., PKCalpha expression is a marker for breast cancer aggressiveness, Mol Cancer, vol.9, p.76, 2010.

I. C. Lopes, S. De-oliveira, and A. M. Oliveira-brett, Temozolomide chemical degradation to 5-aminoimidazole-4-carboxamide -Electrochemical study, Journal of Electroanalytical Chemistry, vol.704, pp.183-189, 2013.

A. M. López-colomé, I. Lee-rivera, R. Benavides-hidalgo, and E. López, Paxillin: a crossroad in pathological cell migration, J Hematol Oncol, vol.10, issue.1, p.50, 2017.

J. Lopiccolo, G. M. Blumenthal, W. B. Bernstein, and P. A. Dennis, Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations, Drug Resist Updat, vol.11, issue.1-2, pp.32-50, 2008.

D. N. Louis, H. Ohgaki, O. D. Wiestler, W. K. Cavenee, P. C. Burger et al., The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol, vol.114, issue.2, pp.97-109, 2007.

D. N. Louis, A. Perry, G. Reifenberger, A. Von-deimling, D. Figarella-branger et al., The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary, Acta Neuropathol, vol.131, issue.6, pp.803-820, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01479018

L. M. Louis, C. C. Lerro, M. C. Friesen, G. Andreotti, S. Koutros et al., A prospective study of cancer risk among Agricultural Health Study farm spouses associated with personal use of organochlorine insecticides, Environ Health, vol.16, issue.1, p.95, 2017.

G. Lu, J. T. Chang, Z. Liu, Y. Chen, M. Li et al., Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma, Mol Neurobiol, vol.53, issue.9, pp.6511-6525, 2016.

W. Lu, H. Lee, C. Xiang, S. Finniss, and C. Brodie, The phosphorylation of tyrosine 332 is necessary for the caspase 3-dependent cleavage of PKCdelta and the regulation of cell apoptosis, Cell Signal, vol.19, issue.10, pp.2165-2173, 2007.

X. Lu, J. Lu, B. Liao, X. Li, X. Qian et al., Driver pattern identification over the gene co-expression of drug response in ovarian cancer by integrating high throughput genomics data, Sci Rep, vol.7, issue.1, p.16188, 2017.

Z. Lu, A. Hornia, Y. W. Jiang, Q. Zang, S. Ohno et al., Tumor promotion by depleting cells of protein kinase C delta, Mol Cell Biol, vol.17, issue.6, pp.3418-3428, 1997.

G. L. Lukov, C. M. Baker, P. J. Ludtke, T. Hu, M. D. Carter et al., Mechanism of assembly of G protein betagamma subunits by protein kinase CK2-phosphorylated phosducin-like protein and the cytosolic chaperonin complex, J Biol Chem, vol.281, issue.31, pp.22261-22274, 2006.

R. Luo, S. Jeong, J. Z. Strokes, N. Li, S. Piao et al., G protein-coupled receptor 56 and collagen III, a receptor-ligand pair, regulates cortical development and lamination, Proc Natl Acad Sci, vol.108, issue.31, pp.12925-12930, 2011.

S. Lutz, A. Freichel-blomquist, U. Rümenapp, M. Schmidt, K. H. Jakobs et al., p63RhoGEF and GEFT are Rho-specific guanine nucleotide exchange factors encoded by the same gene, Naunyn Schmiedebergs Arch Pharmacol, vol.369, issue.5, pp.540-546, 2004.

S. Lutz, A. Freichel-blomquist, Y. Yang, U. Rümenapp, K. H. Jakobs et al., The guanine nucleotide exchange factor p63RhoGEF, a specific link between Gq/11-coupled receptor signaling and RhoA, J Biol Chem, vol.280, issue.12, pp.11134-11139, 2005.

R. B. Luwor, S. S. Stylli, and A. H. Kaye, The role of Stat3 in glioblastoma multiforme, J Clin Neurosci, vol.20, issue.7, pp.907-911, 2013.

J. P. Lynes, V. E. Sanchez, A. K. Nwankwo, G. A. Dominah, and E. K. Nduom, Immune checkpoint modulation: Tenets and implications in glioblastoma, Glioma, vol.2, issue.1, p.20, 2019.

A. M. Lyon and J. Tesmer, Structural insights into phospholipase C-? function, Mol Pharmacol, vol.84, issue.4, pp.488-500, 2013.

H. Ma, T. Li, Z. Tao, L. Hai, L. Tong et al., NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways, J Cell Physiol, vol.234, issue.2, pp.1630-1642, 2019.

X. Ma, T. Aoki, T. Tsuruyama, and S. Narumiya, Definition of Prostaglandin E2-EP2 Signals in the Colon Tumor Microenvironment That Amplify Inflammation and Tumor Growth, Cancer Res, vol.75, issue.14, pp.2822-2832, 2015.

A. M. Magro, A. D. Magro, C. Cunningham, and M. R. Miller, Down-regulation of vinculin upon MK886-induced apoptosis in LN18 glioblastoma cells, Neoplasma, vol.54, issue.6, pp.517-526, 2007.

S. Mahajan-thakur, S. Bien-möller, S. Marx, H. Schroeder, and B. H. Rauch, Sphingosine 1-phosphate (S1P) signaling in glioblastoma multiforme-A systematic review, Int J Mol Sci, vol.18, issue.11, 2017.

S. Mahavadi, A. D. Nalli, H. Wang, D. M. Kendig, M. S. Crowe et al., Regulation of gastric smooth muscle contraction via Ca2+-dependent and Ca2+-independent actin polymerization, PLoS ONE, vol.13, issue.12, p.209359, 2018.

D. B. Mair, J. Zhu, S. H. Weinberg, and R. Li, The Arp2/3 Complex is Necessary for Migration of Glioblastoma Cells on Compliant Substrates due to a Lamellipodia-Provided Mechanical Advantage, Biophysical Journal, vol.114, issue.3, p.17, 2018.

E. Majewska and M. Szeliga, AKT/GSK3? Signaling in Glioblastoma, Neurochem Res, vol.42, issue.3, pp.918-924, 2017.

E. Malchinkhuu, K. Sato, Y. Horiuchi, C. Mogi, S. Ohwada et al., Role of p38 mitogen-activated kinase and c-Jun terminal kinase in migration response to lysophosphatidic acid and sphingosine-1-phosphate in glioma cells, Oncogene, vol.24, issue.44, pp.6676-6688, 2005.

E. Malchinkhuu, K. Sato, T. Maehama, C. Mogi, H. Tomura et al., S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN, Biochem Biophys Res Commun, vol.366, issue.4, pp.963-968, 2008.

L. Malric, S. Monferran, J. Gilhodes, S. Boyrie, P. Dahan et al., Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update, Oncotarget, vol.8, issue.49, pp.86947-86968, 2017.

T. M. Malta, C. F. De-souza, T. S. Sabedot, T. C. Silva, M. S. Mosella et al., Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications, Neuro-oncology, vol.20, issue.5, pp.608-620, 2018.

A. Manglik, A. C. Kruse, T. S. Kobilka, F. S. Thian, J. M. Mathiesen et al., Crystal structure of the µ-opioid receptor bound to a morphinan antagonist, Nature, vol.485, issue.7398, pp.321-326, 2012.

S. Mangmool and H. Kurose, Gi/o Protein-Dependent and -Independent Actions of Pertussis Toxin (PTX), Toxins (Basel), vol.3, issue.7, pp.884-899, 2011.

A. Mansouri, J. Karamchandani, and S. Das, Molecular Genetics of Secondary Glioblastoma, 2017.

L. Manzoli, A. M. Billi, S. Rubbini, A. Bavelloni, I. Faenza et al., Essential role for nuclear phospholipase C beta1 in insulin-like growth factor I-induced mitogenesis, Cancer Res, vol.57, issue.11, pp.2137-2139, 1997.

M. Y. Mapara, K. Bommert, R. C. Bargou, C. Leng, C. Beck et al., G protein subunit G alpha 16 expression is restricted to progenitor B cells during human Bcell differentiation, Blood, vol.85, issue.7, pp.1836-1842, 1995.

. References-bibliographiques-kléouforo-paul, DEMBELE expression to induce cell transformation, J Biol Chem, vol.278, issue.47, pp.46814-46825

A. Marivin, V. Morozova, I. Walawalkar, A. Leyme, D. A. Kretov et al., GPCR-independent activation of G proteins promotes apical cell constriction in vivo, J Cell Biol, vol.218, issue.5, pp.1743-1763, 2019.

G. Martiny-baron and D. Fabbro, Classical PKC isoforms in cancer, Pharmacol Res, vol.55, issue.6, pp.477-486, 2007.

C. Marty, D. D. Browning, and R. D. Ye, Identification of tetratricopeptide repeat 1 as an adaptor protein that interacts with heterotrimeric G proteins and the small GTPase Ras, Mol Cell Biol, vol.23, issue.11, pp.3847-3858, 2003.

M. Massara, P. Persico, O. Bonavita, M. Poeta, V. Locati et al., Neutrophils in Gliomas. Front Immunol, vol.8, p.1349, 2017.

J. Mathieu, Z. Zhang, W. Zhou, A. J. Wang, J. M. Heddleston et al., HIF induces human embryonic stem cell markers in cancer cells, Cancer Res, vol.71, issue.13, pp.4640-4652, 2011.

D. Matias, J. Balça-silva, G. C. Da-graça, C. M. Wanjiru, L. W. Macharia et al., Microglia/Astrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors, Front Cell Neurosci, vol.12, p.235, 2018.

A. Maus and G. J. Peters, Glutamate and ?-ketoglutarate: key players in glioma metabolism, Amino Acids, vol.49, issue.1, pp.21-32, 2017.

R. Mayor and C. Carmona-fontaine, Keeping in touch with contact inhibition of locomotion, Trends Cell Biol, vol.20, issue.6, pp.319-328, 2010.

M. Mccord, Y. Mukouyama, M. R. Gilbert, and S. Jackson, Targeting WNT Signaling for Multifaceted Glioblastoma Therapy. Front Cell Neurosci, vol.11, p.318, 2017.

P. D. Mccrea and C. J. Gottardi, Beyond ?-catenin: prospects for a larger catenin network in the nucleus, Nat Rev Mol Cell Biol, vol.17, issue.1, pp.55-64, 2016.

W. E. Mcintire, G. Maccleery, and J. C. Garrison, The G protein beta subunit is a determinant in the coupling of Gs to the beta 1-adrenergic and A2a adenosine receptors, J Biol Chem, vol.276, pp.15801-15809, 2001.

M. A. Mcjilton, V. Sikes, C. Wescott, G. G. Wu, D. Foreman et al., Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells, Oncogene, vol.22, issue.39, pp.7958-7968, 2003.

G. Mckenzie, E. E. Hinsley, K. Hunter, and D. W. Lambert, The endothelin axis in head and neck cancer: a promising therapeutic opportunity?, J Oral Pathol Med, vol.43, issue.6, pp.395-404, 2014.

D. C. Medynski, K. Sullivan, D. Smith, C. Van-dop, F. H. Chang et al., Amino acid sequence of the alpha subunit of transducin deduced from the cDNA sequence, Proc Natl Acad Sci, vol.82, issue.13, pp.4311-4315, 1985.

A. Mehta and S. Orchard, Nucleoside diphosphate kinase (NDPK, NM23, AWD): recent regulatory advances in endocytosis, metastasis, psoriasis, insulin release, fetal erythroid lineage and heart failure; translational medicine exemplified, Mol Cell Biochem, vol.329, issue.1-2, pp.3-15, 2009.

T. E. Meigs, M. Fedor-chaiken, D. D. Kaplan, R. Brackenbury, and P. J. Casey, Galpha12 and Galpha13 negatively regulate the adhesive functions of cadherin, J Biol Chem, vol.277, issue.27, pp.24594-24600, 2002.

T. E. Meigs, T. A. Fields, D. D. Mckee, and P. J. Casey, Interaction of Galpha 12 and Galpha 13 with the cytoplasmic domain of cadherin provides a mechanism for beta -catenin release, Proc Natl Acad Sci, vol.98, issue.2, pp.519-524, 2001.

O. Melien, Heterotrimeric G proteins and disease, Methods Mol Biol, vol.361, pp.119-144, 2007.

W. Meng, S. Xue, and Y. Chen, The role of CXCL12 in tumor microenvironment, Gene, vol.641, pp.105-110, 2018.

P. Metellus, B. Voutsinos-porche, N. , I. , C. C. Fina et al., Adrenomedullin expression and regulation in human glioblastoma, cultured human glioblastoma cell lines and pilocytic astrocytoma, Eur J Cancer, vol.47, issue.11, pp.1727-1735, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01827562

C. Metz, R. Döger, E. Riquelme, P. Cortés, C. Holmes et al., Galectin-8 promotes migration and proliferation and prevents apoptosis in U87 glioblastoma cells, Biol Res, vol.49, issue.1, p.33, 2016.

D. Michaelson, I. Ahearn, M. Bergo, S. Young, and M. Philips, Membrane trafficking of heterotrimeric G proteins via the endoplasmic reticulum and Golgi, Mol Biol Cell, vol.13, issue.9, pp.3294-3302, 2002.

A. M. Mikheev, S. A. Mikheeva, L. J. Severs, C. C. Funk, L. Huang et al., Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma, Mol Oncol, vol.12, issue.7, pp.1188-1202, 2018.

S. A. Mikheeva, A. M. Mikheev, A. Petit, R. Beyer, R. G. Oxford et al., TWIST1 promotes invasion through mesenchymal change in human glioblastoma, Mol Cancer, vol.9, p.194, 2010.

K. Miller, S. Dixit, A. Bredlau, A. Moore, E. Mckinnon et al., Delivery of a drug cache to glioma cells overexpressing platelet-derived growth factor receptor using lipid nanocarriers, Nanomedicine (Lond), vol.11, issue.6, pp.581-595, 2016.

G. Milligan and E. Kostenis, Heterotrimeric G-proteins: a short history, Br J Pharmacol, vol.147, 2006.

L. Milon, M. F. Rousseau-merck, A. Munier, M. Erent, I. Lascu et al., nm23-H4, a new member of the family of human nm23/nucleoside diphosphate kinase genes localised on chromosome 16p13, Hum Genet, vol.99, issue.4, pp.550-557, 1997.

M. Minata, A. Audia, J. Shi, S. Lu, J. Bernstock et al., Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation, Cell Rep, vol.26, issue.7, pp.1893-1905, 2019.

Y. A. Miroshnikova, J. K. Mouw, J. M. Barnes, M. W. Pickup, J. N. Lakins et al., Tissue mechanics promote IDH1-dependent HIF1?-tenascin C feedback to regulate glioblastoma aggression, Nat Cell Biol, vol.18, issue.12, pp.1336-1345, 2016.

H. Mischak, J. A. Goodnight, W. Kolch, G. Martiny-baron, C. Schaechtle et al., Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity, J Biol Chem, vol.268, issue.9, pp.6090-6096, 1993.

D. A. Mitchell, K. A. Batich, M. D. Gunn, M. Huang, L. Sanchez-perez et al., Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients, Nature, vol.519, issue.7543, pp.366-369, 2015.

S. K. Mitra, D. A. Hanson, and D. D. Schlaepfer, Focal adhesion kinase: in command and control of cell motility, Nat Rev Mol Cell Biol, vol.6, issue.1, pp.56-68, 2005.

A. Moers, A. Nürnberg, S. Goebbels, N. Wettschureck, and S. Offermanns, Galpha12/Galpha13 deficiency causes localized overmigration of neurons in the developing cerebral and cerebellar cortices, Mol Cell Biol, vol.28, issue.5, pp.1480-1488, 2008.

A. Mondal, K. Singh, D. Panda, S. Shiras, and A. , Extracellular Vesicles As Modulators of Tumor Microenvironment and Disease Progression in Glioma, Front Oncol, vol.7, p.144, 2017.

I. S. Moreira, Structural features of the G-protein/GPCR interactions, Biochim Biophys Acta, vol.1840, issue.1, pp.16-33, 2014.

G. T. Motz and G. Coukos, Deciphering and reversing tumor immune suppression, Immunity, vol.39, issue.1, pp.61-73, 2013.

K. M. Mrozik, O. W. Blaschuk, C. M. Cheong, A. Zannettino, and K. Vandyke, N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer, BMC Cancer, vol.18, issue.1, p.939, 2018.

W. M. Mueller, F. Z. Yetkin, T. A. Hammeke, G. L. Morris, S. J. Swanson et al., Functional magnetic resonance imaging mapping of the motor cortex in patients with cerebral tumors, Neurosurgery, vol.39, issue.3, pp.515-520, 1996.

A. A. Mughal, L. Zhang, A. Fayzullin, A. Server, Y. Li et al., Patterns of Invasive Growth in Malignant Gliomas-The Hippocampus Emerges as an Invasion-Spared Brain Region, Neoplasia, vol.20, issue.7, pp.643-656, 2018.

S. Mukhopadhyay and E. M. Ross, Rapid GTP binding and hydrolysis by G(q) promoted by receptor and GTPase-activating proteins, Proc Natl Acad Sci, vol.96, issue.17, pp.9539-9544, 1999.

J. M. Mullin, K. V. Laughlin, N. Ginanni, C. W. Marano, H. M. Clarke et al., Increased tight junction permeability can result from protein kinase C activation/translocation and act as a tumor promotional event in epithelial cancers, Ann N Y Acad Sci, vol.915, pp.231-236, 2000.

J. R. Muppidi, R. Schmitz, J. A. Green, W. Xiao, A. B. Larsen et al., Loss of signalling via G?13 in germinal centre B-cell-derived lymphoma, Nature, vol.516, issue.7530, pp.254-258, 2014.

C. Murga, A. C. Arcones, M. Cruces-sande, A. M. Briones, M. Salaices et al., G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases, Front Pharmacol, vol.10, 2019.

M. Mut, A. S. Hussaini, and I. M. , PKC alpha phosphorylates cytosolic NF-kappaB/p65 and PKC delta delays nuclear translocation of NF-kappaB/p65 in U1242 glioblastoma cells, Turk Neurosurg, vol.20, issue.3, pp.277-285, 2010.

J. K. Myung, S. A. Choi, S. Kim, K. Wang, and S. Park, Snail plays an oncogenic role in glioblastoma by promoting epithelial mesenchymal transition, Int J Clin Exp Pathol, vol.7, issue.5, pp.1977-1987, 2014.

M. Nakamura, T. Watanabe, Y. Yonekawa, P. Kleihues, and H. Ohgaki, Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene, Carcinogenesis, vol.22, issue.10, pp.1715-1719, 2001.

C. Nanoff and G. L. Stiles, Solubilization and characterization of the A2-adenosine receptor, J Recept Res, vol.13, issue.6, pp.961-973, 1993.

E. J. Neer, Heterotrimeric G proteins: organizers of transmembrane signals, Cell, vol.80, issue.2, pp.249-257, 1995.

C. Neftel, J. Laffy, M. G. Filbin, T. Hara, M. E. Shore et al., An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma, Cell, vol.178, issue.4, pp.835-849, 2019.

G. Neuberger, G. Schneider, and F. Eisenhaber, pkaPS: prediction of protein kinase A phosphorylation sites with the simplified kinase-substrate binding model, Biol Direct, vol.2, p.1, 2007.

R. R. Neubig and D. P. Siderovski, Regulators of G-protein signalling as new central nervous system drug targets, Nat Rev Drug Discov, vol.1, issue.3, pp.187-197, 2002.

S. R. Neves, P. T. Ram, and R. Iyengar, G protein pathways, Science, vol.296, issue.5573, pp.1636-1639, 2002.

D. C. New, K. Wu, A. Kwok, and Y. H. Wong, G protein-coupled receptor-induced Akt activity in cellular proliferation and apoptosis, FEBS J, vol.274, issue.23, pp.6025-6036, 2007.

N. Gutierrez, A. Mcdonald, and P. H. , GPCRs: Emerging anti-cancer drug targets, Cell Signal, vol.41, pp.65-74, 2018.

L. L. Nikitenko, S. B. Fox, S. Kehoe, M. Rees, and R. Bicknell, Adrenomedullin and tumour angiogenesis, Br J Cancer, vol.94, issue.1, pp.1-7, 2006.

T. Nishimura, T. Yamaguchi, K. Kato, M. Yoshizawa, Y. Nabeshima et al., PAR-6-PAR-3 mediates Cdc42-induced Rac activation through the Rac GEFs STEF/Tiam1, Nat Cell Biol, vol.7, issue.3, pp.270-277, 2005.

Y. Nishizuka, Turnover of inositol phospholipids and signal transduction, Science, vol.225, issue.4668, pp.1365-1370, 1984.

Y. Nitta, S. Shimizu, Y. Shishido-hara, K. Suzuki, Y. Shiokawa et al., Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo, Cancer Med, vol.5, issue.3, pp.486-499, 2016.

J. P. Noel, H. E. Hamm, and P. B. Sigler, The 2.2 A crystal structure of transducin-alpha complexed with GTP gamma S, Nature, vol.366, issue.6456, pp.654-663, 1993.
URL : https://hal.archives-ouvertes.fr/jpa-00210878

N. Nomura, M. Nomura, N. Mizuki, and J. Hamada, Rac1 mediates phorbol 12-myristate 13-acetateinduced migration of glioblastoma cells via paxillin, Oncol Rep, vol.20, issue.4, pp.705-711, 2008.

L. Nonnenmacher, M. Westhoff, S. Fulda, G. Karpel-massler, M. Halatsch et al., RIST: a potent new combination therapy for glioblastoma, Int J Cancer, vol.136, issue.4, pp.173-187, 2015.

J. Norgauer, B. Metzner, W. Czech, and I. Schraufstatter, Reconstitution of chemokine-induced actin polymerization in undifferentiated human leukemia cells (HL-60) by heterologous expression of interleukin-8 receptors, Inflamm Res, vol.45, issue.3, pp.127-131, 1996.

K. Nordström, T. A. Larsson, and D. Larhammar, Extensive duplications of phototransduction genes in early vertebrate evolution correlate with block (chromosome) duplications, Genomics, vol.83, issue.5, pp.852-872, 2004.

J. K. Northup, P. C. Sternweis, M. D. Smigel, L. S. Schleifer, E. M. Ross et al., Purification of the regulatory component of adenylate cyclase, Proc Natl Acad Sci, vol.77, issue.11, pp.6516-6520, 1980.

A. Nürnberg, T. Kitzing, and R. Grosse, Nucleating actin for invasion, Nat Rev Cancer, vol.11, issue.3, pp.177-187, 2011.

W. Ockenga, S. Kühne, S. Bocksberger, A. Banning, and R. Tikkanen, Non-Neuronal Functions of the M2 Muscarinic Acetylcholine Receptor, Genes (Basel), vol.4, issue.2, pp.171-197, 2013.

S. Offermanns and M. I. Simon, G? 15 and G? 16 Couple a Wide Variety of Receptors to Phospholipase C, Journal of Biological Chemistry, vol.270, issue.25, pp.15175-15180, 1995.

M. O'hayre, M. S. Degese, and J. S. Gutkind, Novel insights into G protein and G protein-coupled receptor signaling in cancer, Curr Opin Cell Biol, vol.27, pp.126-135, 2014.

M. O'hayre, J. Vázquez-prado, I. Kufareva, E. W. Stawiski, T. M. Handel et al., The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer, Nat Rev Cancer, vol.13, issue.6, pp.412-424, 2013.

M. Ohta, K. Mimori, Y. Fukuyoshi, Y. Kita, K. Motoyama et al., Clinical significance of the reduced expression of G protein gamma 7 (GNG7) in oesophageal cancer, Br J Cancer, vol.98, issue.2, pp.410-417, 2008.

Y. Oka, L. R. Saraiva, Y. Y. Kwan, and S. I. Korsching, The fifth class of Galpha proteins, Proc Natl Acad Sci, vol.106, issue.5, pp.1484-1489, 2009.

M. Oksdath, S. L. Perrin, C. Bardy, E. F. Hilder, C. A. Deforest et al., Review: Synthetic scaffolds to control the biochemical, mechanical, and geometrical environment of stem cell-derived brain organoids, APL Bioeng, vol.2, issue.4, p.41501, 2018.

H. Okura, B. J. Golbourn, U. Shahzad, S. Agnihotri, N. Sabha et al., A role for activated Cdc42 in glioblastoma multiforme invasion, Oncotarget, vol.7, issue.35, pp.56958-56975, 2016.

A. Olar and K. D. Aldape, Using the molecular classification of glioblastoma to inform personalized treatment, J Pathol, vol.232, issue.2, pp.165-177, 2014.

W. M. Oldham and H. E. Hamm, Structural basis of function in heterotrimeric G proteins, Q Rev Biophys, vol.39, issue.2, pp.117-166, 2006.

W. M. Oldham and H. E. Hamm, Heterotrimeric G protein activation by G-protein-coupled receptors, Nat Rev Mol Cell Biol, vol.9, issue.1, pp.60-71, 2008.

J. J. Olsen, S. Pohl, A. Deshmukh, M. Visweswaran, N. C. Ward et al., The Role of Wnt Signalling in Angiogenesis, Clin Biochem Rev, vol.38, issue.3, pp.131-142, 2017.

S. Ookawa, M. Wanibuchi, Y. Kataoka-sasaki, M. Sasaki, S. Oka et al., Digital Polymerase Chain Reaction Quantification of SERPINA1 Predicts Prognosis in High-Grade Glioma, World Neurosurg, vol.111, pp.783-789, 2018.

Q. T. Ostrom, H. Gittleman, J. Fulop, M. Liu, R. Blanda et al., CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States, Neuro-oncology, vol.17, pp.1-62, 2008.

Q. T. Ostrom, H. Gittleman, P. Liao, C. Rouse, Y. Chen et al., CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in, Neuro-oncology, vol.16, pp.1-63, 2007.

Q. T. Ostrom, H. Gittleman, P. Liao, T. Vecchione-koval, Y. Wolinsky et al., CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014, vol.19, pp.1-88, 2017.

Q. T. Ostrom, H. Gittleman, L. Stetson, S. Virk, and J. S. Barnholtz-sloan, Epidemiology of Intracranial Gliomas, Prog Neurol Surg, vol.30, pp.1-11, 2018.

A. Ostrovskaya, C. Hick, D. S. Hutchinson, B. W. Stringer, P. J. Wookey et al., Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas, BMC Cancer, vol.19, issue.1, p.157, 2019.

S. Otsuka and G. Bebb, The CXCR4/SDF-1 chemokine receptor axis: a new target therapeutic for nonsmall cell lung cancer, J Thorac Oncol, vol.3, issue.12, pp.1379-1383, 2008.

L. Ouafik, S. Sauze, F. Boudouresque, O. Chinot, C. Delfino et al., Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo, Am J Pathol, vol.160, issue.4, pp.62555-62557, 2002.
URL : https://hal.archives-ouvertes.fr/inserm-00151079

T. Ozawa, M. Riester, Y. Cheng, J. T. Huse, M. Squatrito et al., Most human non-GCIMP glioblastoma subtypes evolve from a common proneurallike precursor glioma, Cancer Cell, vol.26, issue.2, pp.288-300, 2014.

A. Pala, G. Karpel-massler, C. R. Wirtz, and M. Halatsch, Epithelial to Mesenchymal Transition and Progression of Glioblastoma. Clinical Management and Evolving Novel Therapeutic Strategies for Patients with Brain Tumors, 2013.

J. Pallud, O. Rigaux-viode, R. Corns, J. Muto, L. Lopez et al., Direct electrical bipolar electrostimulation for functional cortical and subcortical cerebral mapping in awake craniotomy. Practical considerations, Neurochirurgie, vol.63, issue.3, pp.164-174, 2017.

M. P. Panchenko, K. Saxena, Y. Li, S. Charnecki, P. M. Sternweis et al., Sites important for PLCbeta2 activation by the G protein betagamma subunit map to the sides of the beta propeller structure, J Biol Chem, vol.273, issue.43, pp.28298-28304, 1998.

S. B. Park, K. W. Seo, A. Y. So, M. S. Seo, K. R. Yu et al., SOX2 has a crucial role in the lineage determination and proliferation of mesenchymal stem cells through Dickkopf-1 and c-MYC, Cell Death Differ, vol.19, issue.3, pp.534-545, 2012.

D. Park, D. Y. Jhon, C. W. Lee, K. H. Lee, and S. G. Rhee, Activation of phospholipase C isozymes by G protein beta gamma subunits, J Biol Chem, vol.268, issue.7, pp.4573-4576, 1993.

F. Park, Activators of G protein signaling in the kidney, J Pharmacol Exp Ther, vol.353, issue.2, pp.235-245, 2015.

J. B. Park, C. S. Lee, J. Jang, J. Ghim, Y. Kim et al., Phospholipase signalling networks in cancer, Nat Rev Cancer, vol.12, issue.11, pp.782-792, 2012.

S. Park, J. Won, S. Kim, Y. Lee, C. Park et al., Molecular Testing of Brain Tumor, J Pathol Transl Med, vol.51, issue.3, pp.205-223, 2017.

D. W. Parsons, S. Jones, X. Zhang, J. Lin, R. J. Leary et al., An integrated genomic analysis of human glioblastoma multiforme, Science, vol.321, issue.5897, pp.1807-1812, 2008.

A. P. Patel, I. Tirosh, J. J. Trombetta, A. K. Shalek, S. M. Gillespie et al., Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma, Science, vol.344, issue.6190, pp.1396-1401, 2014.

M. Patel, T. Kawano, N. Suzuki, T. Hamakubo, A. V. Karginov et al., G?13/PDZ-RhoGEF/RhoA signaling is essential for gastrin-releasing peptide receptor-mediated colon cancer cell migration, Mol Pharmacol, vol.86, issue.3, pp.252-262, 2014.

B. S. Paugh, S. W. Paugh, L. Bryan, D. Kapitonov, K. M. Wilczynska et al., EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCdelta, and sphingosine kinase 1 in glioblastoma cells, FASEB J, vol.22, issue.2, pp.455-465, 2008.

L. S. Payne and P. H. Huang, The pathobiology of collagens in glioma, Mol Cancer Res, vol.11, issue.10, pp.1129-1140, 2013.

R. D. Peavy, K. B. Hubbard, A. Lau, R. B. Fields, K. Xu et al., Differential effects of Gq alpha, G14 alpha, and G15 alpha on vascular smooth muscle cell survival and gene expression profiles, Mol Pharmacol, vol.67, issue.6, pp.2102-2114, 2005.

K. H. Pedone and J. R. Hepler, The importance of N-terminal polycysteine and polybasic sequences for G14alpha and G16alpha palmitoylation, plasma membrane localization, and signaling function, J Biol Chem, vol.282, issue.35, pp.25199-25212, 2007.

X. Peng, J. L. Maiers, D. Choudhury, S. W. Craig, and K. A. Demali, 2012. ?-Catenin uses a novel mechanism to activate vinculin, J Biol Chem, vol.287, issue.10, pp.7728-7737
URL : https://hal.archives-ouvertes.fr/hal-02317451

X. Peng, E. S. Nelson, J. L. Maiers, and K. A. Demali, New insights into vinculin function and regulation, Int Rev Cell Mol Biol, vol.287, pp.191-231, 2011.

M. Pereira, F. Klamt, C. C. Thomé, P. V. Worm, and D. L. De-oliveira, Metabotropic glutamate receptors as a new therapeutic target for malignant gliomas, Oncotarget, vol.8, issue.13, pp.22279-22298, 2017.

O. Pertz, Spatio-temporal Rho GTPase signaling -where are we now?, J Cell Sci, vol.123, pp.1841-1850, 2010.

S. L. Perrin, M. S. Samuel, B. Koszyca, M. P. Brown, L. M. Ebert et al., Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments, Biochem Soc Trans, vol.47, issue.2, pp.625-638, 2019.

R. J. Petrie and K. M. Yamada, Multiple mechanisms of 3D migration: the origins of plasticity, Curr Opin Cell Biol, vol.42, pp.7-12, 2016.

M. Pfeilstöcker, H. Karlic, J. Salamon, E. Krömer, H. Mühlberger et al., Expression of G alpha 16, a G-protein alpha subunit specific for hematopoiesis in acute leukemia, Leukemia, vol.10, issue.7, pp.1117-1121, 1996.

E. Phillips, V. Lang, J. Bohlen, F. Bethke, L. Puccio et al., Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism, Int J Cancer, vol.139, issue.8, pp.1776-1787, 2016.

H. S. Phillips, S. Kharbanda, R. Chen, W. F. Forrest, R. H. Soriano et al., Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis, Cancer Cell, vol.9, issue.3, pp.157-173, 2006.

S. Phuphanich, C. J. Wheeler, J. D. Rudnick, M. Mazer, H. Wang et al., Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma, Cancer Immunol Immunother, vol.62, issue.1, pp.125-135, 2013.

K. L. Pierce, R. T. Premont, and R. J. Lefkowitz, Seven-transmembrane receptors, Nat Rev Mol Cell Biol, vol.3, issue.9, pp.639-650, 2002.

J. A. Pitcher, J. Inglese, J. B. Higgins, J. L. Arriza, P. J. Casey et al., Role of beta gamma subunits of G proteins in targeting the betaadrenergic receptor kinase to membrane-bound receptors, Science, vol.257, issue.5074, pp.1264-1267, 1992.

J. A. Pitcher, K. Touhara, E. S. Payne, and R. J. Lefkowitz, Pleckstrin homology domain-mediated membrane association and activation of the beta-adrenergic receptor kinase requires coordinate interaction with G beta gamma subunits and lipid, J Biol Chem, vol.270, pp.11707-11710, 1920.

T. D. Pollard and G. G. Borisy, Cellular motility driven by assembly and disassembly of actin filaments, Cell, vol.112, issue.4, pp.453-465, 2003.

A. M. Popescu, S. O. Purcaru, O. Alexandru, and A. Dricu, New perspectives in glioblastoma antiangiogenic therapy, Contemp Oncol (Pozn), vol.20, issue.2, pp.109-118, 2016.

N. Pouratian, A. Asthagiri, J. Jagannathan, M. E. Shaffrey, and D. Schiff, Surgery Insight: the role of surgery in the management of low-grade gliomas, Nat Clin Pract Neurol, vol.3, issue.11, pp.628-639, 2007.

M. D. Prados, W. Yung, H. A. Fine, H. S. Greenberg, L. Junck et al., Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study, Neurooncology, vol.6, issue.1, pp.33-37, 2004.

G. P. Prévost, M. O. Lonchampt, S. Holbeck, S. Attoub, D. Zaharevitz et al., Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric Galpha/Gbetagamma protein complex, Cancer Res, vol.66, issue.18, pp.9227-9234, 2006.

R. M. Prins, H. Soto, V. Konkankit, S. K. Odesa, A. Eskin et al., Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy, Clin Cancer Res, vol.17, issue.6, pp.1603-1615, 2011.

M. A. Qazi, P. Vora, C. Venugopal, S. S. Sidhu, J. Moffat et al., Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma, Ann Oncol, vol.28, issue.7, pp.1448-1456, 2017.

C. Qi, S. Sorrentino, O. Medalia, and V. M. Korkhov, The structure of a membrane adenylyl cyclase bound to an activated stimulatory G protein, Science, vol.364, issue.6438, pp.389-394, 2019.

D. F. Quail and J. A. Joyce, The Microenvironmental Landscape of Brain Tumors, Cancer Cell, vol.31, issue.3, pp.326-341, 2017.

Y. Rajesh, I. Pal, P. Banik, S. Chakraborty, S. A. Borkar et al., Insights into molecular therapy of glioma: current challenges and next generation blueprint, Acta Pharmacol Sin, vol.38, issue.5, pp.591-613, 2017.

S. Rasheed, C. R. Teo, E. J. Beillard, P. M. Voorhoeve, and P. J. Casey, MicroRNA-182 and microRNA-200a control G-protein subunit ?-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells, J Biol Chem, vol.288, issue.11, pp.7986-7995, 2013.

S. Rasheed, C. R. Teo, E. J. Beillard, P. M. Voorhoeve, W. Zhou et al., MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells, Mol Cancer, vol.14, p.67, 2015.

S. Rasmussen, B. T. Devree, Y. Zou, A. C. Kruse, K. Y. Chung et al., Crystal structure of the ?2 adrenergic receptor-Gs protein complex, Nature, vol.477, issue.7366, pp.549-555, 2011.

S. K. Ray, The Transcription Regulator Krüppel-Like Factor 4 and Its Dual Roles of Oncogene in Glioblastoma and Tumor Suppressor in Neuroblastoma, For Immunopathol Dis Therap, vol.7, issue.1-2, pp.127-139, 2016.

D. A. Reardon, A. Desjardins, K. B. Peters, S. Gururangan, J. H. Sampson et al., Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma, J Neurooncol, vol.107, issue.1, pp.155-164, 2012.

D. A. Reardon, M. J. Egorin, J. A. Quinn, J. N. Rich, J. N. Rich et al., Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme, J Clin Oncol, vol.23, issue.36, pp.9359-9368, 2005.

G. Reig, E. Pulgar, and M. L. Concha, Cell migration: from tissue culture to embryos, Development, vol.141, issue.10, pp.1999-2013, 2014.

T. Reithmeier, E. Graf, T. Piroth, M. Trippel, P. Mo et al., BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors, BMC Cancer, vol.10, p.30, 2010.

S. G. Rhee, Regulation of phosphoinositide-specific phospholipase C, Annu Rev Biochem, vol.70, pp.281-312, 2001.

J. Van-rheenen, J. Condeelis, and M. Glogauer, A common cofilin activity cycle in invasive tumor cells and inflammatory cells, J Cell Sci, vol.122, pp.305-311, 2009.

D. Ribatti, The Contribution of Immune Cells to Angiogenesis in Inflammation and Tumor Growth, pp.27-84, 2017.

G. Riddick, S. Kotliarova, V. Rodriguez, H. S. Kim, A. Linkous et al., A Core Regulatory Circuit in Glioblastoma Stem Cells Links MAPK Activation to a, Transcriptional Program of Neural Stem Cell Identity. Sci Rep, vol.7, p.43605, 2017.

A. J. Ridley, Rho GTPase signalling in cell migration, Curr Opin Cell Biol, vol.36, pp.103-112, 2015.

A. J. Ridley, Life at the leading edge, Cell, vol.145, issue.7, pp.1012-1022, 2011.

L. B. Rivera and G. Bergers, Intertwined regulation of angiogenesis and immunity by myeloid cells, Trends Immunol, vol.36, issue.4, pp.240-249, 2015.

P. J. Roberts and C. J. Der, Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer, Oncogene, vol.26, issue.22, pp.3291-3310, 2007.

B. M. Rock, L. Xin, and J. N. Wilcox, Two Gq class G proteins are expressed in human keratinocytes, J Invest Dermatol, vol.109, issue.5, pp.645-649, 1997.

M. Rodbell, L. Birnbaumer, S. L. Pohl, and H. M. Krans, The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action, J Biol Chem, vol.246, issue.6, pp.1877-1882, 1971.

S. Roesch, C. Rapp, S. Dettling, and C. Herold-mende, When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma, Int J Mol Sci, vol.19, issue.2, 2018.

R. J. Rojas, M. E. Yohe, S. Gershburg, T. Kawano, T. Kozasa et al., Galphaq directly activates p63RhoGEF and Trio via a conserved extension of the Dbl homology-associated pleckstrin homology domain, J Biol Chem, vol.282, issue.40, pp.29201-29210, 2007.

B. J. Rollins, Inflammatory chemokines in cancer growth and progression, Eur J Cancer, vol.42, issue.6, pp.760-767, 2006.

P. Rondard, T. Iiri, S. Srinivasan, E. Meng, T. Fujita et al., Mutant G protein alpha subunit activated by Gbeta gamma: a model for receptor activation?, Proc Natl Acad Sci, vol.98, issue.11, pp.6150-6155, 2001.

A. Roos, Z. Ding, J. C. Loftus, and N. L. Tran, Molecular and Microenvironmental Determinants of Glioma Stem-Like Cell Survival and Invasion, Front Oncol, vol.7, p.120, 2017.

D. M. Rosenbaum, S. Rasmussen, and B. K. Kobilka, The structure and function of G-protein-coupled receptors, Nature, vol.459, issue.7245, pp.356-363, 2009.

E. M. Ross, Coordinating speed and amplitude in G-protein signaling, Curr Biol, vol.18, issue.17, pp.777-783, 2008.

E. M. Ross and A. G. Gilman, Resolution of some components of adenylate cyclase necessary for catalytic activity, J Biol Chem, vol.252, issue.20, pp.6966-6969, 1977.

B. D. Rowland, R. Bernards, and D. S. Peeper, The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene, Nat Cell Biol, vol.7, issue.11, pp.1074-1082, 2005.

A. Roy, J. Ye, F. Deng, and Q. J. Wang, Protein kinase D signaling in cancer: A friend or foe?, Biochim Biophys Acta Rev Cancer, vol.1868, issue.1, pp.283-294, 2017.

A. Roy, A. Coum, V. D. Marinescu, J. Põlajeva, A. Smits et al., Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells, Oncotarget, vol.6, issue.27, pp.23647-23661, 2015.

M. Ruat, E. Traiffort, J. M. Arrang, J. Tardivel-lacombe, J. Diaz et al., A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation, Biochem Biophys Res Commun, vol.193, issue.1, pp.268-276, 1993.

M. G. Rubashkin, L. Cassereau, R. Bainer, C. C. Dufort, Y. Yui et al., Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate, Cancer Res, vol.74, issue.17, pp.4597-4611, 2014.

J. B. Rubin, A. L. Kung, R. S. Klein, J. A. Chan, Y. Sun et al., A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors, Proc Natl Acad Sci, vol.100, issue.23, pp.13513-13518, 2003.

A. Sadok and C. J. Marshall, Rho GTPases: masters of cell migration, Small GTPases, vol.5, p.29710, 2014.

F. Sahm, C. Koelsche, J. Meyer, S. Pusch, K. Lindenberg et al., CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas, Acta Neuropathol, vol.123, issue.6, pp.853-860, 2012.

G. J. Samara, D. M. Lawrence, C. J. Chiarelli, M. D. Valentino, S. Lyubsky et al., CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma, Cancer Lett, vol.214, issue.2, pp.231-241, 2004.

S. Samaradivakara, D. Kankanamge, K. Senarath, K. Ratnayake, and A. Karunarathne, G protein ? (G?) subtype dependent targeting of GRK2 to M3 receptor by G??, Biochem Biophys Res Commun, vol.503, issue.1, pp.165-170, 2018.

N. Sanai and M. S. Berger, Intraoperative stimulation techniques for functional pathway preservation and glioma resection, Neurosurg Focus, vol.28, issue.2, p.1, 2010.

V. P. Satagopam, M. C. Theodoropoulou, C. K. Stampolakis, G. A. Pavlopoulos, N. C. Papandreou et al., GPCRs, G-proteins, effectors and their interactions: human-gpDB, a database employing visualization tools and data integration techniques, Database (Oxford), vol.2010, p.19, 2010.

M. Sato, M. Hiraoka, H. Suzuki, Y. Bai, R. Kurotani et al., Identification of transcription factor E3 (TFE3) as a receptorindependent activator of G?16: gene regulation by nuclear G? subunit and its activator, J Biol Chem, vol.286, issue.20, pp.17766-17776, 2011.

P. Scheerer, J. H. Park, P. W. Hildebrand, Y. J. Kim, N. Krauss et al., Crystal structure of opsin in its G-protein-interacting conformation, Nature, vol.455, issue.7212, pp.497-502, 2008.

G. Sciumè, A. Soriani, M. Piccoli, L. Frati, A. Santoni et al., CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-?1, Neuro-oncology, vol.12, issue.7, pp.701-710, 2010.

W. L. See and J. Mukherjee, Chapter 22 -Targeting the RAS-RAF-MEK-ERK Signaling Pathway in Gliomas, Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy, pp.323-332, 2018.

S. Seidel, B. K. Garvalov, V. Wirta, V. Stechow, L. Schänzer et al., A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha, Brain, vol.133, pp.983-995, 2010.

S. Seifert and H. Sontheimer, Bradykinin enhances invasion of malignant glioma into the brain parenchyma by inducing cells to undergo amoeboid migration, J Physiol (Lond), vol.592, issue.22, pp.5109-5127, 2014.

S. Sen, W. P. Ng, and S. Kumar, Contributions of talin-1 to glioma cell-matrix tensional homeostasis, J R Soc Interface, vol.9, issue.71, pp.1311-1317, 2012.

O. Sensoy and H. Weinstein, A mechanistic role of Helix 8 in GPCRs: Computational modeling of the dopamine D2 receptor interaction with the GIPC1-PDZ-domain, Biochim Biophys Acta, vol.1848, issue.4, pp.976-983, 2015.

J. Servitja, M. J. Marinissen, A. Sodhi, X. R. Bustelo, and J. S. Gutkind, Rac1 function is required for Src-induced transformation. Evidence of a role for Tiam1 and Vav2 in Rac activation by Src, J Biol Chem, vol.278, issue.36, pp.34339-34346, 2003.

K. Seystahl, A. Papachristodoulou, I. Burghardt, H. Schneider, K. Hasenbach et al., Biological Role and Therapeutic Targeting of TGF-?3 in Glioblastoma, Mol Cancer Ther, vol.16, issue.6, pp.1177-1186, 2017.

K. Seystahl, W. Wick, and M. Weller, Therapeutic options in recurrent glioblastoma--An update, Crit Rev Oncol Hematol, vol.99, pp.389-408, 2016.

S. Shangary and W. S. , Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy, Annu Rev Pharmacol Toxicol, vol.49, pp.223-241, 2009.

E. Shankar, S. Krishnamurthy, R. Paranandi, and A. Basu, PKCepsilon induces Bcl-2 by activating CREB, Int J Oncol, vol.36, issue.4, pp.883-888, 2010.

J. Shao, C. Jung, C. Liu, and H. Sheng, Prostaglandin E2 Stimulates the beta-catenin/T cell factordependent transcription in colon cancer, J Biol Chem, vol.280, issue.28, pp.26565-26572, 2005.

T. R. Sharif and M. Sharif, Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples, Int J Oncol, vol.15, issue.2, pp.237-243, 1999.

S. Shashidhar, G. Lorente, U. Nagavarapu, A. Nelson, J. Kuo et al., GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion, Oncogene, vol.24, issue.10, pp.1673-1682, 2005.

T. Shen and Q. Guo, Role of Pyk2 in Human Cancers, Med Sci Monit, vol.24, pp.8172-8182, 2018.

J. Sheng and Z. Xu, Three decades of research on angiogenin: a review and perspective, Acta Biochim Biophys Sin (Shanghai), vol.48, issue.5, pp.399-410, 2016.

N. Shindoh, A. Yoda, Y. Yoda, T. J. Sullivan, O. Weigert et al., Next-generation cDNA screening for oncogene and resistance phenotypes, PLoS ONE, vol.7, issue.11, p.49201, 2012.

N. Shinojima, K. Tada, S. Shiraishi, T. Kamiryo, M. Kochi et al., Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme, Cancer Res, vol.63, issue.20, pp.6962-6970, 2003.

A. K. Shukla, K. Xiao, and R. J. Lefkowitz, Emerging paradigms of ?-arrestin-dependent seven transmembrane receptor signaling, Trends Biochem Sci, vol.36, issue.9, pp.457-469, 2011.

F. A. Siebzehnrubl, D. J. Silver, B. Tugertimur, L. P. Deleyrolle, D. Siebzehnrubl et al., The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance, EMBO Mol Med, vol.5, issue.8, pp.1196-1212, 2013.

D. A. Sierra, D. J. Gilbert, D. Householder, N. V. Grishin, K. Yu et al., Evolution of the regulators of G-protein signaling multigene family in mouse and human, Genomics, vol.79, issue.2, pp.177-185, 2002.

M. I. Simon, M. P. Strathmann, and N. Gautam, Diversity of G proteins in signal transduction, Science, vol.252, issue.5007, pp.802-808, 1991.

S. Sit and E. Manser, Rho GTPases and their role in organizing the actin cytoskeleton, J Cell Sci, vol.124, pp.679-683, 2011.

U. Sivaprasad, E. Shankar, and A. Basu, Downregulation of Bid is associated with PKCepsilonmediated TRAIL resistance, Cell Death Differ, vol.14, issue.4, pp.851-860, 2007.

B. Sjögren, The evolution of regulators of G protein signalling proteins as drug targets -20 years in the making: IUPHAR Review 21, Br J Pharmacol, vol.174, issue.6, pp.427-437, 2017.

K. C. Slep, M. A. Kercher, W. He, C. W. Cowan, T. G. Wensel et al., Structural determinants for regulation of phosphodiesterase by a G protein at 2.0 A, Nature, vol.409, issue.6823, pp.1071-1077, 2001.

E. D. Slosberg, M. G. Klein, Y. Yao, E. K. Han, I. Schieren et al., The alpha isoform of protein kinase C mediates phorbol ester-induced growth inhibition and p21cip1 induction in HC11 mammary epithelial cells, Oncogene, vol.18, issue.48, pp.6658-6666, 1999.

A. V. Smrcka, G protein ?? subunits: central mediators of G protein-coupled receptor signaling, Cell Mol Life Sci, vol.65, issue.14, pp.2191-2214, 2008.

A. V. Smrcka, Regulation of phosphatidylinositol-specific phospholipase C at the nuclear envelope in cardiac myocytes, J Cardiovasc Pharmacol, vol.65, issue.3, pp.203-210, 2015.

A. V. Smrcka, J. R. Hepler, K. O. Brown, and P. C. Sternweis, Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq, Science, vol.251, issue.4995, pp.804-807, 1991.

A. V. Smrcka and P. C. Sternweis, Regulation of purified subtypes of phosphatidylinositol-specific phospholipase C beta by G protein alpha and beta gamma subunits, J Biol Chem, vol.268, issue.13, pp.9667-9674, 1993.

Y. Soda, T. Marumoto, D. Friedmann-morvinski, M. Soda, F. Liu et al., Transdifferentiation of glioblastoma cells into vascular endothelial cells, Proc Natl Acad Sci, vol.108, issue.11, pp.4274-4280, 2011.

Y. Soda, C. Myskiw, A. Rommel, and I. M. Verma, Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme, J Mol Med, vol.91, issue.4, pp.439-448, 2013.

Y. Sonoda, T. Ozawa, K. D. Aldape, D. F. Deen, M. S. Berger et al., Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma, Cancer Res, vol.61, issue.18, pp.6674-6678, 2001.

A. Sottoriva, I. Spiteri, S. Piccirillo, A. Touloumis, V. P. Collins et al., Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics, Proc Natl Acad Sci, vol.110, issue.10, pp.4009-4014, 2013.

D. Spiering and L. Hodgson, Dynamics of the Rho-family small GTPases in actin regulation and motility, Cell Adh Migr, vol.5, issue.2, pp.170-180, 2011.

S. R. Sprang, Invited review: Activation of G proteins by GTP and the mechanism of G?-catalyzed GTP hydrolysis, Biopolymers, vol.105, issue.8, pp.449-462, 2016.

S. R. Sprang, Z. Chen, and X. Du, Structural basis of effector regulation and signal termination in heterotrimeric Galpha proteins, Adv Protein Chem, vol.74, pp.74001-74010, 2007.

G. Stancheva, T. Goranova, M. Laleva, M. Kamenova, A. Mitkova et al., IDH1/IDH2 but not TP53 mutations predict prognosis in Bulgarian glioblastoma patients, Biomed Res Int, p.654727, 2014.

P. S. Steeg, Tumor metastasis: mechanistic insights and clinical challenges, Nat Med, vol.12, issue.8, pp.895-904, 2006.

S. F. Steinberg, Distinctive activation mechanisms and functions for protein kinase Cdelta, Biochem J, vol.384, pp.449-459, 2004.

D. Steinke, S. Hoegg, H. Brinkmann, and A. Meyer, Three rounds (1R/2R/3R) of genome duplications and the evolution of the glycolytic pathway in vertebrates, BMC Biol, vol.4, p.16, 2006.

A. A. Stepanenko and V. P. Chekhonin, Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy? Cancers (Basel), p.10, 2018.

A. A. Stepanenko and V. P. Chekhonin, A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapy, Gene, vol.679, pp.11-18, 2018.

D. Stieber, A. Golebiewska, L. Evers, E. Lenkiewicz, N. Brons et al., Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes, Acta Neuropathol, vol.127, issue.2, pp.203-219, 2014.

D. Stokoe, PTEN. Curr Biol, vol.11, issue.13, p.502, 2001.

B. Stoyanov, S. Volinia, T. Hanck, I. Rubio, M. Loubtchenkov et al., Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase, Science, vol.269, issue.5224, pp.690-693, 1995.

M. Strathmann and M. I. Simon, G protein diversity: a distinct class of alpha subunits is present in vertebrates and invertebrates, Proc Natl Acad Sci, vol.87, issue.23, pp.9113-9117, 1990.

M. P. Strathmann and M. I. Simon, G alpha 12 and G alpha 13 subunits define a fourth class of G protein alpha subunits, Proc Natl Acad Sci, vol.88, issue.13, pp.5582-5586, 1991.

H. M. Strik, M. Kolodziej, W. Oertel, and J. Basecke, Glycobiology in malignant gliomas: expression and functions of galectins and possible therapeutic options, Curr Pharm Biotechnol, vol.13, issue.11, pp.2299-2307, 2012.

A. Stubb, C. Guzmán, E. Närvä, J. Aaron, T. Chew et al., Superresolution architecture of cornerstone focal adhesions in human pluripotent stem cells, Nat Commun, vol.10, issue.1, pp.1-15, 2019.

R. Stupp, N. Pavlidis, and S. Jelic, ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma, Ann Oncol, vol.16, pp.64-65, 2005.

R. Stupp, S. Taillibert, A. Kanner, W. Read, D. Steinberg et al., Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial, JAMA, vol.318, issue.23, pp.2306-2316, 2017.

R. Stupp, S. Taillibert, A. A. Kanner, S. Kesari, D. M. Steinberg et al., Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial, JAMA, vol.314, issue.23, pp.2535-2543, 2015.

B. Stutchbury, P. Atherton, R. Tsang, D. Wang, and C. Ballestrem, Distinct focal adhesion protein modules control different aspects of mechanotransduction, J Cell Sci, vol.130, issue.9, pp.1612-1624, 2017.

Y. Su, M. Ho, and Y. H. Wong, A hematopoietic perspective on the promiscuity and specificity of Galpha16 signaling, Neurosignals, vol.17, issue.1, pp.71-81, 2009.

M. C. Subauste, O. Pertz, E. D. Adamson, C. E. Turner, S. Junger et al., Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility, J Cell Biol, vol.165, issue.3, pp.371-381, 2004.

H. Suga, Z. Chen, A. De-mendoza, A. Sebé-pedrós, M. W. Brown et al., The Capsaspora genome reveals a complex unicellular prehistory of animals, Nat Commun, vol.4, p.2325, 2013.

P. Suh, J. Park, L. Manzoli, L. Cocco, J. C. Peak et al., Multiple roles of phosphoinositide-specific phospholipase C isozymes, BMB Rep, vol.41, issue.6, pp.415-434, 2008.

L. Sun, Y. Zhang, C. Wu, Y. Liang, J. et al., Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma, CNS Neurosci Ther, vol.23, issue.1, pp.69-75, 2017.

R. K. Sunahara, C. W. Dessauer, and A. G. Gilman, Complexity and diversity of mammalian adenylyl cyclases, Annu Rev Pharmacol Toxicol, vol.36, pp.461-480, 1996.

K. Suzuki, T. Kawataki, K. Endo, K. Miyazawa, H. Kinouchi et al., Expression of ZEBs in gliomas is associated with invasive properties and histopathological grade, Oncol Lett, vol.16, issue.2, pp.1758-1764, 2018.

N. Suzuki, S. Nakamura, H. Mano, and T. Kozasa, Galpha 12 activates Rho GTPase through tyrosinephosphorylated leukemia-associated RhoGEF, Proc Natl Acad Sci, vol.100, issue.2, pp.733-738, 2003.

L. Svensson, P. Stanley, F. Willenbrock, and N. Hogg, The G?q/11 proteins contribute to T lymphocyte migration by promoting turnover of integrin LFA-1 through recycling, PLoS ONE, vol.7, issue.6, p.38517, 2012.

K. F. Swaney and R. Li, Function and regulation of the Arp2/3 complex during cell migration in diverse environments, Curr Opin Cell Biol, vol.42, pp.63-72, 2016.

V. Syrovatkina, K. O. Alegre, R. Dey, and X. Huang, Regulation, Signaling, and Physiological Functions of G-Proteins, J Mol Biol, vol.428, issue.19, pp.3850-3868, 2016.

D. Szczepanek, A. Marchel, M. Moska?a, M. Krupa, P. Kunert et al., Efficacy of concomitant and adjuvant temozolomide in glioblastoma treatment. A multicentre randomized study, Neurol Neurochir Pol, vol.47, issue.2, pp.101-108, 2013.

S. Takano, E. Ishikawa, N. Sakamoto, M. Matsuda, H. Akutsu et al., Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas, Brain Tumor Pathol, vol.33, issue.2, pp.107-116, 2016.

A. Takesono, M. J. Cismowski, C. Ribas, M. Bernard, P. Chung et al., Receptor-independent activators of heterotrimeric G-protein signaling pathways, J Biol Chem, vol.274, issue.47, pp.33202-33205, 1999.

N. Takuwa, W. Du, E. Kaneko, Y. Okamoto, K. Yoshioka et al., Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 -Jekyll Hidden behind Hyde, Am J Cancer Res, vol.1, issue.4, pp.460-481, 2011.

W. Tan, D. Martin, and J. S. Gutkind, The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4, J Biol Chem, vol.281, issue.51, pp.39542-39549, 2006.

Z. Tan, K. Chen, W. Wu, Y. Zhou, J. Zhu et al., Overexpression of HOXC10 promotes angiogenesis in human glioma via interaction with PRMT5 and upregulation of VEGFA expression, Theranostics, vol.8, issue.18, pp.5143-5158, 2018.

S. Tanaka, D. N. Louis, W. T. Curry, T. T. Batchelor, and J. Dietrich, Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end, Nat Rev Clin Oncol, vol.10, issue.1, pp.14-26, 2013.

D. D. Tang and B. D. Gerlach, The roles and regulation of the actin cytoskeleton, intermediate filaments and microtubules in smooth muscle cell migration, Respir Res, vol.18, issue.1, p.54, 2017.

X. Tang, J. R. Qu, G. Wang, X. Li, Z. Yuan et al., GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the G?q-p63RhoGEF-Rho GTPase pathway, Cancer Res, vol.73, pp.6206-6218, 1920.

R. Taussig, J. A. Iñiguez-lluhi, and A. G. Gilman, Inhibition of adenylyl cyclase by Gi alpha, Science, vol.261, issue.5118, pp.218-221, 1993.

S. J. Taylor, J. A. Smith, and J. H. Exton, Purification from bovine liver membranes of a guanine nucleotidedependent activator of phosphoinositide-specific phospholipase C. Immunologic identification as a novel G-protein alpha subunit, J Biol Chem, vol.265, issue.28, pp.17150-17156, 1990.

C. Tekin, K. Shi, J. B. Daalhuisen, T. Brink, M. S. Bijlsma et al., PAR1 signaling on tumor cells limits tumor growth by maintaining a mesenchymal phenotype in pancreatic cancer, Oncotarget, vol.9, issue.62, pp.32010-32023, 2018.

B. Temple, C. D. Jones, and A. M. Jones, Evolution of a signaling nexus constrained by protein interfaces and conformational States, PLoS Comput Biol, vol.6, issue.10, p.1000962, 2010.

S. Tenailleau, I. Corre, and S. Hermouet, Specific expression of heterotrimeric G proteins G12 and G16 during human myeloid differentiation, Exp Hematol, vol.25, issue.9, pp.927-934, 1997.

M. Teo, S. Martin, K. Owusu-agyemang, S. Nowicki, B. Clark et al., A survival analysis of GBM patients in the West of Scotland pre-and post-REFERENCES BIBLIOGRAPHIQUES, 2014.

. Kléouforo-paul, DEMBELE introduction of the Stupp regime, Br J Neurosurg, vol.28, issue.3, pp.351-355

J. Teoh, K. Park, Y. Wang, Q. Hu, S. Kim et al., Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis, Cell Signal, vol.26, issue.12, pp.2885-2895, 2014.

J. J. Tesmer, D. M. Berman, A. G. Gilman, and S. R. Sprang, Structure of RGS4 bound to AlF4--activated G(i alpha1): stabilization of the transition state for GTP hydrolysis, Cell, vol.89, issue.2, pp.251-261, 1997.

J. P. Thiery, Epithelial-mesenchymal transitions in tumour progression, Nat Rev Cancer, vol.2, issue.6, pp.442-454, 2002.

V. L. Thijssen, B. Barkan, H. Shoji, I. M. Aries, V. Mathieu et al., Tumor cells secrete galectin-1 to enhance endothelial cell activity, Cancer Res, vol.70, issue.15, pp.6216-6224, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00505249

A. Tinker, The selective interactions and functions of regulators of G-protein signalling, Semin Cell Dev Biol, vol.17, issue.3, pp.377-382, 2006.

L. G. Toussaint, A. E. Nilson, J. M. Goble, K. V. Ballman, C. D. James et al., Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion, Mol Cancer, vol.11, p.32, 2012.

L. Treps, R. Perret, S. Edmond, R. D. Gavard, and J. , Glioblastoma stem-like cells secrete the proangiogenic VEGF-A factor in extracellular vesicles, J Extracell Vesicles, vol.6, issue.1, p.1359479, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01573268

D. Triner and Y. M. Shah, Hypoxia-inducible factors: a central link between inflammation and cancer, J Clin Invest, vol.126, issue.10, pp.3689-3698, 2016.

R. Tsutsumi, Y. Fukata, J. Noritake, T. Iwanaga, F. Perez et al., Identification of G protein alpha subunit-palmitoylating enzyme, Mol Cell Biol, vol.29, issue.2, pp.435-447, 2009.

S. Turcan, D. Rohle, A. Goenka, L. A. Walsh, F. Fang et al., IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype, Nature, vol.483, issue.7390, pp.479-483, 2012.

M. Turcotte, W. Tang, and E. M. Ross, Coordinate regulation of G protein signaling via dynamic interactions of receptor and GAP, PLoS Comput Biol, vol.4, issue.8, p.1000148, 2008.

C. E. Turner, J. R. Glenney, and K. Burridge, Paxillin: a new vinculin-binding protein present in focal adhesions, J Cell Biol, vol.111, issue.3, pp.1059-1068, 1990.

M. C. Turner, D. Krewski, B. K. Armstrong, A. Chetrit, G. G. Giles et al., Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, vol.24, pp.949-960, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00926795

J. Twizere, J. Springael, M. Boxus, A. Burny, F. Dequiedt et al., Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling, Blood, vol.109, issue.3, pp.1051-1060, 2007.

J. J. Tyler, E. G. Allwood, and K. R. Ayscough, WASP family proteins, more than Arp2/3 activators, Biochem Soc Trans, vol.44, issue.5, pp.1339-1345, 2016.

H. Ueda, S. Saga, H. Shinohara, R. Morishita, K. Kato et al., Association of the gamma12 subunit of G proteins with actin filaments, J Cell Sci, vol.110, pp.1503-1511, 1997.

H. Ueno, A. Tomiyama, H. Yamaguchi, T. Uekita, T. Shirakihara et al., Augmentation of invadopodia formation in temozolomide-resistant or adopted glioma is regulated by c-Jun terminal kinase-paxillin axis, Biochem Biophys Res Commun, vol.468, issue.1-2, pp.240-247, 2015.

J. H. Uhm, K. V. Ballman, W. Wu, C. Giannini, J. C. Krauss et al., Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074, Int J Radiat Oncol Biol Phys, vol.80, issue.2, pp.347-353, 2011.

H. Umemori, T. Inoue, S. Kume, N. Sekiyama, M. Nagao et al., Activation of the G protein Gq/11 through tyrosine phosphorylation of the alpha subunit, Science, vol.276, issue.5320, pp.1878-1881, 1997.

N. Upadhyay and A. D. Waldman, Conventional MRI evaluation of gliomas, Br J Radiol, vol.84, issue.2, pp.107-111, 2011.

A. Vakilian, H. Khorramdelazad, P. Heidari, Z. Sheikh-rezaei, and G. Hassanshahi, CCL2/CCR2 signaling pathway in glioblastoma multiforme, Neurochem Int, vol.103, pp.1-7, 2017.

N. Van-eps, C. Altenbach, L. N. Caro, N. R. Latorraca, S. A. Hollingsworth et al., Gi-and Gs-coupled GPCRs show different modes of G-protein binding, Proc Natl Acad Sci, vol.115, issue.10, pp.2383-2388, 2018.

N. Van-eps, W. M. Oldham, H. E. Hamm, and W. L. Hubbell, Structural and dynamical changes in an alphasubunit of a heterotrimeric G protein along the activation pathway, Proc Natl Acad Sci, vol.103, issue.44, pp.16194-16199, 2006.

E. G. Van-meir, C. G. Hadjipanayis, A. D. Norden, H. Shu, P. Y. Wen et al., Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma, CA Cancer J Clin, vol.60, issue.3, pp.166-193, 2010.

C. D. Van-raamsdonk, V. Bezrookove, G. Green, J. Bauer, L. Gaugler et al., Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi, Nature, vol.457, issue.7229, pp.599-602, 2009.

C. D. Van-raamsdonk, K. G. Griewank, M. B. Crosby, M. C. Garrido, S. Vemula et al., Mutations in GNA11 in uveal melanoma, N Engl J Med, vol.363, issue.23, pp.2191-2199, 2010.

D. Vandael, S. Mahapatra, C. Calorio, A. Marcantoni, and E. Carbone, Cav1.3 and Cav1.2 channels of adrenal chromaffin cells: emerging views on cAMP/cGMP-mediated phosphorylation and role in pacemaking, Biochim Biophys Acta, vol.1828, issue.7, pp.1608-1618, 2013.

J. P. Vaqué, R. T. Dorsam, X. Feng, R. Iglesias-bartolome, D. J. Forsthoefel et al., A genome-wide RNAi screen reveals a Trioregulated Rho GTPase circuitry transducing mitogenic signals initiated by G proteincoupled receptors, Mol Cell, vol.49, issue.1, pp.94-108, 2013.

J. Vázquez-prado, I. Bracho-valdés, R. D. Cervantes-villagrana, and G. Reyes-cruz, G?? Pathways in Cell Polarity and Migration Linked to Oncogenic GPCR Signaling: Potential Relevance in Tumor Microenvironment, Mol Pharmacol, vol.90, issue.5, pp.573-586, 2016.

C. Velásquez, S. Mansouri, C. Mora, F. Nassiri, S. Suppiah et al., Molecular and Clinical Insights into the Invasive Capacity of Glioblastoma Cells, J Oncol, p.1740763, 2019.

K. K. Velpula, A. A. Rehman, B. Chelluboina, V. R. Dasari, C. S. Gondi et al., Glioma stem cell invasion through regulation of the interconnected ERK, integrin ?6 and Ncadherin signaling pathway, Cell Signal, vol.24, issue.11, pp.2076-2084, 2012.

A. J. Venkatakrishnan, X. Deupi, G. Lebon, F. M. Heydenreich, T. Flock et al., Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region, Nature, vol.536, issue.7617, pp.484-487, 2016.

A. J. Venkatakrishnan, T. Flock, D. E. Prado, M. E. Oates, J. Gough et al., Structured and disordered facets of the GPCR fold, Curr Opin Struct Biol, vol.27, pp.129-137, 2014.

R. Verhaak, K. A. Hoadley, E. Purdom, V. Wang, Y. Qi et al., Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1, Cancer Cell, vol.17, issue.1, pp.98-110, 2010.

N. Verma, O. Keinan, M. Selitrennik, T. Karn, M. Filipits et al., PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition, Nat Commun, vol.6, p.6064, 2015.

M. Vidal, T. Wieland, M. J. Lohse, and K. Lorenz, 2012. ?-Adrenergic receptor stimulation causes cardiac hypertrophy via a G??/Erk-dependent pathway, Cardiovasc Res, vol.96, issue.2, pp.255-264
URL : https://hal.archives-ouvertes.fr/hal-00920704

T. Van-der-vlis, A. Hoeben, J. C. Beckervordersandforth, L. Ackermans, D. Eekers et al., Impact of the revised WHO classification of diffuse low-grade glioma on clinical decision making: A case report, Surg Neurol Int, vol.8, p.223, 2017.

S. Vogt, R. Grosse, G. Schultz, and S. Offermanns, Receptor-dependent RhoA activation in G12/G13-deficient cells: genetic evidence for an involvement of Gq/G11, J Biol Chem, vol.278, issue.31, pp.28743-28749, 2003.

L. Van-der-voorn and H. L. Ploegh, The WD-40 repeat, FEBS Lett, vol.307, issue.2, pp.131-134, 1992.

G. L. Waldo, T. K. Ricks, S. N. Hicks, M. L. Cheever, T. Kawano et al., Kinetic scaffolding mediated by a phospholipase C-beta and Gq signaling complex, Science, vol.330, issue.6006, pp.974-980, 2010.

M. A. Wall, D. E. Coleman, E. Lee, J. A. Iñiguez-lluhi, B. A. Posner et al., The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2, Cell, vol.83, issue.6, pp.1047-1058, 1995.

L. Wang, J. Learoyd, Y. Duan, A. R. Leff, and X. Zhu, Hematopoietic Pyk2 regulates migration of differentiated HL-60 cells, J Inflamm, p.26, 2010.

Z. Wang, J. Yang, G. Xu, W. Wang, C. Liu et al., Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors, Oncotarget, vol.6, issue.5, pp.3147-3164, 2015.

C. C. Wang, J. Li, C. S. Teo, and T. Lee, The delivery of BCNU to brain tumors, J Control Release, vol.61, issue.1-2, pp.21-41, 1999.

L. Wang, K. Zhao, B. Ren, M. Zhu, C. Zhang et al., Expression of cortactin in human gliomas and its effect on migration and invasion of glioma cells, Oncol Rep, vol.34, issue.4, pp.1815-1824, 2015.

L. Wang, J. G. He, C. Guo, X. Zhou, X. Li et al., G?s protein expression is an independent predictor of recurrence in prostate cancer, J Immunol Res, p.301376, 2014.

Q. Wang, B. Hu, X. Hu, H. Kim, M. Squatrito et al., Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment, Cancer Cell, vol.32, issue.1, pp.42-56, 2017.

Q. J. Wang, PKD at the crossroads of DAG and PKC signaling, Trends Pharmacol Sci, vol.27, issue.6, pp.317-323, 2006.

R. Wang, K. Chadalavada, J. Wilshire, U. Kowalik, K. E. Hovinga et al., Glioblastoma stem-like cells give rise to tumour endothelium, Nature, vol.468, issue.7325, pp.829-833, 2010.

X. Wang, G. Guo, H. Guan, Y. Yu, L. J. et al., Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma, J Exp Clin Cancer Res, vol.38, issue.1, p.87, 2019.

X. Wang, C. Tan, G. Wang, J. Cai, L. Wang et al., Dual action of NSC606985 on cell growth and apoptosis mediated through PKC? in prostatic cancer cells, Int J Oncol, vol.51, issue.5, pp.1601-1610, 2017.

Y. Wang, G. Ho, J. J. Zhang, B. Nieuwenhuijsen, E. W. Chanda et al., Regulator of G protein signaling Z1 (RGSZ1) interacts with Galpha i subunits and regulates Galpha imediated cell signaling, J Biol Chem, vol.277, issue.50, pp.48325-48332, 2002.

Y. Wang, X. Xu, M. Pan, and J. T. , ELMO1 Directly Interacts with G?? Subunit to Transduce GPCR Signaling to Rac1 Activation in Chemotaxis, J Cancer, vol.7, issue.8, pp.973-983, 2016.

Z. Wang, D. Cruz, R. , J. F. Guo, S. Zhang et al., G(i)? proteins exhibit functional differences in the activation of ERK1/2, Akt and mTORC1 by growth factors in normal and breast cancer cells, Cell Commun Signal, vol.12, p.10, 2014.

Z. Wang, B. Liu, P. Wang, X. Dong, C. Fernandez-hernando et al., Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice, J Clin Invest, vol.118, issue.1, pp.195-204, 2008.

M. Watanabe, M. Nakamura, K. Sato, M. Kano, M. I. Simon et al., Patterns of expression for the mRNA corresponding to the four isoforms of phospholipase Cbeta in mouse brain, Eur J Neurosci, vol.10, issue.6, pp.2016-2025, 1998.

T. Watanabe, S. Nobusawa, P. Kleihues, and H. Ohgaki, IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas, Am J Pathol, vol.174, issue.4, pp.1149-1153, 2009.

S. Watkins, S. Robel, I. F. Kimbrough, S. M. Robert, G. Ellis-davies et al., Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells, Nat Commun, vol.5, p.4196, 2014.

S. Watkins and H. Sontheimer, Hydrodynamic cellular volume changes enable glioma cell invasion, J Neurosci, vol.31, issue.47, pp.17250-17259, 2011.

L. S. Weinstein, J. Liu, A. Sakamoto, T. Xie, and M. Chen, Minireview: GNAS: normal and abnormal functions, Endocrinology, vol.145, issue.12, pp.5459-5464, 2004.

H. Welch, W. J. Coadwell, C. D. Ellson, G. J. Ferguson, S. R. Andrews et al., P-Rex1, a PtdIns(3,4,5)P3-and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac, Cell, vol.108, issue.6, pp.809-821, 2002.

M. Weller, N. Butowski, D. D. Tran, L. D. Recht, M. Lim et al., Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial, Lancet Oncol, vol.18, issue.10, p.30517, 2017.

C. D. Wells, M. Liu, J. M. Gutowski, S. Sternweis, P. M. Rothstein et al., Mechanisms for reversible regulation between G13 and Rho exchange factors, J Biol Chem, vol.277, issue.2, pp.1174-1181, 2002.

M. K. Wendt, N. Balanis, C. R. Carlin, and W. P. Schiemann, STAT3 and epithelial-mesenchymal transitions in carcinomas, JAKSTAT, vol.3, issue.1, p.28975, 2014.

M. K. Wendt, B. J. Schiemann, J. G. Parvani, Y. Lee, Y. Kang et al., TGF-? stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer, Oncogene, vol.32, issue.16, pp.2005-2015, 2013.

K. Wenzel-seifert and R. Seifert, Molecular analysis of beta(2)-adrenoceptor coupling to G(s)-, G(i)-, and G(q)-proteins, Mol Pharmacol, vol.58, issue.5, pp.954-966, 2000.

N. Wettschureck and S. Offermanns, Mammalian G proteins and their cell type specific functions, Physiol Rev, vol.85, issue.4, pp.1159-1204, 2005.

M. Whiteway, L. Hougan, D. Dignard, L. Bell, G. Saari et al., Function of the STE4 and STE18 genes in mating pheromone signal transduction in Saccharomyces cerevisiae, Cold Spring Harb Symp Quant Biol, vol.53, pp.585-590, 1988.

W. Wick, T. Gorlia, M. Bendszus, M. Taphoorn, F. Sahm et al., Lomustine and Bevacizumab in Progressive Glioblastoma, N Engl J Med, vol.377, pp.1954-1963, 1920.

W. Wick, M. Platten, and M. Weller, New (alternative) temozolomide regimens for the treatment of glioma, Neuro-oncology, vol.11, issue.1, pp.69-79, 2009.

W. Wick, V. K. Puduvalli, M. C. Chamberlain, M. J. Van-den-bent, A. F. Carpentier et al., Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma, J Clin Oncol, vol.28, issue.7, pp.1168-1174, 2010.

K. D. Wickman and D. E. Clapham, G-protein regulation of ion channels, Curr Opin Neurobiol, vol.5, issue.3, pp.278-285, 1995.

C. Wigerup, S. Påhlman, and D. Bexell, Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer, Pharmacol Ther, vol.164, pp.152-169, 2016.

T. M. Wilkie, D. J. Gilbert, A. S. Olsen, X. N. Chen, T. T. Amatruda et al., Evolution of the mammalian G protein alpha subunit multigene family, Nat Genet, vol.1, issue.2, pp.85-91, 1992.

T. M. Wilkie, P. A. Scherle, M. P. Strathmann, V. Z. Slepak, and M. I. Simon, Characterization of G-protein alpha subunits in the Gq class: expression in murine tissues and in stromal and hematopoietic cell lines, Proc Natl Acad Sci, vol.88, issue.22, pp.10049-10053, 1991.

B. M. Willardson and C. M. Tracy, Chaperone-mediated assembly of G protein complexes, Subcell Biochem, vol.63, pp.131-153, 2012.

S. L. Williams, S. Lutz, N. K. Charlie, C. Vettel, M. Ailion et al., Trio's Rho-specific GEF domain is the missing Galpha q effector in C. elegans, Genes Dev, vol.21, issue.21, pp.2731-2746, 2007.

D. Willoughby and D. Cooper, Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains, Physiol Rev, vol.87, issue.3, pp.965-1010, 2007.

J. G. Wolbers, Novel strategies in glioblastoma surgery aim at safe, supra-maximum resection in conjunction with local therapies, Chin J Cancer, vol.33, issue.1, pp.8-15, 2014.

P. Woo, Y. Li, A. Chan, S. Ng, H. Loong et al., A multifaceted review of temozolomide resistance mechanisms in glioblastoma beyond O-6-methylguanine-DNA methyltransferase, Glioma, vol.2, issue.2, p.68, 2019.

V. Wu, H. Yeerna, N. Nohata, J. Chiou, O. Harismendy et al., Illuminating the Onco-GPCRome: Novel G protein-coupled receptordriven oncocrine networks and targets for cancer immunotherapy, J Biol Chem, vol.294, issue.29, pp.11062-11086, 2019.

D. Wu, Y. Kuang, Y. Wu, and H. Jiang, Selective coupling of beta 2-adrenergic receptor to hematopoietic-specific G proteins, J Biol Chem, vol.270, issue.27, pp.16008-16010, 1995.

D. Wu, G. J. Larosa, and M. I. Simon, G protein-coupled signal transduction pathways for interleukin-8, Science, vol.261, issue.5117, pp.101-103, 1993.

D. Q. Wu, C. H. Lee, S. G. Rhee, and M. I. Simon, Activation of phospholipase C by the alpha subunits of the Gq and G11 proteins in transfected Cos-7 cells, J Biol Chem, vol.267, issue.3, pp.1811-1817, 1992.

E. Wu, R. Lo, and Y. H. Wong, Regulation of STAT3 activity by G16-coupled receptors, Biochem Biophys Res Commun, vol.303, issue.3, pp.920-925, 2003.

J. Wu, J. Qu, H. Cao, C. Jing, Z. Wang et al., Monoclonal antibody AC10364 inhibits cell proliferation in 5-fluorouracil resistant hepatocellular carcinoma via apoptotic pathways, Onco Targets Ther, vol.12, pp.5053-5067, 2019.

J. Wu, N. Xie, X. Zhao, E. C. Nice, and C. Huang, Dissection of aberrant GPCR signaling in tumorigenesis--a systems biology approach, Cancer Genomics Proteomics, vol.9, issue.1, pp.37-50, 2012.

Y. Wu, S. Wang, S. M. Farooq, M. P. Castelvetere, Y. Hou et al., A chemokine receptor CXCR2 macromolecular complex regulates neutrophil functions in inflammatory diseases, J Biol Chem, vol.287, issue.8, pp.5744-5755, 2012.

R. Würth, A. Bajetto, J. K. Harrison, F. Barbieri, and T. Florio, CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment, Front Cell Neurosci, vol.8, p.144, 2014.

T. Xie, A. Plagge, O. Gavrilova, S. Pack, W. Jou et al., The alternative stimulatory G protein alpha-subunit XLalphas is a critical regulator of energy and glucose metabolism and sympathetic nerve activity in adult mice, J Biol Chem, vol.281, issue.28, pp.18989-18999, 2006.

Y. Xu, X. Li, S. Zhang, D. Shen, H. Li et al., Targeting Stat3 suppresses growth of U251 cell-derived tumours in nude mice, J Clin Neurosci, vol.19, issue.3, pp.443-446, 2012.

Y. Xu, Z. Li, C. Zhang, S. Zhang, Y. Ji et al., Knockdown of PKC? expression inhibits growth, induces apoptosis and decreases invasiveness of human glioma cells partially through Stat3, J Mol Neurosci, vol.55, issue.1, pp.21-31, 2015.

L. Yadav, N. Puri, V. Rastogi, P. Satpute, and V. Sharma, Tumour Angiogenesis and Angiogenic Inhibitors: A Review, J Clin Diagn Res, vol.9, issue.6, pp.1-05, 2015.

V. N. Yadav, D. Zamler, G. J. Baker, P. Kadiyala, A. Erdreich-epstein et al., CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study, Oncotarget, vol.7, issue.50, pp.83701-83719, 2016.

H. Yagi, W. Tan, P. Dillenburg-pilla, A. S. Amornphimoltham, P. Simaan et al., A synthetic biology approach reveals a CXCR4-G13, 2011.

, Rho signaling axis driving transendothelial migration of metastatic breast cancer cells, Sci Signal, vol.4, p.60

K. M. Yamada and M. Sixt, Mechanisms of 3D cell migration, Nat Rev Mol Cell Biol, 2019.

H. Yamaguchi and J. Condeelis, Regulation of the actin cytoskeleton in cancer cell migration and invasion, Biochim Biophys Acta, vol.1773, issue.5, pp.642-652, 2007.

B. Yamini, NF-?B, Mesenchymal Differentiation and Glioblastoma. Cells, vol.7, issue.9, 2018.

H. Yang, D. Ye, K. Guan, and Y. Xiong, IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives, Clin Cancer Res, vol.18, issue.20, pp.5562-5571, 2012.

H. W. Yang, L. G. Menon, P. M. Black, R. S. Carroll, and M. D. Johnson, SNAI2/Slug promotes growth and invasion in human gliomas, BMC Cancer, vol.10, p.301, 2010.

L. Yang, J. E. Woerner, B. M. Perry, A. Piwnica-worms, D. Rubin et al., Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo, Cancer Res, vol.67, issue.2, pp.651-658, 2007.

M. Yang, H. Sang, A. Rahman, D. Wu, A. B. Malik et al., G alpha 16 couples chemoattractant receptors to NF-kappa B activation, J Immunol, vol.166, issue.11, pp.6885-6892, 2001.

W. Yang and J. D. Hildebrandt, Genomic analysis of G protein gamma subunits in human and mousethe relationship between conserved gene structure and G protein betagamma dimer formation, Cell Signal, vol.18, issue.2, pp.194-201, 2006.

J. Yao, L. Liang, S. Huang, J. Ding, N. Tan et al., MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma, Hepatology, vol.51, issue.3, pp.846-856, 2010.

H. Yasuda, M. A. Lindorfer, C. S. Myung, and J. C. Garrison, Phosphorylation of the G protein gamma12 subunit regulates effector specificity, J Biol Chem, vol.273, issue.34, pp.21958-21965, 1998.

K. Yatsunami, B. V. Pandya, D. D. Oprian, and H. G. Khorana, cDNA-derived amino acid sequence of the gamma subunit of GTPase from bovine rod outer segments, Proc Natl Acad Sci, vol.82, issue.7, pp.1936-1940, 1985.

W. Yeung and Y. H. Wong, The RhoA-specific guanine nucleotide exchange factor p63RhoGEF binds to activated Galpha(16) and inhibits the canonical phospholipase Cbeta pathway, Cell Signal, vol.21, issue.8, pp.1317-1325, 2009.

L. Yin, N. Bennani-baiti, and C. T. Powell, Phorbol ester-induced apoptosis of C4-2 cells requires both a unique and a redundant protein kinase C signaling pathway, J Biol Chem, vol.280, issue.7, pp.5533-5541, 2005.

M. Yin, M. W. , and A. L. , Cortactin in cancer cell migration and invasion, Oncotarget, vol.8, issue.50, pp.88232-88243, 2017.

A. Yoda, G. Adelmant, J. Tamburini, B. Chapuy, N. Shindoh et al., Mutations in G protein ? subunits promote transformation and kinase inhibitor resistance, Nat Med, vol.21, issue.1, pp.71-75, 2015.

N. Young, D. K. Pearl, and J. R. Van-brocklyn, Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61, Mol Cancer Res, vol.7, issue.1, pp.23-32, 2009.

N. Young and J. R. Van-brocklyn, Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness, Exp Cell Res, vol.313, issue.8, pp.1615-1627, 2007.

M. Y. Yu, M. K. Ho, A. M. Liu, and Y. H. Wong, Mutations on the Switch III region and the alpha3 helix of Galpha16 differentially affect receptor coupling and regulation of downstream effectors, J Mol Signal, vol.3, p.17, 2008.

Q. Yu, L. Xu, L. Chen, B. Sun, Y. Zhiyun et al., Vinculin expression in non-small cell lung cancer, J Int Med Res, p.300060519839523, 2019.

C. Yuan, M. Sato, S. M. Lanier, and A. V. Smrcka, Signaling by a non-dissociated complex of G protein ?? and ? subunits stimulated by a receptor-independent activator of G protein signaling, AGS8, J Biol Chem, vol.282, issue.27, pp.19938-19947, 2007.

D. I. Yule, C. W. Baker, and J. A. Williams, Calcium signaling in rat pancreatic acinar cells: a role for Galphaq, Galpha11, and Galpha14, vol.276, pp.271-279, 1999.

S. Zanini, F. Giovinazzo, D. Alaimo, B. Lawrence, R. Pfragner et al., GNA15 expression in small intestinal neuroendocrine neoplasia: Functional and signalling pathway analyses, Cellular Signalling, vol.27, issue.5, pp.899-907, 2015.

J. P. Zepecki, K. M. Snyder, M. M. Moreno, E. Fajardo, A. Fiser et al., Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a Lck targeted inhibitor, Oncogene, vol.38, issue.10, pp.1734-1750, 2019.

J. Zhang, H. Cai, L. Sun, P. Zhan, M. Chen et al., LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/?-catenin pathway and predicts poor survival of glioma patients, J Exp Clin Cancer Res, vol.37, issue.1, p.225, 2018.

J. Zhang, C. Liu, X. Mo, H. Shi, and S. Li, Mechanisms by which CXCR4/CXCL12 cause metastatic behavior in pancreatic cancer, Oncol Lett, vol.15, issue.2, pp.1771-1776, 2018.

J. Zhang, S. Sarkar, and V. W. Yong, The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase, Carcinogenesis, vol.26, issue.12, pp.2069-2077, 2005.

L. Zhang, G. Mu, Q. Ding, Y. Li, Y. Shi et al., Phosphatase and Tensin Homolog (PTEN) Represses Colon Cancer Progression through Inhibiting Paxillin Transcription via PI3K/AKT/NF-?B Pathway, J Biol Chem, vol.290, issue.24, pp.15018-15029, 2015.

P. Zhang, C. M. Kofron, and U. Mende, Heterotrimeric G protein-mediated signaling and its noncanonical regulation in the heart, Life Sci, vol.129, pp.35-41, 2015.

S. Zhang, X. Qiu, Y. Gu, and E. Wang, Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer, Lung Cancer, vol.62, issue.3, pp.295-301, 2008.

S. Zhang, X. Yang, L. Wang, and C. Zhang, Interplay between inflammatory tumor microenvironment and cancer stem cells, Oncol Lett, vol.16, issue.1, pp.679-686, 2018.

Y. Zhang, M. Moschetta, D. Huynh, Y. Tai, Z. Yong et al., Pyk2 promotes tumor progression in multiple myeloma, Blood, vol.124, issue.17, pp.2675-2686, 2014.

Z. Zhang, X. Tan, J. Luo, B. Cui, S. Lei et al., GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF-?B signaling pathway in colorectal cancer cells, Cancer Med, vol.7, issue.11, pp.5611-5620, 2018.

Z. Zhang, Y. Zhang, Z. Mou, S. Chu, X. Chen et al., Tyrosine 402 phosphorylation of Pyk2 is involved in ionomycin-induced neurotransmitter release, PLoS ONE, vol.9, issue.4, p.94574, 2014.

Y. Zhang, Z. Zhang, Y. Liu, X. Zhou, X. Shi et al., Requirement of G?i1/3-Gab1 signaling complex for keratinocyte growth factor-induced PI3K-AKT-mTORC1 activation, J Invest Dermatol, vol.135, issue.1, pp.181-191, 2015.

L. Zhao, Y. Wang, Y. Xue, W. Lv, Y. Zhang et al., Critical roles of chemokine receptor CCR5 in regulating glioblastoma proliferation and invasion, Acta Biochim Biophys Sin (Shanghai), vol.47, issue.11, pp.890-898, 2015.

Y. Zhao and A. A. Adjei, Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor, Oncologist, vol.20, issue.6, pp.660-673, 2015.

J. Zhong, A. Paul, S. J. Kellie, and G. M. O'neill, Mesenchymal migration as a therapeutic target in glioblastoma, J Oncol, p.430142, 2010.

T. Zhou, C. Wang, H. Yan, R. Zhang, J. Zhao et al., Inhibition of the Rac1-WAVE2-Arp2/3 signaling pathway promotes radiosensitivity via downregulation of cofilin-1 in U251 human glioma cells, Mol Med Rep, vol.13, issue.5, pp.4414-4420, 2016.

G. Zhou, Y. J. Song, and P. , Correlation of ERK/MAPK signaling pathway with proliferation and apoptosis of colon cancer cells, Oncol Lett, vol.17, issue.2, pp.2266-2270, 2019.

P. Zhu and J. Zhu, Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives, Chin Clin Oncol, vol.6, issue.4, p.41, 2017.

X. Zhu, Y. Bao, Y. Guo, and W. Yang, Proline-Rich Protein Tyrosine Kinase 2 in Inflammation and Cancer, Cancers (Basel), issue.5, p.10, 2018.

P. Zylbergold, R. Sleno, S. M. Khan, A. M. Jacobi, M. A. Belhke et al., Kir3 channel ontogenythe role of G?? subunits in channel assembly and trafficking, Front Cell Neurosci, vol.8, 2014.